0001493152-23-027997.txt : 20230814 0001493152-23-027997.hdr.sgml : 20230814 20230814063242 ACCESSION NUMBER: 0001493152-23-027997 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSwiss Inc CENTRAL INDEX KEY: 0001652561 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 474215595 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-208083 FILM NUMBER: 231166117 BUSINESS ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 BUSINESS PHONE: (603)2770-4032 MAIL ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 10-Q 1 form10-q.htm
0001652561 false Q2 --12-31 false Yes No 0001652561 2023-01-01 2023-06-30 0001652561 2023-06-30 0001652561 2022-12-31 0001652561 2023-04-01 2023-06-30 0001652561 2022-04-01 2022-06-30 0001652561 2022-01-01 2022-06-30 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 2021-12-31 0001652561 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001652561 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0001652561 us-gaap:CommonStockMember 2023-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001652561 us-gaap:RetainedEarningsMember 2023-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2023-06-30 0001652561 us-gaap:CommonStockMember 2022-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001652561 us-gaap:RetainedEarningsMember 2022-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2022-06-30 0001652561 2022-06-30 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2023-06-30 0001652561 DQWS:DSwissSdnBhdMember country:MY 2023-06-30 0001652561 country:MY DQWS:DSwissBiotechMember 2023-06-30 0001652561 country:HK DQWS:DSwissBiotechMember 2023-01-17 2023-01-18 0001652561 country:HK DQWS:DSwissBiotechMember 2023-01-18 0001652561 DQWS:DSwissHoldingLimitedMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissHKLimitedMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissBiotechSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:ComputerAndSoftwareMember 2023-06-30 0001652561 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001652561 us-gaap:OfficeEquipmentMember 2023-06-30 0001652561 DQWS:MotorVehiclesMember 2023-06-30 0001652561 DQWS:PeriodEndRMMember 2023-06-30 0001652561 DQWS:PeriodEndRMMember 2022-06-30 0001652561 DQWS:PeriodAverageRMMember 2023-06-30 0001652561 DQWS:PeriodAverageRMMember 2022-06-30 0001652561 DQWS:PeriodEndHKMember 2023-06-30 0001652561 DQWS:PeriodEndHKMember 2022-06-30 0001652561 DQWS:PeriodAverageHKMember 2023-06-30 0001652561 DQWS:PeriodAverageHKMember 2022-06-30 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:DSwissHKLimitedMember 2023-01-17 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2023-01-01 2023-06-30 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2023-01-01 2023-06-30 0001652561 country:US 2023-01-01 2023-06-30 0001652561 country:US 2022-01-01 2022-06-30 0001652561 country:SC 2023-01-01 2023-06-30 0001652561 country:SC 2022-01-01 2022-06-30 0001652561 country:HK 2023-01-01 2023-06-30 0001652561 country:HK 2022-01-01 2022-06-30 0001652561 country:MY 2023-01-01 2023-06-30 0001652561 country:MY 2022-01-01 2022-06-30 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-06-30 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2023-06-30 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MinimumMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MaximumMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2023-06-30 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2023-04-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2023-04-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2023-04-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2023-04-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2023-04-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2023-01-01 2023-06-30 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember us-gaap:TradeAccountsReceivableMember 2023-06-30 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember us-gaap:TradeAccountsReceivableMember 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2023-04-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2023-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2023-04-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2023-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2023-04-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2023-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2023-04-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-04-01 2022-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2023-06-30 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2023-01-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-01-01 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2023-01-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-01-01 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2023-01-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-01-01 2022-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2023-01-01 2023-06-30 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2023-01-01 2023-06-30 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyBMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyCMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyAMember 2023-06-30 0001652561 DQWS:NVMember 2023-01-01 2023-06-30 0001652561 DQWS:NVMember 2023-06-30 0001652561 country:SC 2023-06-30 0001652561 country:HK 2023-06-30 0001652561 country:MY 2023-06-30 0001652561 DQWS:NVMember 2022-01-01 2022-06-30 0001652561 DQWS:NVMember 2022-06-30 0001652561 country:SC 2022-06-30 0001652561 country:HK 2022-06-30 0001652561 country:MY 2022-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares DQWS:Integer xbrli:pure iso4217:MYR xbrli:shares iso4217:MYR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended June 30, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________to _______________

 

Commission File Number 333-208083

 

DSwiss, Inc.

(Exact name of registrant issuer as specified in its charter)

 

Nevada   47-4215595
(State or other jurisdiction   (I.R.S. Employer
of incorporation or organization)   Identification No.)

 

Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite,

Avenue 3, Bangsar South, No.8 Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code (603) 2770-4032

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock   DQWS   The OTC Market – Pink Sheets

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).

 

YES ☐ NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☐ Smaller reporting company

Emerging growth company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at June 30, 2023
Common Stock, $.0001 par value   206,904,585

 

 

 

 
 

 

TABLE OF CONTENTS

 

    Page
PART I FINANCIAL INFORMATION  
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:  
  Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 F-2
  Condensed Consolidated Statements of Operations and Comprehensive Income for the Three Months and Six Months Ended June 30, 2023 and 2022 F-3
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Six Months Ended June 30, 2023 F-4
  Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022 F-5
  Notes to the Condensed Consolidated Financial Statements F-6 - F-18
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 2-4
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 5
ITEM 4. CONTROLS AND PROCEDURES 5
PART II OTHER INFORMATION  
ITEM 1 LEGAL PROCEEDINGS 6
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 6
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 6
ITEM 4 MINE SAFETY DISCLOSURES 6
ITEM 5 OTHER INFORMATION 6
ITEM 6 EXHIBITS 6
SIGNATURES 7

 

1

 

 

DSWISS, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Condensed Consolidated Financial Statements  
   
Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 F-2
Condensed Consolidated Statements of Operations and Comprehensive Income for the Three Months and Six Months Ended June 30, 2023 and 2022 F-3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Six Months Ended June 30, 2023 F-4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022 F-5
Notes to the Condensed Consolidated Financial Statements F-6 - F-18

 

F-1

 

 

PART I FINANCIAL INFORMATION

 

Item 1. Unaudited condensed consolidated financial statements:

 

DSWISS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

As of June 30, 2023 and December 31, 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   June 30, 2023   December 31, 2022 
   Unaudited   Audited 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $113,543   $214,269 
Accounts receivable   87,081    17,492 
Other receivables, prepaid expenses and deposit   19,330    21,749 
Tax recoverable   705    745 
Inventories   4,378    7,483 
Total Current Assets   225,037    261,738 
           
NON-CURRENT ASSETS          
Plant and equipment, net   54,472    72,179 
Intangible assets, net   2,932    3,459 
Operating lease right -of-use, net   21,354    44,548 
Total Non-Current Assets   78,758    120,186 
           
TOTAL ASSETS  $303,795   $381,924 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable  $48,092   $29,539 
Other payables and accrued liabilities   137,495    154,710 
Finance lease liability   7,895    16,515 
Operating lease liability   21,354    44,548 
Total Current Liabilities   214,836    245,312 
           
NON- CURRENT LIABILITIES          
Finance lease liability   36,381    38,461 
Total non-current liabilities   36,381    38,461 
           
TOTAL LIABILITIES  $251,217   $283,773 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding   -    - 
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares issued and outstanding as of June 30, 2023 and December 31, 2022 respectively  $20,690   $20,690 
Additional paid-in capital   1,395,426    1,395,426 
Accumulated other comprehensive income/(loss)   26,006    (5,846)
Accumulated deficit   (1,389,544)   (1,324,002)
           
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY  $52,578   $86,268 
NON-CONTROLLING INTEREST   -    11,883 
TOTAL STOCKHOLDERS’ EQUITY   52,578    98,151 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $303,795   $381,924 

 

See accompanying notes to condensed consolidated financial statements.

 

F-2

 

 

DSWISS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME

FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

   2023   2022   2023   2022 
   Three months ended June 30   Six months ended June 30 
   2023   2022   2023   2022 
   $   $   $   $ 
REVENUE   355,274    739,595    621,195    1,187,232 
                     
COST OF REVENUE   (263,561)   (663,012)   (447,498)   (995,387)
                     
GROSS PROFIT   91,713    76,583    173,697    191,845 
                     
OTHER INCOME   1,574    709    3,078    5,393 
                     
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES   (93,259)   (83,902)   (181,058)   (156,241)
                     
OPERATING EXPENSES   (380)   (348)   (794)   (788)
                     
FINANCE COST   (817)   (1,615)   (1,868)   (3,644)
                     
LEASE EXPENSES   (10,670)   (10,564)   (21,646)   (21,437)
                     
(LOSS)/PROFIT BEFORE INCOME TAX   (11,839)   (19,137)   (28,591)   15,128 
                     
TAXATION   (164)   -    (335)   - 
                     
NET (LOSS)/PROFIT   (12,003)   (19,137)   (28,926)   15,128 
Non-Controlling Interest   -    8,281    -    4,924 
Other comprehensive (loss)/income                    
- Foreign currency translation adjustment   (11,054)   (4,327)   31,852    (5,024)
                     
TOTAL COMPREHENSIVE (LOSS)/INCOME   (23,057)   (15,183)   2,926    15,028 
                     
NET (LOSS)/INCOME PER SHARE – BASIC AND DILUTED   (0.0001)   (0.00007)   0.00001    0.000007 
                     
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED   206,904,585    206,904,585    206,904,585    206,904,585 

 

See accompanying notes to condensed consolidated financial statements.

 

F-3

 

 

DSWISS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”))

(unaudited)

 

Six Months Ended June 30, 2023 (Unaudited)

 

   Number of
shares
   Amount  

PAID-IN

CAPITAL

  

COMPREHENSIVE

INCOME/(LOSS)

  

ACCUMULATED

DEFICIT

  

CONTROLLING

INTEREST

  

TOTAL

EQUITY

 
   COMMON STOCK   ADDITIONAL  

ACCUMULATED

OTHER

       NON-     
   Number of
shares
   Amount  

PAID-IN

CAPITAL

  

COMPREHENSIVE

INCOME/(LOSS)

  

ACCUMULATED

DEFICIT

  

CONTROLLING

INTEREST

  

TOTAL

EQUITY

 
Balance as of December 31, 2022 (audited)   206,904,585    20,690    1,395,426    (5,846)   (1,324,002)   11,883    98,151 
Foreign currency translation adjustment   -    -    -    31,852    -    -    31,852 
Changes in ownership interests in an associate   -    -    -    -    (36,616)   (11,883)   (48,499)
Net loss   -    -    -    -    (28,926)   -    (28,926)
Balance as of June 30, 2023 (unaudited)     206,904,585    20,690    1,395,426    26,006    (1,389,544)   -    52,578 

 

Six Months Ended June 30, 2022 (Unaudited)

 

   COMMON STOCK   ADDITIONAL   ACCUMULATED OTHER       NON-     
   Number of
shares
   Amount   PAID-IN
CAPITAL
   COMPREHENSIVE
LOSS
   ACCUMULATED DEFICIT   CONTROLLING INTEREST   TOTAL EQUITY 
                             
Balance as of December 31, 2021 (audited)   206,904,585    20,690    1,395,426    (32,985)   (1,309,711)   589    74,009 
Foreign currency translation adjustment   -    -    -    (5,024)   -    106    (4,918)
Net profit/(loss)   -    -    -    -    20,052    (4,924)   15,128 
Balance as of June 30, 2022 (unaudited)     206,904,585    20,690    1,395,426    (38,009)   (1,289,659)   (4,229)   84,219 

 

F-4

 

 

DSWISS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

   2023   2022 
   Six months ended June 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net (loss)/profit before income tax  $(28,591)  $15,128 
Adjustments to reconcile net (loss)/profit to net cash
(used in)/generated from operating activities:
          
Depreciation and amortization   36,022    37,129 
Amortization for intangible assets   514    515 
Changes in operating assets and liabilities:          
Accounts payable   20,150    24,332 
Accounts receivable   (70,535)   (27,479)
Other payables and accrued liabilities   (11,582)   (3,917)
Inventories   2,700    4,490 
Other receivables, prepaid expenses and deposits   1,243    3,361 
Lease liabilities   (20,786)   (21,612)
Right of use   -    761 
Tax payable   -    340 
Cash (used in)/generated from operations   (70,865)   33,048 
Tax paid   (335)   (494)
Reversal of deferred tax liabilities   -    (1,927)
Net cash (used in)/generated from operating activities   (71,200)   30,627 
           
CASH FLOWS FROM INVESTING ACTIVITY:          
Purchase of plant and equipment   -    (6,903)
Net cash used in investing activity   -    (6,903)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayment of finance lease   (7,727)   (7,690)
Net cash used in financing activities   (7,727)   (7,690)
           
Effect of exchange rate changes on cash and cash equivalent   (21,799)   (12,424)
           
Net (decrease)/increase in cash and cash equivalents   (100,726)   3,610 
Cash and cash equivalents, beginning of period   214,269    234,546 
CASH AND CASH EQUIVALENTS, END OF PERIOD  $113,543   $238,156 
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $(335)  $(494)
Interest paid  $(414)  $(433)

 

See accompanying notes to condensed consolidated financial statements.

 

F-5

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

1. DESCRIPTION OF BUSINESS AND ORGANIZATION

 

DSwiss, Inc. is organized as a Nevada limited liability company, incorporated on May 28, 2015. For the purposes of financial statement presentation, DSwiss, Inc. and its subsidiaries are herein referred to as “the Company” or “we”. The principal activity of the Company is premier biotech-nutraceutical, beauty supplies, and medical consumables supplies. The Company sells medical consumable supplies, food supplements, skincare, and other related beauty products in Malaysia and around the ASEAN region. We are globally recognized Turnkey Private Label Manufacturing Services for nutraceutical and skincare OEM/ODM products.

 

Our professionals manage from custom formulation of scientifically proven and naturally effective, sourcing raw materials, production, quality control, stability, and safety test, clinical testing by third-party labs, packaging, and shipping, including import and export.

 

Our manufacturing facilities which compliant with GMP (Good Manufacturing Practise), FDA (Food Drug Association), HACCP (Hazard Analysis and Critical Control Point), JAKIM HALAL, and Mesti.

 

The accompanying unaudited condensed consolidated financial statements of DSwiss, Inc. at June 30, 2023 and 2022 have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial statements, instructions to Form 10-Q, and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2022. In management’s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make our financial statements not misleading have been included. The results of operations for the periods ended June 30, 2023 and 2022 presented are not necessarily indicative of the results to be expected for the full year. The December 31, 2022 balance sheet has been derived from our audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2022.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

   Company name  Place and date
of incorporation
  Particulars of issued
capital
  Principal activities  Proportional
of ownership interest
and voting power
held
 
                 
1.  DSwiss Holding Limited  Seychelles, May 28, 2015  1 share of ordinary share of US$1 each  Investment holding   100%
                  
2.  DSwiss (HK) Limited  Hong Kong, May 28, 2015  1 share of ordinary share of HK$1 each  Supply of beauty products   100%
                  
3.  DSwiss Sdn Bhd  Malaysia, March 10, 2011  2 shares of ordinary share of RM 1 each  Supply of beauty products   100%
                  
4.  DSwiss Biotech Sdn Bhd  Malaysia, March 17, 2016  250,000 shares of ordinary share of RM 1 each  Supply of biotech products   100%

 

F-6

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the period ended June 30, 2023, the Company incurred a net loss of $28,926, suffered an accumulated deficit of $1,389,544 and negative operating cash flow of $71,200. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stock holders, in the case of equity financing.

 

Basis of presentation

 

The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables product are sold and accepted by the customers and there are no continuing obligations to the customer.

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

F-7

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Cash and cash equivalents

 

The Company consider all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalent.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

  

Classification   Estimated useful lives
Computer and software   5 years
Furniture and fittings   5 years
Office equipment   10 years
Motor vehicle   5 years

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong, which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the six months ended June 30, 2023.

 

Leases

 

Prior to November 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective November 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods (see Note 10).

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

F-8

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Net income/(loss) per share

 

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia and Hong Kong maintains their books and record in their local currency, Ringgits Malaysia (“RM”) and Hong Kong Dollars (“HK$”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the six months ended
June 30,
 
   2023   2022 
         
Period-end RM : US$1 exchange rate   4.67    4.41 
Period-average RM : US$1 exchange rate   4.45    4.29 
Period-end HK$ : US$1 exchange rate   7.84    7.85 
Period-average HK$ : US$1 exchange rate   7.84    7.83 

 

F-9

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts receivable, deposits, accounts payable, other payables, and accounts payable approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

Level 1: Observable inputs such as quoted prices in active markets;

 

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Segment reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. For the six months ended June 30, 2023, the Company operates in three reportable operating segments in Malaysia and Hong Kong.

 

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.

 

Recently Issued Accounting Standard

 

The Company reviews new accounting standards as issued. Management has not identified any other new standards that is believes will have a significant impact on the Company’s financial statements.

 

F-10

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

3. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

F-11

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

4. STOCKHOLDERS’ EQUITY

 

As of June 30, 2023, the Company had a total of 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 

5. PLANT AND EQUIPMENT

   

June 30,

2023

   

December 31,

2022

 
Computer and software   $ 105,535     $ 105,535  
Furniture and fittings     6,144       6,144  
Office equipment     21,152       21,152  
Motor vehicle     135,868       135,868  
Total plant and equipment   $ 268,699     $ 268,699  
Accumulated depreciation     (201,612 )     (187,236 )
Effect of translation exchange     (12,615 )     (9,284 )
Plant and equipment, net   $ 54,472     $ 72,179  

 

Depreciation expense for the three months and six months ended June 30, 2023 were $6,839 and $14,376 respectively.

 

Depreciation expense for the three months and six months ended June 30, 2022 were $8,191 and $15,692 respectively.

 

6. INTANGIBLE ASSETS

 

  

June 30,

2023

  

December 31,

2022

 
Trademarks  $12,077   $12,077 
Amortization   (8,678)   (8,164)
Effect of translation exchange   (467)   (454)
Intangible assets, net  $2,932   $3,459 

 

Amortization for the three months and six months ended June 30, 2023 was $257 and $514 respectively.

 

Amortization for the three months and six months ended June 30, 2022 was $257 and $515 respectively.

 

7. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

  

June 30,

2023

  

December 31,

2022

 
Other receivables  $66   $- 
Prepaid expenses   658    2,080 
Deposits   18,606    19,669 
Total prepaid expenses and deposits  $19,330   $21,749 

 

8. INVENTORIES

 

  

June 30,

2023

  

December 31,

2022

 
Finished goods, at cost  $4,378   $7,483 
Total inventories  $4,378   $7,483 

 

9. OTHER PAYABLES AND ACCRUED LIABILITIES

 

  

June 30,

2023

  

December 31,

2022

 
Other payables  $86,508   $100,385 
Accrued audit fees   25,636    20,266 
Accrued other expenses   12,864    16,683 
Accrued professional fees   12,487    17,376 
Total payables and accrued liabilities  $137,495   $154,710 

 

F-12

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

10. FINANCE LEASE LIABILITY

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

   As of June 30,
2023
   As of December 31,
2022
 
Finance lease  $46,876   $58,768 
Less: interest expense   (2,600)   (3,792)
Net present value of finance lease   44,276    54,976 
           
Current portion   7,895    16,515 
Non-current portion   36,381    38,461 
Total  $44,276   $54,976 

 

As of June 30, 2023 the maturities of the finance lease for each of the years are as follows:

 

      
2023   7,895 
2024   16,291 
2025   12,441 
2026   7,649 
Total  $44,276 

 

F-13

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

11. INCOME TAXES

 

For the six months ended June 30, 2023 and 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
         
Tax jurisdictions from:          
- Local  $(35,199)  $(20,770)
- Foreign, representing          
Seychelles   (3,178)   (2,169)
Hong Kong   (3,540)   (2,064)
Malaysia   13,326    40,131 
           
(Loss)/Profit before income tax  $(28,591)  $15,128 

 

The provision for income taxes consisted of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
Current:              
- Local  $-   $- 
- Foreign   (335)   - 
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(335)  $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Seychelles, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2023, the operations in the United States of America incurred $507,350 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $106,544 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of June 30, 2023, the operations in the Hong Kong incurred $634,643 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,716 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Malaysia

 

DSwiss Sdn. Bhd. and DSwiss Biotech Sdn. Bhd. are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 15% to 24% on its assessable income. As of June 30, 2023, the operations in the Malaysia incurred $203,977 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 15%. The Company has provided for a full valuation allowance of $30,597 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

F-14

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

12. CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a) Major customers

 

For three months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenue  

Percentage of

revenue

   Accounts receivable 
                         
Customer A  $-   $346,253    -%   46%  $-   $- 
Customer B  $91,754   $155,407    25%   21%  $30,849   $6,843 
Customer C  $50,196   $-    14%   -%  $27,475   $- 
Customer D  $85,002   $-    24%   -%  $-   $- 
   $  226,952   $  501,660    63%   67%  $58,324   $6,843 

 

For six months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenues  

Percentage of

revenues

  

Accounts receivable,

trade

 
                         
Customer A  $63,861   $-    10%   -%  $-   $- 
Customer B  $-   $416,432    -%   35%  $-   $- 
Customer C  $127,102   $255,238    20%   21%  $30,849   $6,843 
Customer D  $100,392   $-    16%   -%  $27,475   $- 
Customer E  $147,848   $-    24%   -%  $-   $- 
   $ 439,203   $671,670    70%   56%  $58,324   $6,843 

 

(b) Major vendors

 

For three months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchase

   Accounts payable 
                         
Vendor A  $51,367   $304,423    19%   45%  $-   $- 
Vendor B  $75,546   $131,132    29%   19%  $3,722   $- 
Vendor C  $71,478   $88,841    27%   13%  $38,604   $26,426 
   $ 198,391   $ 524,396    75%   77%  $42,326   $26,426 

 

For six months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchases

  

Accounts payable,

trade

 
                         
Vendor A  $74,870   $407,162    17%   45%  $-   $- 
Vendor B  $166,206   $187,012    37%   19%  $3,722   $- 
Vendor C  $95,572   $159,895    21%   13%  $38,604   $26,426 
   $ 336,648   $ 754,069    75%   77%  $42,326   $26,426 

 

All vendors are located in Malaysia.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its accounts receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate actually post higher or lower income depending on exchange rate of RM converted to US$ and HK$ converted into US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

F-15

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

13. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$92,606, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.4% adopted from Public Bank Berhad’s base lending rate as a reference for discount rate.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The operating lease right and lease liability as follow:

 

As of June 30, 2023 and December 31, 2022, operating lease right of use asset as follow:

 

   As of June 30, 2023   As of December 31, 2022 
As of beginning of the period/year  $44,548   $92,606 
Accumulated amortization   (21,646)   (42,310)
Effect of translation exchange   (1,548)   (5,748)
Balance as of end of the period/year  $21,354   $44,548 

 

As of June 30, 2023 and December 31, 2022, the amortization of the operating lease right of use asset are $21,646 and $42,310 respectively.

 

F-16

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

As of June 30, 2023, operating lease liability as follow:

 

As of January 1, 2023  $44,548 
Less: gross repayment   (22,488)
Add: imputed interest   842 
Effect of translation exchange   (1,548)
Balance as of June 30, 2023  $21,354 
Less: lease liability current portion   (21,354)
Lease liability non-current portion  $- 

 

Maturities of operating lease obligation as follow:

 

Year ending     
December 31, 2023   21,354 
Total  $21,354 

 

Other information:

 

   As of June 30, 2023   As of December 31, 2022 
   (unaudited)   (audited) 
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flow from operating lease  $20,786   $42,212 
Right-of-use assets obtained in exchange for operating lease liabilities   21,354    44,548 
Remaining lease term for operating lease (years)   0.5    1 
Weighted average discount rate for operating lease   5.4%   5.4%

 

As of June 30, 2023 and December 31, 2022, lease expenses were $21,646 and $42,310 respectively.

 

14. RELATED PARTY TRANSACTIONS

 

For the period ended June 30, 2023 the Company has the following transactions with related party:

 

  

For the period ended

June 30,

2023

(Unaudited)

  

For the period ended

June 30,

2022

(Unaudited)

 
Professional Fees:          
- Related party A  $3,000   $3,000 
           
Sales          
- Related party B  $127,102   $255,239 
- Related party C   45,150    7,572 
           
Total  $175,252   $265,811 

 

The related party A, is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director and shareholder is the founder of the Company.

 

The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

15. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

F-17

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $621,195   $621,195 
Cost of revenues   -    -    -    (447,498)   (447,498)
Depreciation and amortization   -    -    (514)   (36,022)   (36,536)
Net (loss)/profit before taxation   (35,199)   (3,178)   (3,540)   13,326    (28,591)
                          
Total assets  $14,274   $21,998   $13,209   $254,314   $303,795 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $1,187,232   $1,187,232 
Cost of revenues   -    -    -    (995,387)   (995,387)
Depreciation and amortization   -    -    (515)   (37,129)   (37,644)
Net (loss)/profit before taxation   (20,770)   (2,169)   (2,064)   40,131    15,128 
                          
Total assets  $27,187   $7,055   $14,711   $404,780   $453,733 

 

* Revenues and costs are attributed to countries based on the location of customers.

 

16. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2023 up through the date the Company issued the consolidated financial statements.

 

F-18

 

 

Item 2. Management’s discussion and analysis of financial condition and results of operations

 

The information contained in this quarter report on Form 10-Q is intended to update the information contained in our Annual Report on Form 10-K for the year ended December 31, 2022 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.

 

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our Form S-1 Amendment No.8, dated July 20, 2016 in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited Condensed Consolidated Financial Statements and notes thereto that appear elsewhere in this report.

 

Company Overview

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015. DSwiss Holding Limited owns 100% of DSwiss (HK) Limited, a Hong Kong Company, which owns 100% of DSwiss Sdn Bhd, the operating Malaysia Company of which is described below. In 2016, DSwiss (HK) Limited invested in DSwiss Biotech Sdn Bhd, incorporated in Malaysia, and owned 40% equity interest.

 

DSwiss is the leading corporation for premier nutraceutical biotechnology in USA, and has gone into Asian countries such as China, Hong Kong, Singapore, Thailand, and Malaysia with our high quality functional health supplement, skin care solution, wellness products and private labelled supplies turnkey provider (OEM/ODM). Our unique and innovative patented biotechnology, natural ingredients into products & services that has been proven to give better, faster and visible positive results to the end user including health improvement, slimming, anti-aging and beauty effects.

 

Currently, we are fulfilling in Talent Development, product research and development, and providing Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services into functional food and beauty product of which is currently under research and development with Malaysia biotech and research professionals. Our professionals manage from custom formulation of scientifically-proven and naturally-effective, sourcing raw materials, production, quality control, stability and safety test, clinical testing by third-party labs, packaging and shipping including import and export, all licenses needed so customer can concentrate on what they should do. In 2020, with our experience and expertise, we have successfully expanded our client base in OEM/ODM services and developed products and Business-to-business (B2B) DNA genotyping private label services that exceed the clients’ expectation.

 

DSwiss has continuously expanding through launching health and beauty projects to provide premier experiences to the customers. DSwiss has shown a solid growth and is set to advance the biotechnology industry to drive nutraceutical and skincare biotechnology growth.

 

At this time, we operate exclusively online through our website: http://www.dswissbeauty.com.

 

Products which meet the definition of a functional food and cosmetics related products need to be registered or notified with the Drug Control Authority (DCA), Ministry of Health Malaysia. Manufacturing, marketing, importation and the sale of unregistered products is a violation of the Drug Control Regulations and Cosmetics Act 1984 of Malaysia and enforcement action can be taken.

 

At DSwiss, research and development is an ongoing effort whose purpose is to ensure our products on the forefront of quality and effectiveness. Equipped with state of the art machinery, our innovative research and development team are constantly exploring on new development and product lines that will enable us to provide the highest quality standard and remain competitive in the industry.

 

DSwiss’s products are certified and approved by the Ministry of Health (“MOH”) Malaysia. Due to the stringent requirements from MOH Malaysia, we strive to upkeep the highest possible standard in our products to provide assurance and as a prove of our continuing commitment to providing quality products.

 

Our expected growth is planned to occur primarily through the implementation of our social media marketing strategy. DSwiss already has a strong relationship with new retail tech company (eg. Facebook, E-Marketplace). The global presence social media has helped provide to us has been an invaluable resource, and as we continue to expand our business operations and spread our brand awareness, we intend to primarily utilize social media to reach our customers. The benefits of social media are countless, but perhaps the most imperative to our future success is our ability to connect with customers directly, to receive their feedback almost instantaneously. On that note, the feedback we have received from our clients has been overwhelmingly positive, which has helped us to create a robust brand image.

 

While DSwiss has been focused almost exclusively upon pursuing operations within Asia, we do have plans to expand outward and become a household name across the world. Our strategy to do so going forward is by forming partnerships with local companies in various countries that may be willing to stock our products or promote them to their own customers. We believe that by forging strategic relationships and partnerships we can expand our operations across the globe at a greater pace and with greater certainty than we would if we tried to expand on our own.

 

Results of Operation

 

For the Three Months and Six Months Ended June 30, 2023 and June 30, 2022.

 

For the three and six months ended June 30, 2023, we realized revenue in the amount of $355,274 and $621,195, while for the three and six months ended June 30, 2022, we realized revenues in the amount of $739,595 and $1,187,232. Our gross profits for the three and six months ended June 30, 2023 were $91,713 and $173,697, which is more than $15,130 for the three months ended June 30, 2022 but less than $18,148 for the six months ended June 30, 2022. We believe that in order to retain and maintain more customers in the future we must increase our marketing efforts and or develop new products.

 

2

 

 

*Our gross margins may not be comparable to those of other entities, since some entities include all the costs related to their distribution network in cost of revenue. Our cost of revenue includes only the purchase cost of products and packing materials, and does not include any allocation of inbound freight charges, purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs, and the other costs associated with the distribution network.

 

Our net loss for the three and six months ended June 30, 2023 were $12,003 and $28,926 respectively, while the net loss for three months ended June 30, 2022 was $19,137 and net profit for six months ended June 30, 2022 was $15,128.

 

Liquidity and Capital Resources

 

For the six months ended June 30, 2023 and 2022, we had cash and cash equivalents of $113,543 and $238,156 respectively. We have negative operating cash flow and we need to meet our working capital requirements to make capital investments in connection with ongoing operations. The Company expects its current capital resources to meet our basic operating requirements for approximately twelve months.

 

Operating Activities

 

For the six months ended June 30, 2023, net cash used in operating activities was $71,200, compared to net cash generated from operating activities was $30,627 in the prior period. The operating cash flow performance primarily reflects decrease in accounts payable, other payables and accrued liabilities to the prior period.

 

Investing Activities

 

For the six months ended June 30, 2023 and 2022, net cash used in investing activities were $0 and $6,903 respectively, reflecting the cost in purchase of plant and equipment.

 

Financing Activities

 

For the six months ended June 30, 2023 and 2022, net cash used in financing activities were $7,727 and $7,690 respectively resulted from the repayment of finance lease.

 

Capital Expenditures

 

Our capital expenditures primarily relate to the acquisition of plant and equipment. There were $0 and $6,903 used to purchase the computer and software and office equipment for the six months periods ended June 30, 2023 and 2022 respectively.

 

Credit Facilities

 

We do not have any credit facilities or other access to bank credit.

 

Contractual Obligations, Commitments and Contingencies

 

We currently have a lease agreement in place with respect to office premises in Malaysia to commence our business operations.

 

Off-balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders as of June 30, 2023.

 

3

 

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

Additional Information

 

VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request ad hoc quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(iii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

4

 

 

Item 3 Quantitative and Qualitative Disclosures About Market Risk.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 4 Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures:

 

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2016. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2023, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of June 30, 2023, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

 

Changes in Internal Control over Financial Reporting:

 

There were no changes in our internal control over financial reporting during the quarter ending June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

5

 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We know of no material, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest adverse to us.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

ITEM 6. Exhibits

 

Exhibit No.   Description
31.1   Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
32.1   Section 1350 Certification of principal executive officer *
101.INS   Inline XBRL Instance Document*
101.SCH   Inline XBRL Schema Document*
101.CAL   Inline XBRL Calculation Linkbase Document*
101.DEF   Inline XBRL Definition Linkbase Document*
101.LAB   Inline XBRL Label Linkbase Document*
101.PRE   Inline XBRL Presentation Linkbase Document*
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

6

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DSWISS, INC.
  (Name of Registrant)
     
Date: August 14, 2023    
     
  By: /s/ Leong Ming Chia
  Title:

President, Chief Executive Officer,

Chief Financial Officer, Treasurer, Secretary and Director

    (Principal Executive Officer, Principal Financial Officer)

 

7

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, LEONG MING CHIA, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of DSwiss, Inc. (the “Company”) for the quarter ended June 30, 2023;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and

15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023 By: /s/ Leong Ming Chia
    LEONG MING CHIA
   

President, Chief Executive Officer,

Chief Financial Officer, Treasurer, Secretary and Director

    (Principal Executive Officer, Principal Financial Officer)

 

 

 

EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of DSwiss, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 14, 2023 By: /s/ Leong Ming Chia
    LEONG MING CHIA
   

President, Chief Executive Officer,

Chief Financial Officer, Treasurer, Secretary and Director

    (Principal Executive Officer, Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

EX-101.SCH 4 dqws-20230630.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - FINANCE LEASE LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - CONCENTRATIONS OF RISK link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - FINANCE LEASE LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - CONCENTRATIONS OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SEGMENTED INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - FINANCE LEASE LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 dqws-20230630_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 dqws-20230630_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 dqws-20230630_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Investment, Name [Axis] DSwiss Holding Limited [Member] Geographical [Axis] HONG KONG DSwiss Sdn Bhd [Member] MALAYSIA DSwiss Biotech Sdn Bhd [Member] Legal Entity [Axis] DSwiss HK Limited [Member] DSwiss Biotech Sdn Bhd [Member] Long-Lived Tangible Asset [Axis] Computer and Software [Member] Furniture and Fixtures [Member] Office Equipment [Member] Motor Vehicles [Member] Award Type [Axis] Period End RM [Member] Period Average RM [Member] Period-end HK [Member] Period Average HK [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Management Services Agreement I [Member] Ownership [Axis] First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] UNITED STATES SEYCHELLES Income Tax Authority, Name [Axis] United States of America [Member] Hong Kong [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Malaysia [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer A [Member] Accounts Receivable [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customers [Member] Receivable Type [Axis] Trade Accounts Receivable [Member] Customer E [Member] Cost of Goods and Service Benchmark [Member] Supplier Concentration Risk [Member] Vendor A [Member] Accounts Payable [Member] Vendor B [Member] Vendor C [Member] Vendors [Member] Accounting Standards Update [Axis] Accounting Standards Update 2016-02 [Member] Related Party Transaction [Axis] Related Party A [Member] Related Party B [Member] Related Party C [Member] NV [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable Other receivables, prepaid expenses and deposit Tax recoverable Inventories Total Current Assets NON-CURRENT ASSETS Plant and equipment, net Intangible assets, net Operating lease right -of-use, net Total Non-Current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Other payables and accrued liabilities Finance lease liability Operating lease liability Total Current Liabilities NON- CURRENT LIABILITIES Finance lease liability Total non-current liabilities TOTAL LIABILITIES STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares issued and outstanding as of June 30, 2023 and December 31, 2022 respectively Additional paid-in capital Accumulated other comprehensive income/(loss) Accumulated deficit TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY NON-CONTROLLING INTEREST TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE COST OF REVENUE GROSS PROFIT OTHER INCOME SELLING, GENERAL AND ADMINISTRATIVE EXPENSES OPERATING EXPENSES FINANCE COST LEASE EXPENSES (LOSS)/PROFIT BEFORE INCOME TAX TAXATION NET (LOSS)/PROFIT Non-Controlling Interest Other comprehensive (loss)/income - Foreign currency translation adjustment TOTAL COMPREHENSIVE (LOSS)/INCOME Net (loss)/ income per share, basic Net (loss)/ income per share, diluted Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Statement [Table] Statement [Line Items] Balance Balance, shares Foreign currency translation adjustment Changes in ownership interests in an associate Net profit/(loss) Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net (loss)/profit before income tax Adjustments to reconcile net (loss)/profit to net cash (used in)/generated from operating activities: Depreciation and amortization Amortization for intangible assets Changes in operating assets and liabilities: Accounts payable Accounts receivable Other payables and accrued liabilities Inventories Other receivables, prepaid expenses and deposits Lease liabilities Right of use Tax payable Cash (used in)/generated from operations Tax paid Reversal of deferred tax liabilities Net cash (used in)/generated from operating activities CASH FLOWS FROM INVESTING ACTIVITY: Purchase of plant and equipment Net cash used in investing activity CASH FLOWS FROM FINANCING ACTIVITIES: Repayment of finance lease Net cash used in financing activities Effect of exchange rate changes on cash and cash equivalent Net (decrease)/increase in cash and cash equivalents Cash and cash equivalents, beginning of period CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid Accounting Policies [Abstract] DESCRIPTION OF BUSINESS AND ORGANIZATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] VIE STRUCTURE AND ARRANGEMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY Property, Plant and Equipment [Abstract] PLANT AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Inventory Disclosure [Abstract] INVENTORIES Payables and Accruals [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Finance Lease Liability FINANCE LEASE LIABILITY Income Tax Disclosure [Abstract] INCOME TAXES Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISK Leases [Abstract] LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Segment Reporting [Abstract] SEGMENTED INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Going Concern Basis of presentation Basis of consolidation Use of estimates Revenue recognition Cost of revenue Selling and distribution expenses Cash and cash equivalents Inventories Plant and equipment Intangible assets Leases Income taxes Net income/(loss) per share Foreign currencies translation Related parties Fair value of financial instruments Segment reporting Recently Adopted Accounting Standards Recently Issued Accounting Standard SCHEDULE OF VARIABLE INTEREST ENTITY SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE SCHEDULE OF FOREIGN CURRENCIES TRANSLATION SCHEDULE OF PLANT AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS SCHEDULE OF INVENTORIES SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES SCHEDULE OF OBLIGATION UNDER FINANCE LEASE SCHEDULE OF MATURITIES OF FINANCE LEASE SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES SCHEDULE OF PROVISION FOR INCOME TAXES SCHEDULE OF CONCENTRATION OF RISK SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS SCHEDULE OF OPERATING LEASE LIABILITY SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION SCHEDULE OF OPERATING LEASE OTHER INFORMATION SCHEDULE OF RELATED PARTY TRANSACTION SCHEDULE OF REPORTING SEGMENTS Company name Place of incorporation Date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Equity ownership interest rate percentage Stock issued during period, shares, new issues Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, estimated useful lives Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Foreign currency exchange rate, translation Net income loss Accumulated deficit Cash used in operations Intangible asset, useful life Impairment loss Largest amount of tax benefit, description Number of reportable operating segment Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Percentage of annual net profit to be received as fee Number of shares, acquired Equity ownership interest rate percentage Consideration price per share Common stock shares issued Common stock shares outstanding Preferred stock shares issued Preferred stock shares outstanding Total plant and equipment Accumulated depreciation Effect of translation exchange Plant and equipment, net Depreciation expense Trademarks Amortization Effect of translation exchange Intangible assets, net Amortization of intangible assets Other receivables Prepaid expenses Deposits Total prepaid expenses and deposits Finished goods, at cost Total inventories Other payables Accrued audit fees Accrued other expenses Accrued professional fees Total payables and accrued liabilities Schedule Of Obligation Under Finance Lease Finance lease Less: interest expense Total Current portion Non-current portion Schedule Of Maturities Of Finance Lease 2023 2024 2025 2026 Total Finance lease, description (Loss)/Profit before income tax Current: - Local - Foreign Deferred: - Local - Foreign Income tax expense Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Cumulative net operating losses Income tax rate Net operating loss carryforwards expiration Valuation allowance Statutory income tax, rate Concentration Risk [Table] Concentration Risk [Line Items] Revenues Concentration risk, percentage Accounts receivable, trade Purchases Account Payable, Trade Operating lease right of use asset Accumulated amortization Effect of translation exchange Operating lease right of use asset, ending Operating lease liability, beginning Less: gross repayment Add: imputed interest Effect of translation exchange Operating lease liability, ending Less: lease liability current portion Lease liability non-current portion December 31, 2023 Total Operating cash flow from operating lease Right-of-use assets obtained in exchange for operating lease liabilities Remaining lease term for operating lease (years) Weighted average discount rate for operating lease Lease liability Lease asset- right of use Discount rate of lease payment Operating lease right of use asset, amortization Lease expenses Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Professional Fees Sales Total Ownership percentage Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Cost of revenues Depreciation and amortization Net (loss)/profit before taxation Assets Accrued audit fees current. First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] Finance expenses. Net income (loss) attributable to minority interest. United States of America [Member] DSwiss HK Limited [Member] Hong Kong [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Malaysia [Member] Customer A [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customers [Member] Customer E [Member] Customer F [Member] Noncontrolling interest changes in ownership interests in associate. Vendor A [Member] Vendor B [Member] Vendor C [Member] Vendors [Member] Effect of translation exchange of operating lease right of use asset. Schedule Of Operating Lease Liability Disclosure [Text Block] Effect of translation exchange of operating lease liability. Increase decrease in reduction in lease liability. Taxation paid. Schedule of Operating Lease Other Information [Table Text Block] Related Party A [Member] Related Party B [Member] Related Party C [Member] NV [Member] DSwiss Holding Limited [Member] DSwiss Sdn Bhd [Member] DSwiss Biotech Sdn, Bhd [Member] Place of incorporation. Particulars of Issued Capital. DSwiss Biotech Sdn Bhd [Member] Summary of Property and Equipment Useful Life [Table Text Block] Computer and Software [Member] Motor Vehicles [Member] Period End RM [Member] Period Average RM [Member] Period-end HK [Member] Period Average HK [Member] Related Parties [PolicyTextBlock] Schedule Of Obligation Under Finance Lease [Table Text Block] Increase decrease right of use. Increase decrease in lease liability. Increase decrease in right of use. Going Concern [Policy Text Block] Recently Adopted Accounting Standards Policy [PolicyTextBlock] Recently Issued Accounting Standard Policy [PolicyTextBlock] Percentage of annual net profit to be received as fee. Management Services Agreement I [Member] Effect of translation exchange. Intangible assets, Effect of translation exchange. Recently Adopted Accounting Standards [Policy Text Block] Recently Issued Accounting Standard[Policy Text Block] DSwiss Biotech Sdn Bhd [Member] [Default Label] Assets, Current Assets, Noncurrent Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Revenue Gross Profit Selling, General and Administrative Expense FinanceExpenses Operating Lease, Expense Income Tax Expense (Benefit) NetIncomeLossAttributableToMinorityInterest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities, Continuing Operations TaxationPaid Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Income Taxes Paid, Net Interest Paid, Excluding Capitalized Interest, Operating Activities Equity [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Subsidiary, Ownership Percentage, Parent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment EffectOfTranslationExchange Finite-Lived Intangible Assets, Accumulated Amortization IntangibleAssetsEffectOfTranslationExchange Finance Lease, Liability, Undiscounted Excess Amount Current Foreign Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Operating Lease, Payments EffectOfTranslationExchangeOfOperatingLeaseLiability Lessee, Operating Lease, Liability, to be Paid Related Party Transaction, Amounts of Transaction Depreciation, Depletion and Amortization EX-101.PRE 8 dqws-20230630_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
6 Months Ended
Jun. 30, 2023
shares
Cover [Abstract]  
Document Type 10-Q
Amendment Flag false
Document Quarterly Report true
Document Transition Report false
Document Period End Date Jun. 30, 2023
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2023
Current Fiscal Year End Date --12-31
Entity File Number 333-208083
Entity Registrant Name DSwiss, Inc.
Entity Central Index Key 0001652561
Entity Tax Identification Number 47-4215595
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite
Entity Address, Address Line Two Avenue 3, Bangsar South
Entity Address, Address Line Three No.8 Jalan Kerinchi
Entity Address, City or Town Kuala Lumpur
Entity Address, Country MY
Entity Address, Postal Zip Code 59200
City Area Code (603)
Local Phone Number 2770-4032
Title of 12(b) Security Common Stock
Trading Symbol DQWS
Entity Current Reporting Status Yes
Entity Interactive Data Current No
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 206,904,585
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash and cash equivalents $ 113,543 $ 214,269
Accounts receivable 87,081 17,492
Other receivables, prepaid expenses and deposit 19,330 21,749
Tax recoverable 705 745
Inventories 4,378 7,483
Total Current Assets 225,037 261,738
NON-CURRENT ASSETS    
Plant and equipment, net 54,472 72,179
Intangible assets, net 2,932 3,459
Operating lease right -of-use, net 21,354 44,548
Total Non-Current Assets 78,758 120,186
TOTAL ASSETS 303,795 [1] 381,924
CURRENT LIABILITIES    
Accounts payable 48,092 29,539
Other payables and accrued liabilities 137,495 154,710
Finance lease liability 7,895 16,515
Operating lease liability 21,354 44,548
Total Current Liabilities 214,836 245,312
NON- CURRENT LIABILITIES    
Finance lease liability 36,381 38,461
Total non-current liabilities 36,381 38,461
TOTAL LIABILITIES 251,217 283,773
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares issued and outstanding as of June 30, 2023 and December 31, 2022 respectively 20,690 20,690
Additional paid-in capital 1,395,426 1,395,426
Accumulated other comprehensive income/(loss) 26,006 (5,846)
Accumulated deficit (1,389,544) (1,324,002)
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY 52,578 86,268
NON-CONTROLLING INTEREST 11,883
TOTAL STOCKHOLDERS’ EQUITY 52,578 98,151
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 303,795 $ 381,924
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 600,000,000 600,000,000
Common stock, shares issued 206,904,585 206,904,585
Common stock, shares outstanding 206,904,585 206,904,585
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
REVENUE $ 355,274 $ 739,595 $ 621,195 [1] $ 1,187,232 [1]
COST OF REVENUE (263,561) (663,012) (447,498) [1] (995,387) [1]
GROSS PROFIT 91,713 76,583 173,697 191,845
OTHER INCOME 1,574 709 3,078 5,393
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (93,259) (83,902) (181,058) (156,241)
OPERATING EXPENSES (380) (348) (794) (788)
FINANCE COST (817) (1,615) (1,868) (3,644)
LEASE EXPENSES (10,670) (10,564) (21,646) (21,437)
(LOSS)/PROFIT BEFORE INCOME TAX (11,839) (19,137) (28,591) [1] 15,128 [1]
TAXATION (164) (335)
NET (LOSS)/PROFIT (12,003) (19,137) (28,926) 15,128
Non-Controlling Interest 8,281 4,924
Other comprehensive (loss)/income        
- Foreign currency translation adjustment (11,054) (4,327) 31,852 (5,024)
TOTAL COMPREHENSIVE (LOSS)/INCOME $ (23,057) $ (15,183) $ 2,926 $ 15,028
Net (loss)/ income per share, basic $ (0.0001) $ (0.00007) $ 0.00001 $ 0.000007
Net (loss)/ income per share, diluted $ (0.0001) $ (0.00007) $ 0.00001 $ 0.000007
Weighted average number of common shares outstanding, basic 206,904,585 206,904,585 206,904,585 206,904,585
Weighted average number of common shares outstanding, diluted 206,904,585 206,904,585 206,904,585 206,904,585
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2021 $ 20,690 $ 1,395,426 $ (32,985) $ (1,309,711) $ 589 $ 74,009
Balance, shares at Dec. 31, 2021 206,904,585          
Foreign currency translation adjustment (5,024) 106 (4,918)
Net profit/(loss) 20,052 (4,924) 15,128
Balance at Jun. 30, 2022 $ 20,690 1,395,426 (38,009) (1,289,659) (4,229) 84,219
Balance, shares at Jun. 30, 2022 206,904,585          
Balance at Dec. 31, 2022 $ 20,690 1,395,426 (5,846) (1,324,002) 11,883 98,151
Balance, shares at Dec. 31, 2022 206,904,585          
Foreign currency translation adjustment 31,852 31,852
Changes in ownership interests in an associate (36,616) (11,883) (48,499)
Net profit/(loss) (28,926) (28,926)
Balance at Jun. 30, 2023 $ 20,690 $ 1,395,426 $ 26,006 $ (1,389,544) $ 52,578
Balance, shares at Jun. 30, 2023 206,904,585          
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss)/profit before income tax [1] $ (28,591) $ 15,128
Adjustments to reconcile net (loss)/profit to net cash (used in)/generated from operating activities:    
Depreciation and amortization 36,022 37,129
Amortization for intangible assets 514 515
Changes in operating assets and liabilities:    
Accounts payable 20,150 24,332
Accounts receivable (70,535) (27,479)
Other payables and accrued liabilities (11,582) (3,917)
Inventories 2,700 4,490
Other receivables, prepaid expenses and deposits 1,243 3,361
Lease liabilities (20,786) (21,612)
Right of use 761
Tax payable 340
Cash (used in)/generated from operations (70,865) 33,048
Tax paid (335) (494)
Reversal of deferred tax liabilities (1,927)
Net cash (used in)/generated from operating activities (71,200) 30,627
CASH FLOWS FROM INVESTING ACTIVITY:    
Purchase of plant and equipment (6,903)
Net cash used in investing activity (6,903)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of finance lease (7,727) (7,690)
Net cash used in financing activities (7,727) (7,690)
Effect of exchange rate changes on cash and cash equivalent (21,799) (12,424)
Net (decrease)/increase in cash and cash equivalents (100,726) 3,610
Cash and cash equivalents, beginning of period 214,269 234,546
CASH AND CASH EQUIVALENTS, END OF PERIOD 113,543 238,156
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid (335) (494)
Interest paid $ (414) $ (433)
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF BUSINESS AND ORGANIZATION
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
DESCRIPTION OF BUSINESS AND ORGANIZATION

1. DESCRIPTION OF BUSINESS AND ORGANIZATION

 

DSwiss, Inc. is organized as a Nevada limited liability company, incorporated on May 28, 2015. For the purposes of financial statement presentation, DSwiss, Inc. and its subsidiaries are herein referred to as “the Company” or “we”. The principal activity of the Company is premier biotech-nutraceutical, beauty supplies, and medical consumables supplies. The Company sells medical consumable supplies, food supplements, skincare, and other related beauty products in Malaysia and around the ASEAN region. We are globally recognized Turnkey Private Label Manufacturing Services for nutraceutical and skincare OEM/ODM products.

 

Our professionals manage from custom formulation of scientifically proven and naturally effective, sourcing raw materials, production, quality control, stability, and safety test, clinical testing by third-party labs, packaging, and shipping, including import and export.

 

Our manufacturing facilities which compliant with GMP (Good Manufacturing Practise), FDA (Food Drug Association), HACCP (Hazard Analysis and Critical Control Point), JAKIM HALAL, and Mesti.

 

The accompanying unaudited condensed consolidated financial statements of DSwiss, Inc. at June 30, 2023 and 2022 have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial statements, instructions to Form 10-Q, and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2022. In management’s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make our financial statements not misleading have been included. The results of operations for the periods ended June 30, 2023 and 2022 presented are not necessarily indicative of the results to be expected for the full year. The December 31, 2022 balance sheet has been derived from our audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2022.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

   Company name  Place and date
of incorporation
  Particulars of issued
capital
  Principal activities  Proportional
of ownership interest
and voting power
held
 
                 
1.  DSwiss Holding Limited  Seychelles, May 28, 2015  1 share of ordinary share of US$1 each  Investment holding   100%
                  
2.  DSwiss (HK) Limited  Hong Kong, May 28, 2015  1 share of ordinary share of HK$1 each  Supply of beauty products   100%
                  
3.  DSwiss Sdn Bhd  Malaysia, March 10, 2011  2 shares of ordinary share of RM 1 each  Supply of beauty products   100%
                  
4.  DSwiss Biotech Sdn Bhd  Malaysia, March 17, 2016  250,000 shares of ordinary share of RM 1 each  Supply of biotech products   100%

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 16 R8.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the period ended June 30, 2023, the Company incurred a net loss of $28,926, suffered an accumulated deficit of $1,389,544 and negative operating cash flow of $71,200. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stock holders, in the case of equity financing.

 

Basis of presentation

 

The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables product are sold and accepted by the customers and there are no continuing obligations to the customer.

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Cash and cash equivalents

 

The Company consider all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalent.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

  

Classification   Estimated useful lives
Computer and software   5 years
Furniture and fittings   5 years
Office equipment   10 years
Motor vehicle   5 years

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong, which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the six months ended June 30, 2023.

 

Leases

 

Prior to November 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective November 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods (see Note 10).

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Net income/(loss) per share

 

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia and Hong Kong maintains their books and record in their local currency, Ringgits Malaysia (“RM”) and Hong Kong Dollars (“HK$”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the six months ended
June 30,
 
   2023   2022 
         
Period-end RM : US$1 exchange rate   4.67    4.41 
Period-average RM : US$1 exchange rate   4.45    4.29 
Period-end HK$ : US$1 exchange rate   7.84    7.85 
Period-average HK$ : US$1 exchange rate   7.84    7.83 

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts receivable, deposits, accounts payable, other payables, and accounts payable approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

Level 1: Observable inputs such as quoted prices in active markets;

 

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Segment reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. For the six months ended June 30, 2023, the Company operates in three reportable operating segments in Malaysia and Hong Kong.

 

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.

 

Recently Issued Accounting Standard

 

The Company reviews new accounting standards as issued. Management has not identified any other new standards that is believes will have a significant impact on the Company’s financial statements.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.23.2
VIE STRUCTURE AND ARRANGEMENTS
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VIE STRUCTURE AND ARRANGEMENTS

3. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

4. STOCKHOLDERS’ EQUITY

 

As of June 30, 2023, the Company had a total of 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.23.2
PLANT AND EQUIPMENT
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
PLANT AND EQUIPMENT

5. PLANT AND EQUIPMENT

   

June 30,

2023

   

December 31,

2022

 
Computer and software   $ 105,535     $ 105,535  
Furniture and fittings     6,144       6,144  
Office equipment     21,152       21,152  
Motor vehicle     135,868       135,868  
Total plant and equipment   $ 268,699     $ 268,699  
Accumulated depreciation     (201,612 )     (187,236 )
Effect of translation exchange     (12,615 )     (9,284 )
Plant and equipment, net   $ 54,472     $ 72,179  

 

Depreciation expense for the three months and six months ended June 30, 2023 were $6,839 and $14,376 respectively.

 

Depreciation expense for the three months and six months ended June 30, 2022 were $8,191 and $15,692 respectively.

 

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

6. INTANGIBLE ASSETS

 

  

June 30,

2023

  

December 31,

2022

 
Trademarks  $12,077   $12,077 
Amortization   (8,678)   (8,164)
Effect of translation exchange   (467)   (454)
Intangible assets, net  $2,932   $3,459 

 

Amortization for the three months and six months ended June 30, 2023 was $257 and $514 respectively.

 

Amortization for the three months and six months ended June 30, 2022 was $257 and $515 respectively.

 

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS
6 Months Ended
Jun. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

7. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

  

June 30,

2023

  

December 31,

2022

 
Other receivables  $66   $- 
Prepaid expenses   658    2,080 
Deposits   18,606    19,669 
Total prepaid expenses and deposits  $19,330   $21,749 

 

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.23.2
INVENTORIES
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORIES

8. INVENTORIES

 

  

June 30,

2023

  

December 31,

2022

 
Finished goods, at cost  $4,378   $7,483 
Total inventories  $4,378   $7,483 

 

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER PAYABLES AND ACCRUED LIABILITIES
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

9. OTHER PAYABLES AND ACCRUED LIABILITIES

 

  

June 30,

2023

  

December 31,

2022

 
Other payables  $86,508   $100,385 
Accrued audit fees   25,636    20,266 
Accrued other expenses   12,864    16,683 
Accrued professional fees   12,487    17,376 
Total payables and accrued liabilities  $137,495   $154,710 

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCE LEASE LIABILITY
6 Months Ended
Jun. 30, 2023
Finance Lease Liability  
FINANCE LEASE LIABILITY

10. FINANCE LEASE LIABILITY

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

   As of June 30,
2023
   As of December 31,
2022
 
Finance lease  $46,876   $58,768 
Less: interest expense   (2,600)   (3,792)
Net present value of finance lease   44,276    54,976 
           
Current portion   7,895    16,515 
Non-current portion   36,381    38,461 
Total  $44,276   $54,976 

 

As of June 30, 2023 the maturities of the finance lease for each of the years are as follows:

 

      
2023   7,895 
2024   16,291 
2025   12,441 
2026   7,649 
Total  $44,276 

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 25 R17.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

11. INCOME TAXES

 

For the six months ended June 30, 2023 and 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
         
Tax jurisdictions from:          
- Local  $(35,199)  $(20,770)
- Foreign, representing          
Seychelles   (3,178)   (2,169)
Hong Kong   (3,540)   (2,064)
Malaysia   13,326    40,131 
           
(Loss)/Profit before income tax  $(28,591)  $15,128 

 

The provision for income taxes consisted of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
Current:              
- Local  $-   $- 
- Foreign   (335)   - 
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(335)  $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Seychelles, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2023, the operations in the United States of America incurred $507,350 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $106,544 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of June 30, 2023, the operations in the Hong Kong incurred $634,643 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,716 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Malaysia

 

DSwiss Sdn. Bhd. and DSwiss Biotech Sdn. Bhd. are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 15% to 24% on its assessable income. As of June 30, 2023, the operations in the Malaysia incurred $203,977 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 15%. The Company has provided for a full valuation allowance of $30,597 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 26 R18.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS OF RISK
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISK

12. CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a) Major customers

 

For three months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenue  

Percentage of

revenue

   Accounts receivable 
                         
Customer A  $-   $346,253    -%   46%  $-   $- 
Customer B  $91,754   $155,407    25%   21%  $30,849   $6,843 
Customer C  $50,196   $-    14%   -%  $27,475   $- 
Customer D  $85,002   $-    24%   -%  $-   $- 
   $  226,952   $  501,660    63%   67%  $58,324   $6,843 

 

For six months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenues  

Percentage of

revenues

  

Accounts receivable,

trade

 
                         
Customer A  $63,861   $-    10%   -%  $-   $- 
Customer B  $-   $416,432    -%   35%  $-   $- 
Customer C  $127,102   $255,238    20%   21%  $30,849   $6,843 
Customer D  $100,392   $-    16%   -%  $27,475   $- 
Customer E  $147,848   $-    24%   -%  $-   $- 
   $ 439,203   $671,670    70%   56%  $58,324   $6,843 

 

(b) Major vendors

 

For three months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchase

   Accounts payable 
                         
Vendor A  $51,367   $304,423    19%   45%  $-   $- 
Vendor B  $75,546   $131,132    29%   19%  $3,722   $- 
Vendor C  $71,478   $88,841    27%   13%  $38,604   $26,426 
   $ 198,391   $ 524,396    75%   77%  $42,326   $26,426 

 

For six months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchases

  

Accounts payable,

trade

 
                         
Vendor A  $74,870   $407,162    17%   45%  $-   $- 
Vendor B  $166,206   $187,012    37%   19%  $3,722   $- 
Vendor C  $95,572   $159,895    21%   13%  $38,604   $26,426 
   $ 336,648   $ 754,069    75%   77%  $42,326   $26,426 

 

All vendors are located in Malaysia.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its accounts receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate actually post higher or lower income depending on exchange rate of RM converted to US$ and HK$ converted into US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

XML 27 R19.htm IDEA: XBRL DOCUMENT v3.23.2
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

13. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$92,606, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.4% adopted from Public Bank Berhad’s base lending rate as a reference for discount rate.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The operating lease right and lease liability as follow:

 

As of June 30, 2023 and December 31, 2022, operating lease right of use asset as follow:

 

   As of June 30, 2023   As of December 31, 2022 
As of beginning of the period/year  $44,548   $92,606 
Accumulated amortization   (21,646)   (42,310)
Effect of translation exchange   (1,548)   (5,748)
Balance as of end of the period/year  $21,354   $44,548 

 

As of June 30, 2023 and December 31, 2022, the amortization of the operating lease right of use asset are $21,646 and $42,310 respectively.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

As of June 30, 2023, operating lease liability as follow:

 

As of January 1, 2023  $44,548 
Less: gross repayment   (22,488)
Add: imputed interest   842 
Effect of translation exchange   (1,548)
Balance as of June 30, 2023  $21,354 
Less: lease liability current portion   (21,354)
Lease liability non-current portion  $- 

 

Maturities of operating lease obligation as follow:

 

Year ending     
December 31, 2023   21,354 
Total  $21,354 

 

Other information:

 

   As of June 30, 2023   As of December 31, 2022 
   (unaudited)   (audited) 
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flow from operating lease  $20,786   $42,212 
Right-of-use assets obtained in exchange for operating lease liabilities   21,354    44,548 
Remaining lease term for operating lease (years)   0.5    1 
Weighted average discount rate for operating lease   5.4%   5.4%

 

As of June 30, 2023 and December 31, 2022, lease expenses were $21,646 and $42,310 respectively.

 

XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

14. RELATED PARTY TRANSACTIONS

 

For the period ended June 30, 2023 the Company has the following transactions with related party:

 

  

For the period ended

June 30,

2023

(Unaudited)

  

For the period ended

June 30,

2022

(Unaudited)

 
Professional Fees:          
- Related party A  $3,000   $3,000 
           
Sales          
- Related party B  $127,102   $255,239 
- Related party C   45,150    7,572 
           
Total  $175,252   $265,811 

 

The related party A, is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director and shareholder is the founder of the Company.

 

The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

XML 29 R21.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENTED INFORMATION
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SEGMENTED INFORMATION

15. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $621,195   $621,195 
Cost of revenues   -    -    -    (447,498)   (447,498)
Depreciation and amortization   -    -    (514)   (36,022)   (36,536)
Net (loss)/profit before taxation   (35,199)   (3,178)   (3,540)   13,326    (28,591)
                          
Total assets  $14,274   $21,998   $13,209   $254,314   $303,795 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $1,187,232   $1,187,232 
Cost of revenues   -    -    -    (995,387)   (995,387)
Depreciation and amortization   -    -    (515)   (37,129)   (37,644)
Net (loss)/profit before taxation   (20,770)   (2,169)   (2,064)   40,131    15,128 
                          
Total assets  $27,187   $7,055   $14,711   $404,780   $453,733 

 

* Revenues and costs are attributed to countries based on the location of customers.

 

XML 30 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

16. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2023 up through the date the Company issued the consolidated financial statements.

XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Going Concern

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the period ended June 30, 2023, the Company incurred a net loss of $28,926, suffered an accumulated deficit of $1,389,544 and negative operating cash flow of $71,200. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stock holders, in the case of equity financing.

 

Basis of presentation

Basis of presentation

 

The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Revenue recognition

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables product are sold and accepted by the customers and there are no continuing obligations to the customer.

 

Cost of revenue

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Selling and distribution expenses

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company consider all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalent.

 

Inventories

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Plant and equipment

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

  

Classification   Estimated useful lives
Computer and software   5 years
Furniture and fittings   5 years
Office equipment   10 years
Motor vehicle   5 years

 

Intangible assets

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong, which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the six months ended June 30, 2023.

 

Leases

Leases

 

Prior to November 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective November 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods (see Note 10).

 

Income taxes

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Net income/(loss) per share

Net income/(loss) per share

 

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia and Hong Kong maintains their books and record in their local currency, Ringgits Malaysia (“RM”) and Hong Kong Dollars (“HK$”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the six months ended
June 30,
 
   2023   2022 
         
Period-end RM : US$1 exchange rate   4.67    4.41 
Period-average RM : US$1 exchange rate   4.45    4.29 
Period-end HK$ : US$1 exchange rate   7.84    7.85 
Period-average HK$ : US$1 exchange rate   7.84    7.83 

 

 

DSWISS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

Related parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts receivable, deposits, accounts payable, other payables, and accounts payable approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

Level 1: Observable inputs such as quoted prices in active markets;

 

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Segment reporting

Segment reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. For the six months ended June 30, 2023, the Company operates in three reportable operating segments in Malaysia and Hong Kong.

 

Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.

 

Recently Issued Accounting Standard

Recently Issued Accounting Standard

 

The Company reviews new accounting standards as issued. Management has not identified any other new standards that is believes will have a significant impact on the Company’s financial statements.

XML 32 R24.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF VARIABLE INTEREST ENTITY

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

  

   Company name  Place and date
of incorporation
  Particulars of issued
capital
  Principal activities  Proportional
of ownership interest
and voting power
held
 
                 
1.  DSwiss Holding Limited  Seychelles, May 28, 2015  1 share of ordinary share of US$1 each  Investment holding   100%
                  
2.  DSwiss (HK) Limited  Hong Kong, May 28, 2015  1 share of ordinary share of HK$1 each  Supply of beauty products   100%
                  
3.  DSwiss Sdn Bhd  Malaysia, March 10, 2011  2 shares of ordinary share of RM 1 each  Supply of beauty products   100%
                  
4.  DSwiss Biotech Sdn Bhd  Malaysia, March 17, 2016  250,000 shares of ordinary share of RM 1 each  Supply of biotech products   100%
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE

Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

  

Classification   Estimated useful lives
Computer and software   5 years
Furniture and fittings   5 years
Office equipment   10 years
Motor vehicle   5 years
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION

Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the six months ended
June 30,
 
   2023   2022 
         
Period-end RM : US$1 exchange rate   4.67    4.41 
Period-average RM : US$1 exchange rate   4.45    4.29 
Period-end HK$ : US$1 exchange rate   7.84    7.85 
Period-average HK$ : US$1 exchange rate   7.84    7.83 
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.23.2
PLANT AND EQUIPMENT (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PLANT AND EQUIPMENT

   

June 30,

2023

   

December 31,

2022

 
Computer and software   $ 105,535     $ 105,535  
Furniture and fittings     6,144       6,144  
Office equipment     21,152       21,152  
Motor vehicle     135,868       135,868  
Total plant and equipment   $ 268,699     $ 268,699  
Accumulated depreciation     (201,612 )     (187,236 )
Effect of translation exchange     (12,615 )     (9,284 )
Plant and equipment, net   $ 54,472     $ 72,179  
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

 

  

June 30,

2023

  

December 31,

2022

 
Trademarks  $12,077   $12,077 
Amortization   (8,678)   (8,164)
Effect of translation exchange   (467)   (454)
Intangible assets, net  $2,932   $3,459 
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)
6 Months Ended
Jun. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

  

June 30,

2023

  

December 31,

2022

 
Other receivables  $66   $- 
Prepaid expenses   658    2,080 
Deposits   18,606    19,669 
Total prepaid expenses and deposits  $19,330   $21,749 
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.23.2
INVENTORIES (Tables)
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

 

  

June 30,

2023

  

December 31,

2022

 
Finished goods, at cost  $4,378   $7,483 
Total inventories  $4,378   $7,483 
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES

 

  

June 30,

2023

  

December 31,

2022

 
Other payables  $86,508   $100,385 
Accrued audit fees   25,636    20,266 
Accrued other expenses   12,864    16,683 
Accrued professional fees   12,487    17,376 
Total payables and accrued liabilities  $137,495   $154,710 
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCE LEASE LIABILITY (Tables)
6 Months Ended
Jun. 30, 2023
Finance Lease Liability  
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE

 

   As of June 30,
2023
   As of December 31,
2022
 
Finance lease  $46,876   $58,768 
Less: interest expense   (2,600)   (3,792)
Net present value of finance lease   44,276    54,976 
           
Current portion   7,895    16,515 
Non-current portion   36,381    38,461 
Total  $44,276   $54,976 
SCHEDULE OF MATURITIES OF FINANCE LEASE

As of June 30, 2023 the maturities of the finance lease for each of the years are as follows:

 

      
2023   7,895 
2024   16,291 
2025   12,441 
2026   7,649 
Total  $44,276 
XML 40 R32.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES (Tables)
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES

For the six months ended June 30, 2023 and 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
         
Tax jurisdictions from:          
- Local  $(35,199)  $(20,770)
- Foreign, representing          
Seychelles   (3,178)   (2,169)
Hong Kong   (3,540)   (2,064)
Malaysia   13,326    40,131 
           
(Loss)/Profit before income tax  $(28,591)  $15,128 
SCHEDULE OF PROVISION FOR INCOME TAXES

The provision for income taxes consisted of the following:

 

   For the six months ended June 30, 2023   For the six months ended June 30, 2022 
Current:              
- Local  $-   $- 
- Foreign   (335)   - 
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(335)  $- 
XML 41 R33.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS OF RISK (Tables)
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
SCHEDULE OF CONCENTRATION OF RISK

(a) Major customers

 

For three months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenue  

Percentage of

revenue

   Accounts receivable 
                         
Customer A  $-   $346,253    -%   46%  $-   $- 
Customer B  $91,754   $155,407    25%   21%  $30,849   $6,843 
Customer C  $50,196   $-    14%   -%  $27,475   $- 
Customer D  $85,002   $-    24%   -%  $-   $- 
   $  226,952   $  501,660    63%   67%  $58,324   $6,843 

 

For six months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Revenues  

Percentage of

revenues

  

Accounts receivable,

trade

 
                         
Customer A  $63,861   $-    10%   -%  $-   $- 
Customer B  $-   $416,432    -%   35%  $-   $- 
Customer C  $127,102   $255,238    20%   21%  $30,849   $6,843 
Customer D  $100,392   $-    16%   -%  $27,475   $- 
Customer E  $147,848   $-    24%   -%  $-   $- 
   $ 439,203   $671,670    70%   56%  $58,324   $6,843 

 

(b) Major vendors

 

For three months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchase

   Accounts payable 
                         
Vendor A  $51,367   $304,423    19%   45%  $-   $- 
Vendor B  $75,546   $131,132    29%   19%  $3,722   $- 
Vendor C  $71,478   $88,841    27%   13%  $38,604   $26,426 
   $ 198,391   $ 524,396    75%   77%  $42,326   $26,426 

 

For six months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:

 

   2023   2022   2023   2022   2023   2022 
   Purchase  

Percentage of

purchases

  

Accounts payable,

trade

 
                         
Vendor A  $74,870   $407,162    17%   45%  $-   $- 
Vendor B  $166,206   $187,012    37%   19%  $3,722   $- 
Vendor C  $95,572   $159,895    21%   13%  $38,604   $26,426 
   $ 336,648   $ 754,069    75%   77%  $42,326   $26,426 
XML 42 R34.htm IDEA: XBRL DOCUMENT v3.23.2
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS

As of June 30, 2023 and December 31, 2022, operating lease right of use asset as follow:

 

   As of June 30, 2023   As of December 31, 2022 
As of beginning of the period/year  $44,548   $92,606 
Accumulated amortization   (21,646)   (42,310)
Effect of translation exchange   (1,548)   (5,748)
Balance as of end of the period/year  $21,354   $44,548 
SCHEDULE OF OPERATING LEASE LIABILITY

As of June 30, 2023, operating lease liability as follow:

 

As of January 1, 2023  $44,548 
Less: gross repayment   (22,488)
Add: imputed interest   842 
Effect of translation exchange   (1,548)
Balance as of June 30, 2023  $21,354 
Less: lease liability current portion   (21,354)
Lease liability non-current portion  $- 
SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION

Maturities of operating lease obligation as follow:

 

Year ending     
December 31, 2023   21,354 
Total  $21,354 
SCHEDULE OF OPERATING LEASE OTHER INFORMATION

Other information:

 

   As of June 30, 2023   As of December 31, 2022 
   (unaudited)   (audited) 
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flow from operating lease  $20,786   $42,212 
Right-of-use assets obtained in exchange for operating lease liabilities   21,354    44,548 
Remaining lease term for operating lease (years)   0.5    1 
Weighted average discount rate for operating lease   5.4%   5.4%
XML 43 R35.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTY TRANSACTIONS (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTION

For the period ended June 30, 2023 the Company has the following transactions with related party:

 

  

For the period ended

June 30,

2023

(Unaudited)

  

For the period ended

June 30,

2022

(Unaudited)

 
Professional Fees:          
- Related party A  $3,000   $3,000 
           
Sales          
- Related party B  $127,102   $255,239 
- Related party C   45,150    7,572 
           
Total  $175,252   $265,811 
XML 44 R36.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENTED INFORMATION (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SCHEDULE OF REPORTING SEGMENTS

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $621,195   $621,195 
Cost of revenues   -    -    -    (447,498)   (447,498)
Depreciation and amortization   -    -    (514)   (36,022)   (36,536)
Net (loss)/profit before taxation   (35,199)   (3,178)   (3,540)   13,326    (28,591)
                          
Total assets  $14,274   $21,998   $13,209   $254,314   $303,795 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the period ended June 30, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenues  $-   $-   $-   $1,187,232   $1,187,232 
Cost of revenues   -    -    -    (995,387)   (995,387)
Depreciation and amortization   -    -    (515)   (37,129)   (37,644)
Net (loss)/profit before taxation   (20,770)   (2,169)   (2,064)   40,131    15,128 
                          
Total assets  $27,187   $7,055   $14,711   $404,780   $453,733 

 

* Revenues and costs are attributed to countries based on the location of customers.
XML 45 R37.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF VARIABLE INTEREST ENTITY (Details)
6 Months Ended
Jun. 30, 2023
DSwiss Holding Limited [Member]  
Company name DSwiss Holding Limited
Place of incorporation Seychelles
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
DSwiss HK Limited [Member]  
Company name DSwiss (HK) Limited
Place of incorporation Hong Kong
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of HK$1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Sdn Bhd [Member]  
Company name DSwiss Sdn Bhd
Place of incorporation Malaysia
Date of incorporation Mar. 10, 2011
Particulars of issued capital 2 shares of ordinary share of RM 1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Biotech Sdn Bhd [Member]  
Company name DSwiss Biotech Sdn Bhd
Place of incorporation Malaysia
Date of incorporation Mar. 17, 2016
Particulars of issued capital 250,000 shares of ordinary share of RM 1 each
Principal activities Supply of biotech products
Proportional of ownership interest and voting power held 100.00%
XML 46 R38.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative) - shares
Jan. 18, 2023
Jun. 30, 2023
DSwiss Holding Limited [Member] | HONG KONG    
Equity ownership interest rate percentage   100.00%
DSwiss Sdn Bhd [Member] | MALAYSIA    
Equity ownership interest rate percentage   100.00%
DSwiss Biotech Sdn Bhd [Member] | HONG KONG    
Equity ownership interest rate percentage 60.00%  
Stock issued during period, shares, new issues 1,500  
DSwiss Biotech Sdn Bhd [Member] | MALAYSIA    
Equity ownership interest rate percentage   40.00%
XML 47 R39.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)
Jun. 30, 2023
Computer and Software [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 10 years
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
XML 48 R40.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)
Jun. 30, 2023
Jun. 30, 2022
Period End RM [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.67 4.41
Period Average RM [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.45 4.29
Period-end HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.84 7.85
Period Average HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.84 7.83
XML 49 R41.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Integer
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Accounting Policies [Abstract]          
Net income loss $ 12,003 $ 19,137 $ 28,926 $ (15,128)  
Accumulated deficit $ 1,389,544   1,389,544   $ 1,324,002
Cash used in operations     $ 71,200 $ (30,627)  
Intangible asset, useful life 10 years   10 years    
Impairment loss     $ 0    
Largest amount of tax benefit, description     greater than 50%    
Number of reportable operating segment | Integer     3    
XML 50 R42.htm IDEA: XBRL DOCUMENT v3.23.2
VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) - RM / shares
Jan. 18, 2023
Jun. 27, 2016
DSwiss HK Limited [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares, acquired 150,000  
Equity ownership interest rate percentage 60.00%  
Consideration price per share RM 1  
Management Services Agreement I [Member] | DSwiss HK Limited [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percentage of annual net profit to be received as fee   100.00%
XML 51 R43.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Details Narrative) - shares
Jun. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
Common stock shares issued 206,904,585 206,904,585
Common stock shares outstanding 206,904,585 206,904,585
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
XML 52 R44.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF PLANT AND EQUIPMENT (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total plant and equipment $ 268,699 $ 268,699
Accumulated depreciation (201,612) (187,236)
Effect of translation exchange (12,615) (9,284)
Plant and equipment, net 54,472 72,179
Computer and Software [Member]    
Property, Plant and Equipment [Line Items]    
Total plant and equipment 105,535 105,535
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total plant and equipment 6,144 6,144
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total plant and equipment 21,152 21,152
Motor Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Total plant and equipment $ 135,868 $ 135,868
XML 53 R45.htm IDEA: XBRL DOCUMENT v3.23.2
PLANT AND EQUIPMENT (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 6,839 $ 8,191 $ 14,376 $ 15,692
XML 54 R46.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Trademarks $ 12,077 $ 12,077
Amortization (8,678) (8,164)
Effect of translation exchange (467) (454)
Intangible assets, net $ 2,932 $ 3,459
XML 55 R47.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization of intangible assets $ 257 $ 257 $ 514 $ 515
XML 56 R48.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Other receivables $ 66
Prepaid expenses 658 2,080
Deposits 18,606 19,669
Total prepaid expenses and deposits $ 19,330 $ 21,749
XML 57 R49.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF INVENTORIES (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods, at cost $ 4,378 $ 7,483
Total inventories $ 4,378 $ 7,483
XML 58 R50.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Other payables $ 86,508 $ 100,385
Accrued audit fees 25,636 20,266
Accrued other expenses 12,864 16,683
Accrued professional fees 12,487 17,376
Total payables and accrued liabilities $ 137,495 $ 154,710
XML 59 R51.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Finance Lease Liability    
Finance lease $ 46,876 $ 58,768
Less: interest expense (2,600) (3,792)
Total 44,276 54,976
Current portion 7,895 16,515
Non-current portion $ 36,381 $ 38,461
XML 60 R52.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Finance Lease Liability    
2023 $ 7,895  
2024 16,291  
2025 12,441  
2026 7,649  
Total $ 44,276 $ 54,976
XML 61 R53.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCE LEASE LIABILITY (Details Narrative)
6 Months Ended
Jun. 30, 2023
First Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly
Second Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly
XML 62 R54.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
(Loss)/Profit before income tax $ (11,839) $ (19,137) $ (28,591) [1] $ 15,128 [1]
UNITED STATES        
(Loss)/Profit before income tax     (35,199) (20,770)
SEYCHELLES        
(Loss)/Profit before income tax [1]     (3,178) (2,169)
HONG KONG        
(Loss)/Profit before income tax [1]     (3,540) (2,064)
MALAYSIA        
(Loss)/Profit before income tax [1]     $ 13,326 $ 40,131
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 63 R55.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF PROVISION FOR INCOME TAXES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Current:        
- Local    
- Foreign     (335)
Deferred:        
- Local    
- Foreign    
Income tax expense $ (164) $ (335)
XML 64 R56.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
United States of America [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 507,350
Income tax rate 21.00%
Net operating loss carryforwards expiration The net operating loss carry forwards begin to expire in 2038, if unutilized
Valuation allowance $ 106,544
Hong Kong [Member] | DSwiss HK Limited [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 634,643
Income tax rate 16.50%
Valuation allowance $ 104,716
Statutory income tax, rate 16.50%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 203,977
Income tax rate 15.00%
Valuation allowance $ 30,597
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Minimum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 15.00%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Maximum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 24.00%
XML 65 R57.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CONCENTRATION OF RISK (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Concentration Risk [Line Items]        
Revenues $ 355,274 $ 739,595 $ 621,195 [1] $ 1,187,232 [1]
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]        
Concentration Risk [Line Items]        
Revenues $ 346,253 $ 63,861
Concentration risk, percentage 46.00% 10.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]        
Concentration Risk [Line Items]        
Revenues $ 91,754 $ 155,407 $ 416,432
Concentration risk, percentage 25.00% 21.00% 35.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]        
Concentration Risk [Line Items]        
Revenues $ 50,196 $ 127,102 $ 255,238
Concentration risk, percentage 14.00% 20.00% 21.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer D [Member]        
Concentration Risk [Line Items]        
Revenues $ 85,002 $ 100,392
Concentration risk, percentage 24.00% 16.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers [Member]        
Concentration Risk [Line Items]        
Revenues $ 226,952 $ 501,660 $ 439,203 $ 671,670
Concentration risk, percentage 63.00% 67.00% 70.00% 56.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer E [Member]        
Concentration Risk [Line Items]        
Revenues     $ 147,848
Concentration risk, percentage     24.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 30,849 6,843 30,849 6,843
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 27,475 27,475
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 30,849 6,843 30,849 6,843
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer D [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer D [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 27,475 27,475
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customers [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 58,324 6,843 58,324 6,843
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customers [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade 58,324 6,843 58,324 6,843
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer E [Member] | Trade Accounts Receivable [Member]        
Concentration Risk [Line Items]        
Accounts receivable, trade
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage 19.00% 45.00% 17.00% 45.00%
Purchases $ 51,367 $ 304,423 $ 74,870 $ 407,162
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage 29.00% 19.00% 37.00% 19.00%
Purchases $ 75,546 $ 131,132 $ 166,206 $ 187,012
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage 27.00% 13.00% 21.00% 13.00%
Purchases $ 71,478 $ 88,841 $ 95,572 $ 159,895
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendors [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage 75.00% 77.00% 75.00% 77.00%
Purchases $ 198,391 $ 524,396 $ 336,648 $ 754,069
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]        
Concentration Risk [Line Items]        
Account Payable, Trade
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]        
Concentration Risk [Line Items]        
Account Payable, Trade 3,722 3,722
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]        
Concentration Risk [Line Items]        
Account Payable, Trade 38,604 26,426 38,604 26,426
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendors [Member]        
Concentration Risk [Line Items]        
Account Payable, Trade $ 42,326 $ 26,426 $ 42,326 $ 26,426
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 66 R58.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right of use asset $ 44,548 $ 92,606
Accumulated amortization (21,646) (42,310)
Effect of translation exchange (1,548) (5,748)
Operating lease right of use asset, ending $ 21,354 $ 44,548
XML 67 R59.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OPERATING LEASE LIABILITY (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease liability, beginning $ 44,548  
Less: gross repayment (22,488)  
Add: imputed interest 842  
Effect of translation exchange (1,548)  
Operating lease liability, ending 21,354  
Less: lease liability current portion (21,354) $ (44,548)
Lease liability non-current portion  
XML 68 R60.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details)
Jun. 30, 2023
USD ($)
Leases [Abstract]  
December 31, 2023 $ 21,354
Total $ 21,354
XML 69 R61.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating cash flow from operating lease $ 20,786 $ 42,212
Right-of-use assets obtained in exchange for operating lease liabilities $ 21,354 $ 44,548
Remaining lease term for operating lease (years) 6 months 1 year
Weighted average discount rate for operating lease 5.40% 5.40%
XML 70 R62.htm IDEA: XBRL DOCUMENT v3.23.2
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Lease liability $ 21,354 $ 44,548    
Lease asset- right of use $ 21,354 $ 44,548   $ 92,606
Discount rate of lease payment 5.40% 5.40%    
Operating lease right of use asset, amortization $ 21,646 $ 42,310    
Lease expenses 21,646 42,310    
Accounting Standards Update 2016-02 [Member]        
Lease liability     $ 92,606  
Lease asset- right of use     $ 92,606  
Discount rate of lease payment     5.40%  
Operating lease right of use asset, amortization $ 21,646 $ 42,310    
XML 71 R63.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF RELATED PARTY TRANSACTION (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Related Party Transaction [Line Items]    
Total $ 175,252 $ 265,811
Related Party A [Member]    
Related Party Transaction [Line Items]    
Professional Fees 3,000 3,000
Related Party B [Member]    
Related Party Transaction [Line Items]    
Sales 127,102 255,239
Related Party C [Member]    
Related Party Transaction [Line Items]    
Sales $ 45,150 $ 7,572
XML 72 R64.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTY TRANSACTIONS (Details Narrative)
Jun. 30, 2023
Related Party A [Member]  
Ownership percentage 7.33%
XML 73 R65.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF REPORTING SEGMENTS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues $ 355,274 $ 739,595 $ 621,195 [1] $ 1,187,232 [1]  
Cost of revenues (263,561) (663,012) (447,498) [1] (995,387) [1]  
Depreciation and amortization [1]     (36,536) (37,644)  
Net (loss)/profit before taxation (11,839) (19,137) (28,591) [1] 15,128 [1]  
Assets 303,795 [1] 453,733 [1] 303,795 [1] 453,733 [1] $ 381,924
NV [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues [1]      
Cost of revenues [1]      
Depreciation and amortization [1]      
Net (loss)/profit before taxation [1]     (35,199) (20,770)  
Assets [1] 14,274 27,187 14,274 27,187  
SEYCHELLES          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues [1]      
Cost of revenues [1]      
Depreciation and amortization [1]      
Net (loss)/profit before taxation [1]     (3,178) (2,169)  
Assets [1] 21,998 7,055 21,998 7,055  
HONG KONG          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues [1]      
Cost of revenues [1]      
Depreciation and amortization [1]     (514) (515)  
Net (loss)/profit before taxation [1]     (3,540) (2,064)  
Assets [1] 13,209 14,711 13,209 14,711  
MALAYSIA          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues [1]     621,195 1,187,232  
Cost of revenues [1]     (447,498) (995,387)  
Depreciation and amortization [1]     (36,022) (37,129)  
Net (loss)/profit before taxation [1]     13,326 40,131  
Assets [1] $ 254,314 $ 404,780 $ 254,314 $ 404,780  
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 74 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001652561 2023-01-01 2023-06-30 0001652561 2023-06-30 0001652561 2022-12-31 0001652561 2023-04-01 2023-06-30 0001652561 2022-04-01 2022-06-30 0001652561 2022-01-01 2022-06-30 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 2021-12-31 0001652561 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001652561 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0001652561 us-gaap:CommonStockMember 2023-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001652561 us-gaap:RetainedEarningsMember 2023-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2023-06-30 0001652561 us-gaap:CommonStockMember 2022-06-30 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001652561 us-gaap:RetainedEarningsMember 2022-06-30 0001652561 us-gaap:NoncontrollingInterestMember 2022-06-30 0001652561 2022-06-30 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2023-06-30 0001652561 DQWS:DSwissSdnBhdMember country:MY 2023-06-30 0001652561 DQWS:DSwissBiotechMember country:MY 2023-06-30 0001652561 DQWS:DSwissBiotechMember country:HK 2023-01-17 2023-01-18 0001652561 DQWS:DSwissBiotechMember country:HK 2023-01-18 0001652561 DQWS:DSwissHoldingLimitedMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissHKLimitedMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:DSwissBiotechSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:ComputerAndSoftwareMember 2023-06-30 0001652561 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001652561 us-gaap:OfficeEquipmentMember 2023-06-30 0001652561 DQWS:MotorVehiclesMember 2023-06-30 0001652561 DQWS:PeriodEndRMMember 2023-06-30 0001652561 DQWS:PeriodEndRMMember 2022-06-30 0001652561 DQWS:PeriodAverageRMMember 2023-06-30 0001652561 DQWS:PeriodAverageRMMember 2022-06-30 0001652561 DQWS:PeriodEndHKMember 2023-06-30 0001652561 DQWS:PeriodEndHKMember 2022-06-30 0001652561 DQWS:PeriodAverageHKMember 2023-06-30 0001652561 DQWS:PeriodAverageHKMember 2022-06-30 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:DSwissHKLimitedMember 2023-01-17 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2023-01-01 2023-06-30 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2023-01-01 2023-06-30 0001652561 country:US 2023-01-01 2023-06-30 0001652561 country:US 2022-01-01 2022-06-30 0001652561 country:SC 2023-01-01 2023-06-30 0001652561 country:SC 2022-01-01 2022-06-30 0001652561 country:HK 2023-01-01 2023-06-30 0001652561 country:HK 2022-01-01 2022-06-30 0001652561 country:MY 2023-01-01 2023-06-30 0001652561 country:MY 2022-01-01 2022-06-30 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-06-30 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-01-01 2023-06-30 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2023-01-01 2023-06-30 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2023-06-30 0001652561 srt:MinimumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-06-30 0001652561 srt:MaximumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-06-30 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomerAMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerAMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomerBMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerBMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomerCMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerCMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomerDMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerDMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomerEMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomerEMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:CustomersMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001652561 DQWS:CustomersMember us-gaap:TradeAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-06-30 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-06-30 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-06-30 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-06-30 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-06-30 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-06-30 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-06-30 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-04-01 2023-06-30 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-06-30 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-06-30 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2023-01-01 2023-06-30 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyBMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyCMember 2023-01-01 2023-06-30 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-06-30 0001652561 DQWS:RelatedPartyAMember 2023-06-30 0001652561 DQWS:NVMember 2023-01-01 2023-06-30 0001652561 DQWS:NVMember 2023-06-30 0001652561 country:SC 2023-06-30 0001652561 country:HK 2023-06-30 0001652561 country:MY 2023-06-30 0001652561 DQWS:NVMember 2022-01-01 2022-06-30 0001652561 DQWS:NVMember 2022-06-30 0001652561 country:SC 2022-06-30 0001652561 country:HK 2022-06-30 0001652561 country:MY 2022-06-30 iso4217:USD shares iso4217:USD shares DQWS:Integer pure iso4217:MYR shares iso4217:MYR 0001652561 false Q2 --12-31 false Yes No 10-Q true 2023-06-30 2023 false 333-208083 DSwiss, Inc. NV 47-4215595 Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite Avenue 3, Bangsar South No.8 Jalan Kerinchi 59200 Kuala Lumpur MY (603) 2770-4032 Common Stock DQWS Non-accelerated Filer true true false 206904585 113543 214269 87081 17492 19330 21749 705 745 4378 7483 225037 261738 54472 72179 2932 3459 21354 44548 78758 120186 303795 381924 48092 29539 137495 154710 7895 16515 21354 44548 214836 245312 36381 38461 36381 38461 251217 283773 0.0001 0.0001 200000000 200000000 0 0 0 0 0.0001 0.0001 600000000 600000000 206904585 206904585 206904585 206904585 20690 20690 1395426 1395426 26006 -5846 -1389544 -1324002 52578 86268 11883 52578 98151 303795 381924 355274 739595 621195 1187232 263561 663012 447498 995387 91713 76583 173697 191845 1574 709 3078 5393 93259 83902 181058 156241 -380 -348 -794 -788 817 1615 1868 3644 10670 10564 21646 21437 -11839 -19137 -28591 15128 164 335 -12003 -19137 -28926 15128 -8281 -4924 -11054 -4327 31852 -5024 -23057 -15183 2926 15028 -0.0001 -0.0001 -0.00007 -0.00007 0.00001 0.00001 0.000007 0.000007 206904585 206904585 206904585 206904585 206904585 206904585 206904585 206904585 206904585 20690 1395426 -5846 -1324002 11883 98151 31852 31852 -36616 -11883 -48499 -28926 -28926 206904585 20690 1395426 26006 -1389544 52578 206904585 20690 1395426 -32985 -1309711 589 74009 206904585 20690 1395426 -32985 -1309711 589 74009 -5024 106 -4918 20052 -4924 15128 20052 -4924 15128 206904585 20690 1395426 -38009 -1289659 -4229 84219 206904585 20690 1395426 -38009 -1289659 -4229 84219 -28591 15128 36022 37129 514 515 20150 24332 70535 27479 -11582 -3917 -2700 -4490 -1243 -3361 -20786 -21612 761 340 -70865 33048 335 494 -1927 -71200 30627 6903 -6903 7727 7690 -7727 -7690 -21799 -12424 -100726 3610 214269 234546 113543 238156 335 494 414 433 <p id="xdx_803_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zuEQwhhNCBya" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_822_zEv6yoqK5YY7">DESCRIPTION OF BUSINESS AND ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss, Inc. is organized as a Nevada limited liability company, incorporated on May 28, 2015. For the purposes of financial statement presentation, DSwiss, Inc. and its subsidiaries are herein referred to as “the Company” or “we”. The principal activity of the Company is premier biotech-nutraceutical, beauty supplies, and medical consumables supplies. The Company sells medical consumable supplies, food supplements, skincare, and other related beauty products in Malaysia and around the ASEAN region. We are globally recognized Turnkey Private Label Manufacturing Services for nutraceutical and skincare OEM/ODM products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our professionals manage from custom formulation of scientifically proven and naturally effective, sourcing raw materials, production, quality control, stability, and safety test, clinical testing by third-party labs, packaging, and shipping, including import and export.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our manufacturing facilities which compliant with GMP (Good Manufacturing Practise), FDA (Food Drug Association), HACCP (Hazard Analysis and Critical Control Point), JAKIM HALAL, and Mesti.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of DSwiss, Inc. at June 30, 2023 and 2022 have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial statements, instructions to Form 10-Q, and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2022. In management’s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make our financial statements not misleading have been included. The results of operations for the periods ended June 30, 2023 and 2022 presented are not necessarily indicative of the results to be expected for the full year. The December 31, 2022 balance sheet has been derived from our audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissHoldingLimitedMember__srt--StatementGeographicalAxis__country--HK_ztJzvUbU3Yrg" title="Equity ownership interest rate percentage">100</span>% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissSdnBhdMember__srt--StatementGeographicalAxis__country--MY_ziUzy5oPHlj1" title="Equity ownership interest rate percentage">100</span>% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--StatementGeographicalAxis__country--MY__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zGGjaWXpZ4O5" title="Equity ownership interest rate percentage">40</span>% equity interest. <span style="background-color: white">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dp_uShares_c20230117__20230118__srt--StatementGeographicalAxis__country--HK__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zgrCwehsr9Y5" title="Stock issued during period, shares, new issues">150,000</span> shares, representing <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230118__srt--StatementGeographicalAxis__country--HK__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zYrHzrvuTBXb" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_z4cbwKiuNNAj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPUOalQ1tAsd" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Company name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place and date <br/>of incorporation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of issued <br/>capital</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Proportional <br/>of ownership interest <br/>and voting power <br/>held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 4%">1.</td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_907_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zWYBsaaojEuk" title="Company name">DSwiss Holding Limited</span></td><td style="width: 2%"> </td> <td style="width: 19%"><span id="xdx_902_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zhU5j40VVkv" title="Place and date of incorporation">Seychelles</span>, <span id="xdx_90E_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zJd7uWah1Kd4" title="Place and date of incorporation">May 28, 2015</span></td><td style="width: 2%"> </td> <td style="width: 18%"><span id="xdx_907_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z1Og7J2gGq2a" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></td><td style="width: 2%"> </td> <td style="width: 15%; text-align: left"><span id="xdx_907_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z61I6Gjq505" title="Principal activities">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zR0WQbcuwHZ4" style="width: 14%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>2.</td><td> </td> <td style="text-align: left"><span id="xdx_90E_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zHJ9LRUmMWVh" title="Company name">DSwiss (HK) Limited</span></td><td> </td> <td><span id="xdx_907_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zMNn6M05aeWe">Hong Kong</span>, <span id="xdx_900_edei--EntityIncorporationDateOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_ztb7uRsJlbIf">May 28, 2015</span></td><td> </td> <td><span id="xdx_901_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zUKzZpEOAS9h" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_909_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_znldacZlhdkg" title="Principal activities">Supply of beauty products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_z5zj1vncCmRb" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>3.</td><td> </td> <td style="text-align: left"><span id="xdx_90E_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zy0OrFz1VK7a" title="Company name">DSwiss Sdn Bhd</span></td><td> </td> <td><span id="xdx_90A_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zf8u8e0pNA77">Malaysia</span>, <span id="xdx_906_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zsowsLPlPNg4">March 10, 2011</span></td><td> </td> <td><span id="xdx_90E_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zJtTAb0vkg99" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_904_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zDbyswhvNIvb" title="Principal activities">Supply of beauty products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zlXYDmbvwcDc" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>4.</td><td> </td> <td style="text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zFrmRYIQkTW1">DSwiss Biotech Sdn Bhd</span></td><td> </td> <td><span id="xdx_902_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_ztLuqkuH2im3" title="Place of incorporation">Malaysia</span>, <span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zy0LYgjf3hKa" title="Date of incorporation">March 17, 2016</span></td><td> </td> <td><span id="xdx_904_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z4ghWt80WaTb" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_90C_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zxqRFs5Tw2Fd" title="Principal activities">Supply of biotech products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z5C9j4v1ALml" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AE_zOxl1B4LCD9l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 0.40 1500 0.60 <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_z4cbwKiuNNAj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPUOalQ1tAsd" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Company name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place and date <br/>of incorporation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of issued <br/>capital</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Proportional <br/>of ownership interest <br/>and voting power <br/>held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 4%">1.</td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_907_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zWYBsaaojEuk" title="Company name">DSwiss Holding Limited</span></td><td style="width: 2%"> </td> <td style="width: 19%"><span id="xdx_902_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zhU5j40VVkv" title="Place and date of incorporation">Seychelles</span>, <span id="xdx_90E_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zJd7uWah1Kd4" title="Place and date of incorporation">May 28, 2015</span></td><td style="width: 2%"> </td> <td style="width: 18%"><span id="xdx_907_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z1Og7J2gGq2a" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></td><td style="width: 2%"> </td> <td style="width: 15%; text-align: left"><span id="xdx_907_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z61I6Gjq505" title="Principal activities">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zR0WQbcuwHZ4" style="width: 14%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>2.</td><td> </td> <td style="text-align: left"><span id="xdx_90E_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zHJ9LRUmMWVh" title="Company name">DSwiss (HK) Limited</span></td><td> </td> <td><span id="xdx_907_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zMNn6M05aeWe">Hong Kong</span>, <span id="xdx_900_edei--EntityIncorporationDateOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_ztb7uRsJlbIf">May 28, 2015</span></td><td> </td> <td><span id="xdx_901_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zUKzZpEOAS9h" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_909_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_znldacZlhdkg" title="Principal activities">Supply of beauty products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_z5zj1vncCmRb" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>3.</td><td> </td> <td style="text-align: left"><span id="xdx_90E_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zy0OrFz1VK7a" title="Company name">DSwiss Sdn Bhd</span></td><td> </td> <td><span id="xdx_90A_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zf8u8e0pNA77">Malaysia</span>, <span id="xdx_906_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zsowsLPlPNg4">March 10, 2011</span></td><td> </td> <td><span id="xdx_90E_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zJtTAb0vkg99" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_904_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zDbyswhvNIvb" title="Principal activities">Supply of beauty products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zlXYDmbvwcDc" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>4.</td><td> </td> <td style="text-align: left"><span id="xdx_90F_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zFrmRYIQkTW1">DSwiss Biotech Sdn Bhd</span></td><td> </td> <td><span id="xdx_902_ecustom--PlaceOfIncorporation_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_ztLuqkuH2im3" title="Place of incorporation">Malaysia</span>, <span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zy0LYgjf3hKa" title="Date of incorporation">March 17, 2016</span></td><td> </td> <td><span id="xdx_904_ecustom--ParticularsOfIssuedCapital_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z4ghWt80WaTb" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></td><td> </td> <td style="text-align: left"><span id="xdx_90C_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zxqRFs5Tw2Fd" title="Principal activities">Supply of biotech products</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z5C9j4v1ALml" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> </table> DSwiss Holding Limited Seychelles 2015-05-28 1 share of ordinary share of US$1 each Investment holding 1 DSwiss (HK) Limited Hong Kong 2015-05-28 1 share of ordinary share of HK$1 each Supply of beauty products 1 DSwiss Sdn Bhd Malaysia 2011-03-10 2 shares of ordinary share of RM 1 each Supply of beauty products 1 DSwiss Biotech Sdn Bhd Malaysia 2016-03-17 250,000 shares of ordinary share of RM 1 each Supply of biotech products 1 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zDhoRiUmdYOd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_820_zoxMP1VkrJai">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--GoingConcernPolicyTextBlock_zQp46V3EF0A1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zIZLxRVBzDpk">Going Concern</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the period ended June 30, 2023, the Company incurred a net loss of $<span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230101__20230630_zfRMy1hTmGD" title="Net income loss">28,926</span>, suffered an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20230630_zif4WRLiSiJ7" title="Accumulated deficit">1,389,544</span> and negative operating cash flow of $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20230630_zpW7PAXL2g" title="Cash used in operations">71,200</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stock holders, in the case of equity financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zE3UgwAWVYb8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zx0Uo0lB6rng">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zX82Am2rZQO3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z8J8Qp80LM5d">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zdqdBxVlS3Ab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zKO7YOagsBPd">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zlZimvV46Atf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zOVaX4bVZYcg">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables product are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CostOfSalesPolicyTextBlock_z6Rdcm07Psmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zIpITeArXpE6">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zsfOsIqGMuia" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zlO8u2pPOUFj">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zdI74pNNnwIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zHhogiQ11hra">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consider all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalent.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zgemkyRKwTb9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zY0PsG8QKgA">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zEruuYXFFoS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_ziRcTFeT3owk">Plant and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zn0cadKnh6Vd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z0Q5WWdQoIt" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated useful lives</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zj8vYQJVHigi" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fittings</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqDfDDGDxK5l" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLFQj76AZ506" title="Property and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z6aZqDuZQZU2" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> </table> <p id="xdx_8A9_zKig3FCYUkee" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zTKKHNkHJNa9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zDgnKHDToXch">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong, which are amortized on a straight-line basis over a useful life of <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dc_c20230630_zJAEHhbvGbKg" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_900_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20230101__20230630_zQ9D03plNTw" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the six months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zE9e9N7RRpub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zLtKTcJHvica">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to November 1, 2019, the Company accounted for leases under ASC 840, <i>Accounting for Leases</i>. Effective November 1, 2019, the Company adopted the guidance of ASC 842, <i>Leases,</i> which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods (see Note 10).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zAdwOM6O1vDk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z2J4n3d2LYZ2">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230630_zDznFExdHpW6" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zBNZaJH56gdg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zS0JF5Xzrcw">Net income/(loss) per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net income/(loss) per share in accordance with ASC Topic 260, <i>“Earnings per Share.”</i> Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVJligxiOpw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zvf4vvRztknb">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia and Hong Kong maintains their books and record in their local currency, Ringgits Malaysia (“RM”) and Hong Kong Dollars (“HK$”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zC6CBj6KgSA2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zPgzdjdXuDTi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the six months ended <br/>June 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Period-end RM : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zYJ4XxJublt2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zHnkWZcwy0x6" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average RM : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zVXjE0I2rrYb" style="text-align: right" title="Foreign currency exchange rate, translation">4.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zUVMpbnZFnN2" style="text-align: right" title="Foreign currency exchange rate, translation">4.29</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Period-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_zcHaXGLkljS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_z7OdpSQd6uoe" style="text-align: right" title="Foreign currency exchange rate, translation">7.85</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_zGv50TrbxVGf" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_z7MaeCEH2jWd" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zzVWiyloDT3l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--RelatedPartiesPolicyTextBlock_zu4CDBK4g21k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_z7xFiXqtD7eh">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zaNRhyQ0yX7g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zYLsodJn9hW6">Fair value of financial instruments</span>:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts receivable, deposits, accounts payable, other payables, and accounts payable approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1</i>: Observable inputs such as quoted prices in active markets;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2</i>: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3</i>: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zcyTbf1csoi9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_ztERpIaoOHCk">Segment reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. For the six months ended June 30, 2023, the Company operates in <span id="xdx_90B_eus-gaap--NumberOfReportableSegments_dc_uInteger_c20230101__20230630_z6yOWMQqhc47" title="Number of reportable operating segment">three</span> reportable operating segments in Malaysia and Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLuoTPSpvBTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zJO4Yc1gXSh">Recently Adopted Accounting Standards</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--RecentlyIssuedAccountingStandardPolicyTextBlock_zO5WIMBWGyUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zkkcJSJm7Kuk">Recently Issued Accounting Standard</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews new accounting standards as issued. Management has not identified any other new standards that is believes will have a significant impact on the Company’s financial statements.</span></p> <p id="xdx_856_z0aWPAfQ0Jr9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--GoingConcernPolicyTextBlock_zQp46V3EF0A1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zIZLxRVBzDpk">Going Concern</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the period ended June 30, 2023, the Company incurred a net loss of $<span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230101__20230630_zfRMy1hTmGD" title="Net income loss">28,926</span>, suffered an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20230630_zif4WRLiSiJ7" title="Accumulated deficit">1,389,544</span> and negative operating cash flow of $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20230630_zpW7PAXL2g" title="Cash used in operations">71,200</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stock holders, in the case of equity financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -28926 -1389544 -71200 <p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zE3UgwAWVYb8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zx0Uo0lB6rng">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zX82Am2rZQO3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z8J8Qp80LM5d">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zdqdBxVlS3Ab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zKO7YOagsBPd">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zlZimvV46Atf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zOVaX4bVZYcg">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables product are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CostOfSalesPolicyTextBlock_z6Rdcm07Psmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zIpITeArXpE6">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zsfOsIqGMuia" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zlO8u2pPOUFj">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zdI74pNNnwIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zHhogiQ11hra">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consider all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalent.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zgemkyRKwTb9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zY0PsG8QKgA">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zEruuYXFFoS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_ziRcTFeT3owk">Plant and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zn0cadKnh6Vd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z0Q5WWdQoIt" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated useful lives</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zj8vYQJVHigi" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fittings</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqDfDDGDxK5l" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLFQj76AZ506" title="Property and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z6aZqDuZQZU2" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> </table> <p id="xdx_8A9_zKig3FCYUkee" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zn0cadKnh6Vd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z0Q5WWdQoIt" style="display: none">SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated useful lives</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zj8vYQJVHigi" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fittings</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqDfDDGDxK5l" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLFQj76AZ506" title="Property and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z6aZqDuZQZU2" title="Property and equipment, estimated useful lives">5</span> years</span></td></tr> </table> P5Y P5Y P10Y P5Y <p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zTKKHNkHJNa9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zDgnKHDToXch">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong, which are amortized on a straight-line basis over a useful life of <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dc_c20230630_zJAEHhbvGbKg" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_900_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20230101__20230630_zQ9D03plNTw" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the six months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y 0 <p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zE9e9N7RRpub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zLtKTcJHvica">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to November 1, 2019, the Company accounted for leases under ASC 840, <i>Accounting for Leases</i>. Effective November 1, 2019, the Company adopted the guidance of ASC 842, <i>Leases,</i> which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods (see Note 10).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zAdwOM6O1vDk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z2J4n3d2LYZ2">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230630_zDznFExdHpW6" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zBNZaJH56gdg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zS0JF5Xzrcw">Net income/(loss) per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net income/(loss) per share in accordance with ASC Topic 260, <i>“Earnings per Share.”</i> Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVJligxiOpw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zvf4vvRztknb">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia and Hong Kong maintains their books and record in their local currency, Ringgits Malaysia (“RM”) and Hong Kong Dollars (“HK$”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zC6CBj6KgSA2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zPgzdjdXuDTi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the six months ended <br/>June 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Period-end RM : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zYJ4XxJublt2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zHnkWZcwy0x6" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average RM : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zVXjE0I2rrYb" style="text-align: right" title="Foreign currency exchange rate, translation">4.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zUVMpbnZFnN2" style="text-align: right" title="Foreign currency exchange rate, translation">4.29</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Period-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_zcHaXGLkljS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_z7OdpSQd6uoe" style="text-align: right" title="Foreign currency exchange rate, translation">7.85</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_zGv50TrbxVGf" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_z7MaeCEH2jWd" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zzVWiyloDT3l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zC6CBj6KgSA2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from RM into US$1 and HK$ into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zPgzdjdXuDTi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the six months ended <br/>June 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Period-end RM : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zYJ4XxJublt2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndRMMember_zHnkWZcwy0x6" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average RM : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zVXjE0I2rrYb" style="text-align: right" title="Foreign currency exchange rate, translation">4.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageRMMember_zUVMpbnZFnN2" style="text-align: right" title="Foreign currency exchange rate, translation">4.29</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Period-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_zcHaXGLkljS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndHKMember_z7OdpSQd6uoe" style="text-align: right" title="Foreign currency exchange rate, translation">7.85</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_zGv50TrbxVGf" style="text-align: right" title="Foreign currency exchange rate, translation">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodAverageHKMember_z7MaeCEH2jWd" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> </table> 4.67 4.41 4.45 4.29 7.84 7.85 7.84 7.83 <p id="xdx_844_ecustom--RelatedPartiesPolicyTextBlock_zu4CDBK4g21k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_z7xFiXqtD7eh">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zaNRhyQ0yX7g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zYLsodJn9hW6">Fair value of financial instruments</span>:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts receivable, deposits, accounts payable, other payables, and accounts payable approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1</i>: Observable inputs such as quoted prices in active markets;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2</i>: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3</i>: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zcyTbf1csoi9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_ztERpIaoOHCk">Segment reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. For the six months ended June 30, 2023, the Company operates in <span id="xdx_90B_eus-gaap--NumberOfReportableSegments_dc_uInteger_c20230101__20230630_z6yOWMQqhc47" title="Number of reportable operating segment">three</span> reportable operating segments in Malaysia and Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3 <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLuoTPSpvBTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zJO4Yc1gXSh">Recently Adopted Accounting Standards</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--RecentlyIssuedAccountingStandardPolicyTextBlock_zO5WIMBWGyUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zkkcJSJm7Kuk">Recently Issued Accounting Standard</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews new accounting standards as issued. Management has not identified any other new standards that is believes will have a significant impact on the Company’s financial statements.</span></p> <p id="xdx_800_eus-gaap--VariableInterestEntityDisclosureTextBlock_z3qNDWLzWlyj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_82D_zPQmeDLMwMy8">VIE STRUCTURE AND ARRANGEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to <span id="xdx_904_ecustom--PercentageOfAnnualNetProfitToBeReceivedAsFee_dp_uPure_c20160626__20160627__us-gaap--TypeOfArrangementAxis__custom--ManagementServicesAgreementIMember__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zHocQCsjgw5d" title="Percentage of annual net profit to be received as fee">100</span>% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an Equity Pledge Agreement that pledges the shares in DSBT.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230117__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zKIOavRNrlh8" title="Number of shares, acquired">150,000</span> shares, representing <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zgwpkE1A8wye" title="Equity ownership interest rate percentage">60</span>% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM <span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zmwXEESZ1oC7" title="Consideration price per share">1</span>. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 150000 0.60 1 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zmUBGJsGSauk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_822_z8Lbd4ooKYZ7">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had a total of <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20230630_zqaOt1Wv2146" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20230630_z1hNJRMfLuMj" title="Common stock shares outstanding">206,904,585</span></span> of its common stock issued and outstanding. There are <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20230630_zCGXMPdemp9l" title="Preferred stock shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20230630_zQC7JyWhki07" title="Preferred stock shares outstanding">no</span></span> shares of preferred stock issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 206904585 206904585 0 0 <p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zSQj4yALqBj4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_82B_zcCL1pe2i4N8">PLANT AND EQUIPMENT</span></b></span></p> <p id="xdx_892_eus-gaap--PropertyPlantAndEquipmentTextBlock_zLoEz2shWL0g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; background-color: white"><span id="xdx_8B4_z2YtBeXuiLj1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PLANT AND EQUIPMENT  </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_z5aulu9s6Fb2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_498_20221231_zUbdZboIwlSa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zuhj20Zhw1q8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and software</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,535</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,535</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zJmhB7j4eY4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fittings</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,144</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,144</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zRy8VfkcBSV6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,152</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,152</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zToQILP8i9tj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,868</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,868</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zx5Tr8as3xGd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total plant and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,699</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,699</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zXKVEv9oq65k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(201,612</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(187,236</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_znC07ewldtF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of translation exchange</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,615</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,284</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_zCHLYVWCsTe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,472</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,179</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_z4NGThISiN46" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months and six months ended June 30, 2023 were $<span id="xdx_903_eus-gaap--Depreciation_pp0p0_c20230401__20230630_z2rejJzCYAqh" title="Depreciation expense">6,839</span> and $<span id="xdx_90F_eus-gaap--Depreciation_pp0p0_c20230101__20230630_z23iNivaW9I7" title="Depreciation expense">14,376</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months and six months ended June 30, 2022 were $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20220401__20220630_zsivc3EIXWel" title="Depreciation expense">8,191</span> and $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20220101__20220630_zFAdoTni3f8g" title="Depreciation expense">15,692</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--PropertyPlantAndEquipmentTextBlock_zLoEz2shWL0g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; background-color: white"><span id="xdx_8B4_z2YtBeXuiLj1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PLANT AND EQUIPMENT  </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_z5aulu9s6Fb2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_498_20221231_zUbdZboIwlSa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zuhj20Zhw1q8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and software</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,535</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,535</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zJmhB7j4eY4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fittings</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,144</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,144</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zRy8VfkcBSV6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,152</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,152</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zToQILP8i9tj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,868</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,868</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zx5Tr8as3xGd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total plant and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,699</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,699</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zXKVEv9oq65k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(201,612</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(187,236</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_znC07ewldtF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of translation exchange</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,615</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,284</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_zCHLYVWCsTe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,472</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,179</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 105535 105535 6144 6144 21152 21152 135868 135868 268699 268699 201612 187236 12615 9284 54472 72179 6839 14376 8191 15692 <p id="xdx_805_eus-gaap--IntangibleAssetsDisclosureTextBlock_zCwaC8PJkHJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_823_zWGIHw2UIm6">INTANGIBLE ASSETS</span></b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zchLWrrvnep8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span id="xdx_8B3_zcPTexDV0pkf" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230630_zeB06w3wtN24" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_znlh3LROCIti" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_z5qZwO3d9Qkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zKdkqrdATuDf" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,678</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_zRWT1L6BRtMe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(467</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_zmKZ8rbDogje" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,932</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zTkCqSj1tnic" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization for the three months and six months ended June 30, 2023 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630_zUV9bVh2fvE2" title="Amortization of intangible assets">257</span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630_zQBmmlKcUBj9" title="Amortization of intangible assets">514</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization for the three months and six months ended June 30, 2022 was $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630_zskaT5r5kwcl" title="Amortization of intangible assets">257</span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630_zfGt5U9ozZMa" title="Amortization of intangible assets">515</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zchLWrrvnep8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span id="xdx_8B3_zcPTexDV0pkf" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230630_zeB06w3wtN24" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_znlh3LROCIti" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_z5qZwO3d9Qkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zKdkqrdATuDf" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,678</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_zRWT1L6BRtMe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(467</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_zmKZ8rbDogje" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,932</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12077 12077 8678 8164 467 454 2932 3459 257 514 257 515 <p id="xdx_802_eus-gaap--OtherCurrentAssetsTextBlock_zFx8BTFAApEd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_822_zRVCB8Wahpc9">OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></b></span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zXBgnxSWd1Vl" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="display: none"><span id="xdx_8B6_zYCPOimzw7wd">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zGxZN4iRllN6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zHChgxN2jjO6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--OtherReceivables_iI_maPEAOAzAo0_zfQY8i2mKtC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">66</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_z2pDHkeWQIza" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">658</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_z41evEcDkGUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,606</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,669</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_zbSoPBTMHgP5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,330</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,749</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zO14PoMnh3Fa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zXBgnxSWd1Vl" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="display: none"><span id="xdx_8B6_zYCPOimzw7wd">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zGxZN4iRllN6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zHChgxN2jjO6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--OtherReceivables_iI_maPEAOAzAo0_zfQY8i2mKtC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">66</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_z2pDHkeWQIza" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">658</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_z41evEcDkGUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,606</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,669</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_zbSoPBTMHgP5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,330</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,749</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 66 658 2080 18606 19669 19330 21749 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zPLwk1geFr3e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_82B_z9z7HQQJa2k1">INVENTORIES</span></b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zVwILGNk5M9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z1BBwt5wT0W1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zzbjtkaHHuUl" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zMUg6eHSMJGh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_zcyjp6EcJu9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">4,378</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zwGOpJ7WpVG4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,378</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zH99OT0IqaZ2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zVwILGNk5M9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z1BBwt5wT0W1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zzbjtkaHHuUl" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zMUg6eHSMJGh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_zcyjp6EcJu9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">4,378</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zwGOpJ7WpVG4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,378</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4378 7483 4378 7483 <p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zio9ObZiCyyj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_821_zlvD5y88cX52">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zDBW57SFJIEa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z0xXY51GGl26" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230630_zDLpn4RhNf0g" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zg40xVNoXzA" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zn0yvTnOSt0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">86,508</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_ztVlWyfSuAK8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zaWX9mRRJa2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,864</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_zIqY7TYcLEp4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,487</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zW6cfKysqSp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">137,495</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zTKz9LFxob2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zDBW57SFJIEa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z0xXY51GGl26" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230630_zDLpn4RhNf0g" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zg40xVNoXzA" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zn0yvTnOSt0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">86,508</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_ztVlWyfSuAK8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zaWX9mRRJa2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,864</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_zIqY7TYcLEp4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,487</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zW6cfKysqSp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">137,495</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 86508 100385 25636 20266 12864 16683 12487 17376 137495 154710 <p id="xdx_80A_eus-gaap--LesseeFinanceLeasesTextBlock_zHRS6qggf3ff" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_825_zfwSKGSYE5qd">FINANCE LEASE LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company purchased motor vehicles with finance lease. <span id="xdx_90B_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--FirstFinanceLeaseAgreementMember_znWd3CrNH7v" title="Finance lease, description">The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly</span>. <span id="xdx_90F_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--SecondFinanceLeaseAgreementMember_zaZmSlzBNvUf" title="Finance lease, description">The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly</span>. The obligation under the finance lease is as follows:</span></p> <p id="xdx_89D_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_zqYyBL7c66zi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zHeHfywGIs17" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630_z4WGV70HILMb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_z2kzhK1XmE9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zejtrUUDdUAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finance lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">46,876</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_ztEOZb3aj1C6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,600</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zwYOgwEMIwpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zhanzifT9Kwh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zUQ3azLXfkw5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,381</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zvbvkcabN5jg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z5kyEODISxse" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zQyHEieSXAD9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 the maturities of the finance lease for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z7TYomF3iqCc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20230630_zAf87rCGU6m3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maFLLPDzFyD_z1I4eg6nvUz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">7,895</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_z0ScYruTiytk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,291</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_z9y1KOVd4Gm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,441</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_za30XgtEC5mj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_z7QH97t0oKj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zuwfkj9xwmVl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly <p id="xdx_89D_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_zqYyBL7c66zi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zHeHfywGIs17" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630_z4WGV70HILMb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_z2kzhK1XmE9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zejtrUUDdUAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finance lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">46,876</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_ztEOZb3aj1C6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,600</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zwYOgwEMIwpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zhanzifT9Kwh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zUQ3azLXfkw5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,381</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiability_iI_pp0p0_zvbvkcabN5jg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 46876 58768 2600 3792 44276 54976 7895 16515 36381 38461 44276 54976 <p id="xdx_89A_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zQyHEieSXAD9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 the maturities of the finance lease for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z7TYomF3iqCc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20230630_zAf87rCGU6m3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maFLLPDzFyD_z1I4eg6nvUz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">7,895</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_z0ScYruTiytk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,291</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_z9y1KOVd4Gm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,441</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_za30XgtEC5mj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_z7QH97t0oKj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,276</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7895 16291 12441 7649 44276 <p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_z3lWcIhwgkVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82D_ziLAzxezbODc">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zue1A3ztDIO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023 and 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zWHnGDYaFIqg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630_zGl2kud7pKP4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zaRqB2zlfWB1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zWlhqIxm51kh" style="vertical-align: bottom; background-color: White"> <td style="width: 64%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(35,199</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(20,770</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_z2NPJt0R9Vad" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,178</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,169</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_z62eYOYVzVq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,540</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,064</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zj9vdbkvPt4d" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,326</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,131</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwjSgSL5xjTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">(Loss)/Profit before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(28,591</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,128</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zP5uFwzcxe6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zw22yu8pf8gi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zMcTcwdodiE" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PROVISION FOR INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630_zGdy9qTAO281" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220630_z7gEuidEZQk2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zSfBJT67npQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">     </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_zaTh6vu2X8i5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_zJcfWetZOCaa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-left: 10pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(335</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zInnHJ8vydmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_zgEAqFwScyl3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_zgbqQne0qn3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_zkiyUky4mCEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(335</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zH21hMDGiJPc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Seychelles, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2023, the operations in the United States of America incurred $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20230630__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zUSkXm9NMbfj" title="Cumulative net operating losses">507,350</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20230101__20230630__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zj38Zk4zypJ2" title="Income tax rate">21</span>%. <span id="xdx_900_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_c20230101__20230630__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zFWq7kbaFPsa" title="Net operating loss carryforwards expiration">The net operating loss carry forwards begin to expire in 2038, if unutilized</span>. The Company has provided for a full valuation allowance of $<span id="xdx_906_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20230630__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zVSVUluc6Fxf" title="Valuation allowance">106,544</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Seychelles</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zPojaRKtxsN6" title="Income tax rate">16.5</span>% on its assessable income. As of June 30, 2023, the operations in the Hong Kong incurred $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zeTBIIOuGiAf" title="Cumulative net operating losses">634,643</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zwCmbz1Q1ZX8" title="Statutory income tax, rate">16.5</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_900_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zYbsNs5y0z6" title="Valuation allowance">104,716</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss Sdn. Bhd. and DSwiss Biotech Sdn. Bhd. are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MinimumMember_zLNWgzB3gfMl" title="Percentage of statutory income rate">15</span>% to <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MaximumMember_zjq9ydtljWK3" title="Statutory income tax, rate">24</span>% on its assessable income. As of June 30, 2023, the operations in the Malaysia incurred $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zaCbx6cN9b2h" title="Cumulative net operating losses">203,977</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20230101__20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zce11wY42RO8" title="Income tax rate">15</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_906_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zxeAxnUJJCA3" title="Valuation allowance">30,597</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zue1A3ztDIO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023 and 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zWHnGDYaFIqg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630_zGl2kud7pKP4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zaRqB2zlfWB1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zWlhqIxm51kh" style="vertical-align: bottom; background-color: White"> <td style="width: 64%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(35,199</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(20,770</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_z2NPJt0R9Vad" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,178</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,169</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_z62eYOYVzVq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,540</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,064</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zj9vdbkvPt4d" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,326</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,131</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwjSgSL5xjTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">(Loss)/Profit before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(28,591</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,128</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -35199 -20770 -3178 -2169 -3540 -2064 13326 40131 -28591 15128 <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zw22yu8pf8gi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zMcTcwdodiE" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PROVISION FOR INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630_zGdy9qTAO281" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220630_z7gEuidEZQk2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zSfBJT67npQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">     </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_zaTh6vu2X8i5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_zJcfWetZOCaa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-left: 10pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(335</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zInnHJ8vydmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_zgEAqFwScyl3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_zgbqQne0qn3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_zkiyUky4mCEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(335</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 335 335 507350 0.21 The net operating loss carry forwards begin to expire in 2038, if unutilized 106544 0.165 634643 0.165 104716 0.15 0.24 203977 0.15 30597 <p id="xdx_80C_eus-gaap--ConcentrationRiskDisclosureTextBlock_zlqvrvsHnFcl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_82F_zPdkJXgQgJek">CONCENTRATIONS OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to the following concentrations of risk:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zKr8cDqSVz29" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zWxAPfF1bEq1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF CONCENTRATION OF RISK</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For three months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>revenue</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zkyv1VDLflyl" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zUzH1ZORkywg" style="width: 6%; text-align: right" title="Revenues">346,253</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zALhJf2PLwRe" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zTLCBlxXKq97" style="width: 6%; text-align: right" title="Percentage of revenues">46</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zkTBrFqVnbW2" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEj5QC0oY7G6" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z19FN33F8rhh" style="text-align: right" title="Revenues">91,754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjCs5rFEPLfh" style="text-align: right" title="Revenues">155,407</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zL1PMdB7BFm3" style="text-align: right" title="Percentage of revenues">25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_znJ25eG2w0b3" style="text-align: right" title="Percentage of revenues">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zz8jRhRyEL7" style="text-align: right" title="Accounts receivable, trade">30,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zKOEFJxQE6L3" style="text-align: right" title="Accounts receivable, trade">6,843</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zoMflESR0rjj" style="text-align: right" title="Revenues">50,196</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGurVm3Ls4q3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zYocyE4V5a7i" style="text-align: right" title="Revenues">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zR0n3YaLLDA6" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zs3fZprjyAhg" style="text-align: right" title="Accounts receivable, trade">27,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPLO0BGvZqMe" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0886">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z1tHhqVDw2B3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">85,002</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z7eWNr3TZut2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zzdGmsAtV4vb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">24</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zdNEYQ520lLh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zXeLnRnT2j7i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zgnKTNcnRK9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0898">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zly9qFk3tpG7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">  226,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zKPy23xNvOse" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">  501,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zCtjMQBOwwkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">63</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z0HKdFy8gQE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">67</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zafIAihlzLi3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">58,324</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zarCtD0UUGLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">6,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For six months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>revenues</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts receivable, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>trade</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zTjLTyLd6d4l" style="width: 6%; text-align: right" title="Revenues">63,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zeK6ZZcCahfk" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zL6BLtQIrnja" style="width: 6%; text-align: right" title="Percentage of revenues">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zbLwAtZZftc6" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z5LrGObR0s9b" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zAmsqfKW6Gq" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zmDju0umSVsc" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zGhy3nTkF8P2" style="text-align: right" title="Revenues">416,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z2a3Ghe73wFf" style="text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zlYeoV9j9OA" style="text-align: right" title="Percentage of revenues">35</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z4ky1g8A70Aj" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zxAuClCGTA4f" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z0iecfXzdN94" style="text-align: right" title="Revenues">127,102</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z15fMbqZOGEb" style="text-align: right" title="Revenues">255,238</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zlvon3J2rYy2" style="text-align: right" title="Revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zTeGgJVNpMYj" style="text-align: right" title="Revenues">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z5ee1c25mbX6" style="text-align: right" title="Accounts receivable, trade">30,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zyxa7rhDYPTc" style="text-align: right" title="Accounts receivable, trade">6,843</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zhVlhQh6CVFk" style="text-align: right" title="Revenues">100,392</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zuWR1PHpxcCb" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zfx76WZ0rMh1" style="text-align: right" title="Revenues">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z36NxHnsWJZc" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zsRB62nncSIk" style="text-align: right" title="Accounts receivable, trade">27,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zI28965IJU1c" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z6B0EB2X3Me4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">147,848</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zlJRDQeeKg89" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zk7Cirrko43f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">24</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z6XYTmOQ8BDi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zHdLhvRBROa3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z9yRuwuT58n6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zt8FezLmqtg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"> 439,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zk2zzsmNoVD7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">671,670</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z3DlaLXLlxHa" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">70</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zEmnyzUMOxng" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">56</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z08ZarO2ajMj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">58,324</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zfdsYCDCKyNc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">6,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For three months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>purchase</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts payable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z91T4AqgB1Nb" style="width: 6%; text-align: right" title="Purchase">51,367</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z5QvSfeB5t29" style="width: 6%; text-align: right" title="Purchase">304,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zvkqk6X6k39c" style="width: 6%; text-align: right" title="Percentage of revenues">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zRztaGOCapx9" style="width: 6%; text-align: right" title="Percentage of revenues">45</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zf348M3GV0W4" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zILGq5Jp7TP" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_ztqdR5nZFRs" style="text-align: right" title="Purchase">75,546</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zcesqeegagf1" style="text-align: right" title="Purchase">131,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zCBVyAlSKp25" style="text-align: right" title="Percentage of revenues">29</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z6UlnYnqFdqg" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zzfg0cZ9bws7" style="text-align: right">3,722</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zrt7gkDuz7rh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zqPDMVjAaBKd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">71,478</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zwI1aC9H74p5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">88,841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z2kvpFwG1Gyk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">27</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zbu0lzPpnWL7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">13</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zmzPMwGOei1i" style="border-bottom: Black 1.5pt solid; text-align: right">38,604</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zW8VRC3g7JHc" style="border-bottom: Black 1.5pt solid; text-align: right">26,426</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_ztXViYO7J3md" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"> 198,391</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z8zmLucyaf1f" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases"> 524,396</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zWrH2zh6Jpf9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">75</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z6jjbe30ewnf" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">77</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zQjezXig0Oz9" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">42,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zpgnSwCd8YFg" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade">26,426</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For six months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>purchases</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts payable,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>trade</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z9s0bzBLZOna" style="width: 6%; text-align: right" title="Purchase">74,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zbRpTZTuznAi" style="width: 6%; text-align: right" title="Purchase">407,162</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z38YrtnvyWL1" style="width: 6%; text-align: right" title="Percentage of revenues">17</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zIdM0kJ8MXLh" style="width: 6%; text-align: right" title="Percentage of revenues">45</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z1pO2PVINZkg" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zYkSJjQPyTCa" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z2KX5SgO3dH" style="text-align: right" title="Purchase">166,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zCjAhFAsVAj7" style="text-align: right" title="Purchase">187,012</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zz252l7uQWUf" style="text-align: right" title="Percentage of revenues">37</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zlQIBeP5Yjzh" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zOyKWgDZi0Rg" style="text-align: right">3,722</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zY2wNOW3C5Yd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1048">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zbJRahhKZXJ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">95,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zWeOAFXnFhJ5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">159,895</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zxV8uGMisJfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">21</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zsVaWyXrJAzk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">13</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zNtaGp5ZALze" style="border-bottom: Black 1.5pt solid; text-align: right">38,604</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z5iyhbUlg5Vb" style="border-bottom: Black 1.5pt solid; text-align: right">26,426</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zYRpHp2qckK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"> 336,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zOAjLPVHq0Yf" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases"> 754,069</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zOHUbEjNI87g" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">75</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zV0HvgXMaic7" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">77</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zNb8Gq3wNAS6" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">42,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zoTQKQ6dK4fh" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade">26,426</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zbFkfELvZzqf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All vendors are located in Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its accounts receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate actually post higher or lower income depending on exchange rate of RM converted to US$ and HK$ converted into US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zKr8cDqSVz29" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zWxAPfF1bEq1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF CONCENTRATION OF RISK</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For three months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>revenue</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zkyv1VDLflyl" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zUzH1ZORkywg" style="width: 6%; text-align: right" title="Revenues">346,253</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zALhJf2PLwRe" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zTLCBlxXKq97" style="width: 6%; text-align: right" title="Percentage of revenues">46</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zkTBrFqVnbW2" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEj5QC0oY7G6" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z19FN33F8rhh" style="text-align: right" title="Revenues">91,754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjCs5rFEPLfh" style="text-align: right" title="Revenues">155,407</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zL1PMdB7BFm3" style="text-align: right" title="Percentage of revenues">25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_znJ25eG2w0b3" style="text-align: right" title="Percentage of revenues">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zz8jRhRyEL7" style="text-align: right" title="Accounts receivable, trade">30,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zKOEFJxQE6L3" style="text-align: right" title="Accounts receivable, trade">6,843</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zoMflESR0rjj" style="text-align: right" title="Revenues">50,196</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGurVm3Ls4q3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zYocyE4V5a7i" style="text-align: right" title="Revenues">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zR0n3YaLLDA6" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zs3fZprjyAhg" style="text-align: right" title="Accounts receivable, trade">27,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPLO0BGvZqMe" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0886">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z1tHhqVDw2B3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">85,002</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z7eWNr3TZut2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zzdGmsAtV4vb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">24</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zdNEYQ520lLh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zXeLnRnT2j7i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0896">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zgnKTNcnRK9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0898">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zly9qFk3tpG7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">  226,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zKPy23xNvOse" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">  501,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zCtjMQBOwwkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">63</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z0HKdFy8gQE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">67</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zafIAihlzLi3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">58,324</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zarCtD0UUGLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">6,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For six months ended June 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>revenues</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts receivable, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>trade</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zTjLTyLd6d4l" style="width: 6%; text-align: right" title="Revenues">63,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zeK6ZZcCahfk" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zL6BLtQIrnja" style="width: 6%; text-align: right" title="Percentage of revenues">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zbLwAtZZftc6" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z5LrGObR0s9b" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zAmsqfKW6Gq" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zmDju0umSVsc" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zGhy3nTkF8P2" style="text-align: right" title="Revenues">416,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z2a3Ghe73wFf" style="text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zlYeoV9j9OA" style="text-align: right" title="Percentage of revenues">35</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z4ky1g8A70Aj" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zxAuClCGTA4f" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z0iecfXzdN94" style="text-align: right" title="Revenues">127,102</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z15fMbqZOGEb" style="text-align: right" title="Revenues">255,238</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zlvon3J2rYy2" style="text-align: right" title="Revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zTeGgJVNpMYj" style="text-align: right" title="Revenues">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z5ee1c25mbX6" style="text-align: right" title="Accounts receivable, trade">30,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zyxa7rhDYPTc" style="text-align: right" title="Accounts receivable, trade">6,843</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zhVlhQh6CVFk" style="text-align: right" title="Revenues">100,392</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zuWR1PHpxcCb" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zfx76WZ0rMh1" style="text-align: right" title="Revenues">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z36NxHnsWJZc" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zsRB62nncSIk" style="text-align: right" title="Accounts receivable, trade">27,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zI28965IJU1c" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z6B0EB2X3Me4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">147,848</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zlJRDQeeKg89" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zk7Cirrko43f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">24</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z6XYTmOQ8BDi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zHdLhvRBROa3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z9yRuwuT58n6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zt8FezLmqtg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"> 439,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zk2zzsmNoVD7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">671,670</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z3DlaLXLlxHa" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">70</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zEmnyzUMOxng" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">56</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_z08ZarO2ajMj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">58,324</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--TradeAccountsReceivableMember_zfdsYCDCKyNc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">6,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For three months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>purchase</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts payable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z91T4AqgB1Nb" style="width: 6%; text-align: right" title="Purchase">51,367</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z5QvSfeB5t29" style="width: 6%; text-align: right" title="Purchase">304,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zvkqk6X6k39c" style="width: 6%; text-align: right" title="Percentage of revenues">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zRztaGOCapx9" style="width: 6%; text-align: right" title="Percentage of revenues">45</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zf348M3GV0W4" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zILGq5Jp7TP" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_ztqdR5nZFRs" style="text-align: right" title="Purchase">75,546</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zcesqeegagf1" style="text-align: right" title="Purchase">131,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zCBVyAlSKp25" style="text-align: right" title="Percentage of revenues">29</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z6UlnYnqFdqg" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zzfg0cZ9bws7" style="text-align: right">3,722</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zrt7gkDuz7rh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zqPDMVjAaBKd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">71,478</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zwI1aC9H74p5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">88,841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z2kvpFwG1Gyk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">27</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zbu0lzPpnWL7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">13</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zmzPMwGOei1i" style="border-bottom: Black 1.5pt solid; text-align: right">38,604</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zW8VRC3g7JHc" style="border-bottom: Black 1.5pt solid; text-align: right">26,426</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_ztXViYO7J3md" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"> 198,391</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z8zmLucyaf1f" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases"> 524,396</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zWrH2zh6Jpf9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">75</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z6jjbe30ewnf" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">77</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zQjezXig0Oz9" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">42,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zpgnSwCd8YFg" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade">26,426</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For six months ended June 30, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at period-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>purchases</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts payable,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>trade</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z9s0bzBLZOna" style="width: 6%; text-align: right" title="Purchase">74,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zbRpTZTuznAi" style="width: 6%; text-align: right" title="Purchase">407,162</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z38YrtnvyWL1" style="width: 6%; text-align: right" title="Percentage of revenues">17</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zIdM0kJ8MXLh" style="width: 6%; text-align: right" title="Percentage of revenues">45</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z1pO2PVINZkg" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zYkSJjQPyTCa" style="width: 6%; text-align: right" title="Account Payable, trade"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_z2KX5SgO3dH" style="text-align: right" title="Purchase">166,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zCjAhFAsVAj7" style="text-align: right" title="Purchase">187,012</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zz252l7uQWUf" style="text-align: right" title="Percentage of revenues">37</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zlQIBeP5Yjzh" style="text-align: right" title="Percentage of revenues">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zOyKWgDZi0Rg" style="text-align: right">3,722</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zY2wNOW3C5Yd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1048">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zbJRahhKZXJ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">95,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zWeOAFXnFhJ5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">159,895</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zxV8uGMisJfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">21</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zsVaWyXrJAzk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">13</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zNtaGp5ZALze" style="border-bottom: Black 1.5pt solid; text-align: right">38,604</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_z5iyhbUlg5Vb" style="border-bottom: Black 1.5pt solid; text-align: right">26,426</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zYRpHp2qckK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"> 336,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zOAjLPVHq0Yf" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchases"> 754,069</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zOHUbEjNI87g" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">75</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zV0HvgXMaic7" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">77</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zNb8Gq3wNAS6" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, trade">42,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zoTQKQ6dK4fh" style="border-bottom: Black 2.5pt double; text-align: right" title="Account Payable, Trade">26,426</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 346253 0.46 91754 155407 0.25 0.21 30849 6843 50196 0.14 27475 85002 0.24 226952 501660 0.63 0.67 58324 6843 63861 0.10 416432 0.35 127102 255238 0.20 0.21 30849 6843 100392 0.16 27475 147848 0.24 439203 671670 0.70 0.56 58324 6843 51367 304423 0.19 0.45 75546 131132 0.29 0.19 3722 71478 88841 0.27 0.13 38604 26426 198391 524396 0.75 0.77 42326 26426 74870 407162 0.17 0.45 166206 187012 0.37 0.19 3722 95572 159895 0.21 0.13 38604 26426 336648 754069 0.75 0.77 42326 26426 <p id="xdx_809_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zi5bsavlh9Wj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_829_zNTZBx0QBkd4">LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022, the Company recognized approximately US$<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_z5wLLQPtPrml" title="Lease liability"><span id="xdx_906_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zvbaGYuHc90g" title="Lease asset- right of use">92,606</span></span>, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of <span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_ztTTqhmXqoxl" title="Discount rate of lease payment">5.4</span>% adopted from Public Bank Berhad’s base lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The operating lease right and lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zHhqJFotEYI2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 and December 31, 2022, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_z3BlF7zwJ7Ja" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">As of beginning of the period/year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20230101__20230630_zl8NtMNrS0U8" style="width: 14%; text-align: right" title="Operating lease right of use asset">44,548</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20220101__20221231_zQmVlU31f3Z8" style="width: 14%; text-align: right" title="Operating lease right of use asset">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20230101__20230630_zPinzVEdeQGa" style="text-align: right" title="Accumulated amortization">(21,646</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zxcUqwvzjDja" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20230101__20230630_zOpJgvllnEXk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,548</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_ztEf0OKA1yJi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of end of the period/year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20230101__20230630_zGvQYCEsAxQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">21,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_zDADsxqKFFii" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zwOk8yx3EWub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 and December 31, 2022, the amortization of the operating lease right of use asset are $<span id="xdx_909_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20230101__20230630__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zTdta82V6RO5" title="Operating lease right of use asset, amortization">21,646</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20220101__20221231__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zK4q9H1YTwYa" title="Operating lease right of use asset, amortization">42,310</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zFrLfDQ84dXj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zoclfxCw5eD4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">As of January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_iS_c20230101__20230630_zD4qI47VHhIa" style="width: 14%; text-align: right" title="Operating lease liability, beginning">44,548</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20230101__20230630_zGZIJjGurVk6" style="text-align: right" title="Less: gross repayment">(22,488</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20230630_zdaSpidm28Ka" style="text-align: right" title="Add: imputed interest">842</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20230101__20230630_z3z3q3Hnersb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,548</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of June 30, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20230101__20230630_zny3zTe8gvU9" style="text-align: right" title="Operating lease liability, ending">21,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_c20230630_zSHkTjw1gvr8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion">(21,354</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20230630_zm5arPl4mdY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zQsqsEymZ5K8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQEVzoLAob9b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease obligation as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zdtGicWvVGZi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Year ending</td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20230630_zHOViMYYzfje" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzlLl_zg9DCEaooxx9" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; padding-bottom: 1.5pt">December 31, 2023</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">21,354</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzlLl_zhDqURxb39Fb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zTmqLeipplAj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_zHHEYlhBdGel" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other information:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zG5mwSIPqm7g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify">Operating cash flow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20230101__20230630_zBkQf8bdvfCf" style="width: 16%; text-align: right" title="Operating cash flow from operating lease">20,786</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_zTnhyB9X7twb" style="width: 16%; text-align: right" title="Operating cash flow from operating lease">42,212</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Right-of-use assets obtained in exchange for operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20230101__20230630_zdxo6jpydsb1" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">21,354</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_z1FuGbNvg907" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">44,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Remaining lease term for operating lease (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zf4OROTgW26g" title="Remaining lease term for operating lease (years)">0.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zyBNpsKK128l" title="Remaining lease term for operating lease (years)">1</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Weighted average discount rate for operating lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zmYtgb8MBXL7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zWXKKSVurB7a" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A1_zTdtdrQXLlVc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 and December 31, 2022, lease expenses were $<span id="xdx_900_eus-gaap--PaymentsForRent_c20230101__20230630_zDQOt5cXJlY3" title="Lease expenses">21,646</span> and $<span id="xdx_907_eus-gaap--PaymentsForRent_c20220101__20221231_zMYMD0mX4vB" title="Lease expenses">42,310</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 92606 92606 0.054 <p id="xdx_89F_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zHhqJFotEYI2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 and December 31, 2022, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_z3BlF7zwJ7Ja" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">As of beginning of the period/year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20230101__20230630_zl8NtMNrS0U8" style="width: 14%; text-align: right" title="Operating lease right of use asset">44,548</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20220101__20221231_zQmVlU31f3Z8" style="width: 14%; text-align: right" title="Operating lease right of use asset">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20230101__20230630_zPinzVEdeQGa" style="text-align: right" title="Accumulated amortization">(21,646</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zxcUqwvzjDja" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20230101__20230630_zOpJgvllnEXk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,548</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_ztEf0OKA1yJi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of end of the period/year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20230101__20230630_zGvQYCEsAxQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">21,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_zDADsxqKFFii" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44548 92606 21646 42310 -1548 -5748 21354 44548 21646 42310 <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zFrLfDQ84dXj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zoclfxCw5eD4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify">As of January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_iS_c20230101__20230630_zD4qI47VHhIa" style="width: 14%; text-align: right" title="Operating lease liability, beginning">44,548</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20230101__20230630_zGZIJjGurVk6" style="text-align: right" title="Less: gross repayment">(22,488</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20230630_zdaSpidm28Ka" style="text-align: right" title="Add: imputed interest">842</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20230101__20230630_z3z3q3Hnersb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,548</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of June 30, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20230101__20230630_zny3zTe8gvU9" style="text-align: right" title="Operating lease liability, ending">21,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_c20230630_zSHkTjw1gvr8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion">(21,354</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20230630_zm5arPl4mdY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44548 22488 842 -1548 21354 21354 <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQEVzoLAob9b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease obligation as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zdtGicWvVGZi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Year ending</td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20230630_zHOViMYYzfje" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzlLl_zg9DCEaooxx9" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; padding-bottom: 1.5pt">December 31, 2023</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">21,354</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzlLl_zhDqURxb39Fb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 21354 21354 <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_zHHEYlhBdGel" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other information:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zG5mwSIPqm7g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify">Operating cash flow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20230101__20230630_zBkQf8bdvfCf" style="width: 16%; text-align: right" title="Operating cash flow from operating lease">20,786</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_zTnhyB9X7twb" style="width: 16%; text-align: right" title="Operating cash flow from operating lease">42,212</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Right-of-use assets obtained in exchange for operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20230101__20230630_zdxo6jpydsb1" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">21,354</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_z1FuGbNvg907" style="text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities">44,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Remaining lease term for operating lease (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zf4OROTgW26g" title="Remaining lease term for operating lease (years)">0.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zyBNpsKK128l" title="Remaining lease term for operating lease (years)">1</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Weighted average discount rate for operating lease</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zmYtgb8MBXL7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zWXKKSVurB7a" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average discount rate for operating lease">5.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 20786 42212 21354 44548 P0Y6M P1Y 0.054 0.054 21646 42310 <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBt57b3HWnvf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_82D_zHCrPjqDVVL2">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zBF7BywwmFVe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the period ended June 30, 2023 the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zlKnmXYJDcs6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF RELATED PARTY TRANSACTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">- Related party A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ProfessionalFees_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z2FgYSX42FOh" style="width: 16%; text-align: right" title="Professional Fees">3,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ProfessionalFees_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zp7isQLYC464" style="width: 16%; text-align: right" title="Professional Fees">3,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_z1Im1bcYYvve" style="text-align: right" title="Sales">127,102</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_znTBm46KLM43" style="text-align: right" title="Sales">255,239</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">- Related party C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zggcS7iYUOic" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">45,150</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zcrtyuXnsBXl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">7,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20230101__20230630_zDl3L43Ahn7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">175,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20220101__20220630_zPs5FxEFxD2g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">265,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z3VZ2hpj8Ghb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party A, is a wholly owned subsidiary of a <span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20230630__srt--OwnershipAxis__custom--RelatedPartyAMember_zlH1k3aX4UQa" title="Ownership percentage">7.33</span>% shareholder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party B’s director and shareholder is the founder of the Company. <span style="background-color: white">Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party C’s director and shareholder is the founder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party D’s director is the founder of the Company. The shareholder of related party D is related party C.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zBF7BywwmFVe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the period ended June 30, 2023 the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zlKnmXYJDcs6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF RELATED PARTY TRANSACTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">- Related party A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ProfessionalFees_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_z2FgYSX42FOh" style="width: 16%; text-align: right" title="Professional Fees">3,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ProfessionalFees_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zp7isQLYC464" style="width: 16%; text-align: right" title="Professional Fees">3,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_z1Im1bcYYvve" style="text-align: right" title="Sales">127,102</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_znTBm46KLM43" style="text-align: right" title="Sales">255,239</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">- Related party C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20230101__20230630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zggcS7iYUOic" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">45,150</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20220101__20220630__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zcrtyuXnsBXl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales">7,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20230101__20230630_zDl3L43Ahn7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">175,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pp0p0_c20220101__20220630_zPs5FxEFxD2g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">265,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 3000 3000 127102 255239 45150 7572 175252 265811 0.0733 <p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zoO0Kt5HKvbk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_82A_z2C4JvRMz7n6">SEGMENTED INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA5Hy5kUglE2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zXCodIBHDEvd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REPORTING SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630__srt--StatementGeographicalAxis__custom--NVMember_zhqG0Amob1Ge" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F5B_zKNPtkmBeN6c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230630__srt--StatementGeographicalAxis__country--SC_zzbpJRhJXYkd" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F51_zaJl6v4xT0Hd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230630__srt--StatementGeographicalAxis__country--HK_zwlDEPRWEey5" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F53_zcBAqGgXqFG5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630__srt--StatementGeographicalAxis__country--MY_zYhTKZ5si5v2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F5C_zixQAb9IC0pj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230630_z481sCUJzMIc" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F50_zvSwra2W17j2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the period ended June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS3UA40347T6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1172">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,195</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,195</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_z68WPB3M9iv3" style="vertical-align: bottom; background-color: White"> <td>Cost of revenues</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(447,498</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(447,498</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_znEeqNgmQXua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(514</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,022</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,536</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zqbkTVzsARce" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(35,199</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,178</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,540</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,326</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(28,591</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F47_zhjTUEDtm8og" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zWjJjqeSB0H9" style="text-align: right">14,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--SC_fKg_____z8bcNeAgihU8" style="text-align: right">21,998</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--HK_fKg_____zvE2KcC5wkA6" style="text-align: right">13,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--MY_fKg_____zVAza0AvB5e9" style="text-align: right">254,314</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_c20230630_fKg_____zfNq8OmP1VA2" style="text-align: right">303,795</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20220630__srt--StatementGeographicalAxis__custom--NVMember_zVMOMjYwq2Q9" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F58_z5L8MbPYsCi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20220630__srt--StatementGeographicalAxis__country--SC_zMFiAxg24gNf" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F58_z53NlfSAnXDd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220630__srt--StatementGeographicalAxis__country--HK_zftcKJ1yxM7a" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F5D_zQix13Vr1pm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220630__srt--StatementGeographicalAxis__country--MY_z1GMNwwaH6M5" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F57_z57UbvoTINjb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zLhEj6L3H3W7" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F5C_zeYKLa5GHqbf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the period ended June 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zXgFk8Dzveq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,187,232</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,187,232</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_z1HxDljvDLJ2" style="vertical-align: bottom; background-color: White"> <td>Cost of revenues</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1208">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(995,387</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(995,387</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_z5AQV5IUSb1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(515</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(37,129</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(37,644</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8Xp1dWWFE59" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,770</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,169</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,064</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,131</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,128</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zwlnVojFdJwj" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zchNFWFs5Iol" style="text-align: right">27,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--SC_fKg_____zS0trAQt5G5b" style="text-align: right">7,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--HK_fKg_____z5AS9C2Muhn2" style="text-align: right">14,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--MY_fKg_____zbTbz0KKMf7e" style="text-align: right">404,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_c20220630_fKg_____zGJUimoRpO6f" style="text-align: right">453,733</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zxK9OQHweCge" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zOlkYp4us4H5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td></tr> </table> <p id="xdx_8A2_z5ygbQbOYGNf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA5Hy5kUglE2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zXCodIBHDEvd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REPORTING SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630__srt--StatementGeographicalAxis__custom--NVMember_zhqG0Amob1Ge" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F5B_zKNPtkmBeN6c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230630__srt--StatementGeographicalAxis__country--SC_zzbpJRhJXYkd" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F51_zaJl6v4xT0Hd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230630__srt--StatementGeographicalAxis__country--HK_zwlDEPRWEey5" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F53_zcBAqGgXqFG5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630__srt--StatementGeographicalAxis__country--MY_zYhTKZ5si5v2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F5C_zixQAb9IC0pj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230630_z481sCUJzMIc" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F50_zvSwra2W17j2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the period ended June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS3UA40347T6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1172">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,195</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,195</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_z68WPB3M9iv3" style="vertical-align: bottom; background-color: White"> <td>Cost of revenues</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(447,498</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(447,498</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_znEeqNgmQXua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(514</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,022</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,536</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zqbkTVzsARce" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(35,199</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,178</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,540</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,326</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(28,591</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F47_zhjTUEDtm8og" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zWjJjqeSB0H9" style="text-align: right">14,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--SC_fKg_____z8bcNeAgihU8" style="text-align: right">21,998</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--HK_fKg_____zvE2KcC5wkA6" style="text-align: right">13,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20230630__srt--StatementGeographicalAxis__country--MY_fKg_____zVAza0AvB5e9" style="text-align: right">254,314</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_c20230630_fKg_____zfNq8OmP1VA2" style="text-align: right">303,795</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20220630__srt--StatementGeographicalAxis__custom--NVMember_zVMOMjYwq2Q9" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F58_z5L8MbPYsCi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20220630__srt--StatementGeographicalAxis__country--SC_zMFiAxg24gNf" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F58_z53NlfSAnXDd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220630__srt--StatementGeographicalAxis__country--HK_zftcKJ1yxM7a" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F5D_zQix13Vr1pm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220630__srt--StatementGeographicalAxis__country--MY_z1GMNwwaH6M5" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F57_z57UbvoTINjb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zLhEj6L3H3W7" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F5C_zeYKLa5GHqbf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the period ended June 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zXgFk8Dzveq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,187,232</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,187,232</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_z1HxDljvDLJ2" style="vertical-align: bottom; background-color: White"> <td>Cost of revenues</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1208">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(995,387</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(995,387</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_z5AQV5IUSb1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(515</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(37,129</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(37,644</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8Xp1dWWFE59" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,770</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,169</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,064</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,131</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,128</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zwlnVojFdJwj" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zchNFWFs5Iol" style="text-align: right">27,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--SC_fKg_____zS0trAQt5G5b" style="text-align: right">7,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--HK_fKg_____z5AS9C2Muhn2" style="text-align: right">14,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20220630__srt--StatementGeographicalAxis__country--MY_fKg_____zbTbz0KKMf7e" style="text-align: right">404,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_c20220630_fKg_____zGJUimoRpO6f" style="text-align: right">453,733</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zxK9OQHweCge" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zOlkYp4us4H5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td></tr> </table> 621195 621195 447498 447498 514 36022 36536 -35199 -3178 -3540 13326 -28591 14274 21998 13209 254314 303795 1187232 1187232 995387 995387 515 37129 37644 -20770 -2169 -2064 40131 15128 27187 7055 14711 404780 453733 <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zid41eONGxZ2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_82E_zSXfJa6Zk3w">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2023 up through the date the Company issued the consolidated financial statements.</span></p> Revenues and costs are attributed to countries based on the location of customers. EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ƽ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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 173 239 1 true 57 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://dswissbeauty.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://dswissbeauty.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://dswissbeauty.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Sheet http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://dswissbeauty.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION Sheet http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganization DESCRIPTION OF BUSINESS AND ORGANIZATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS Sheet http://dswissbeauty.com/role/VieStructureAndArrangements VIE STRUCTURE AND ARRANGEMENTS Notes 9 false false R10.htm 00000010 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://dswissbeauty.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 10 false false R11.htm 00000011 - Disclosure - PLANT AND EQUIPMENT Sheet http://dswissbeauty.com/role/PlantAndEquipment PLANT AND EQUIPMENT Notes 11 false false R12.htm 00000012 - Disclosure - INTANGIBLE ASSETS Sheet http://dswissbeauty.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 12 false false R13.htm 00000013 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Notes 13 false false R14.htm 00000014 - Disclosure - INVENTORIES Sheet http://dswissbeauty.com/role/Inventories INVENTORIES Notes 14 false false R15.htm 00000015 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 15 false false R16.htm 00000016 - Disclosure - FINANCE LEASE LIABILITY Sheet http://dswissbeauty.com/role/FinanceLeaseLiability FINANCE LEASE LIABILITY Notes 16 false false R17.htm 00000017 - Disclosure - INCOME TAXES Sheet http://dswissbeauty.com/role/IncomeTaxes INCOME TAXES Notes 17 false false R18.htm 00000018 - Disclosure - CONCENTRATIONS OF RISK Sheet http://dswissbeauty.com/role/ConcentrationsOfRisk CONCENTRATIONS OF RISK Notes 18 false false R19.htm 00000019 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Notes 19 false false R20.htm 00000020 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://dswissbeauty.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 20 false false R21.htm 00000021 - Disclosure - SEGMENTED INFORMATION Sheet http://dswissbeauty.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 21 false false R22.htm 00000022 - Disclosure - SUBSEQUENT EVENTS Sheet http://dswissbeauty.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 00000024 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables) Sheet http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationTables DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables) Tables http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganization 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - PLANT AND EQUIPMENT (Tables) Sheet http://dswissbeauty.com/role/PlantAndEquipmentTables PLANT AND EQUIPMENT (Tables) Tables http://dswissbeauty.com/role/PlantAndEquipment 26 false false R27.htm 00000027 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://dswissbeauty.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://dswissbeauty.com/role/IntangibleAssets 27 false false R28.htm 00000028 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Tables http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits 28 false false R29.htm 00000029 - Disclosure - INVENTORIES (Tables) Sheet http://dswissbeauty.com/role/InventoriesTables INVENTORIES (Tables) Tables http://dswissbeauty.com/role/Inventories 29 false false R30.htm 00000030 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities 30 false false R31.htm 00000031 - Disclosure - FINANCE LEASE LIABILITY (Tables) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilityTables FINANCE LEASE LIABILITY (Tables) Tables http://dswissbeauty.com/role/FinanceLeaseLiability 31 false false R32.htm 00000032 - Disclosure - INCOME TAXES (Tables) Sheet http://dswissbeauty.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://dswissbeauty.com/role/IncomeTaxes 32 false false R33.htm 00000033 - Disclosure - CONCENTRATIONS OF RISK (Tables) Sheet http://dswissbeauty.com/role/ConcentrationsOfRiskTables CONCENTRATIONS OF RISK (Tables) Tables http://dswissbeauty.com/role/ConcentrationsOfRisk 33 false false R34.htm 00000034 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Tables http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities 34 false false R35.htm 00000035 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://dswissbeauty.com/role/RelatedPartyTransactions 35 false false R36.htm 00000036 - Disclosure - SEGMENTED INFORMATION (Tables) Sheet http://dswissbeauty.com/role/SegmentedInformationTables SEGMENTED INFORMATION (Tables) Tables http://dswissbeauty.com/role/SegmentedInformation 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Details 37 false false R38.htm 00000038 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative) Sheet http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative) Details http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationTables 38 false false R39.htm 00000039 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Sheet http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Details 40 false false R41.htm 00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables 41 false false R42.htm 00000042 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Sheet http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Details http://dswissbeauty.com/role/VieStructureAndArrangements 42 false false R43.htm 00000043 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://dswissbeauty.com/role/StockholdersEquity 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) Sheet http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails SCHEDULE OF PLANT AND EQUIPMENT (Details) Details 44 false false R45.htm 00000045 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) Sheet http://dswissbeauty.com/role/PlantAndEquipmentDetailsNarrative PLANT AND EQUIPMENT (Details Narrative) Details http://dswissbeauty.com/role/PlantAndEquipmentTables 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 46 false false R47.htm 00000047 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://dswissbeauty.com/role/IntangibleAssetsTables 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Details 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Details 52 false false R53.htm 00000053 - Disclosure - FINANCE LEASE LIABILITY (Details Narrative) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative FINANCE LEASE LIABILITY (Details Narrative) Details http://dswissbeauty.com/role/FinanceLeaseLiabilityTables 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Details 55 false false R56.htm 00000056 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://dswissbeauty.com/role/IncomeTaxesTables 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details) Sheet http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails SCHEDULE OF CONCENTRATION OF RISK (Details) Details 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) Details 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails SCHEDULE OF OPERATING LEASE LIABILITY (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Details 61 false false R62.htm 00000062 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Details http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails SCHEDULE OF RELATED PARTY TRANSACTION (Details) Details 63 false false R64.htm 00000064 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://dswissbeauty.com/role/RelatedPartyTransactionsTables 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails SCHEDULE OF REPORTING SEGMENTS (Details) Details 65 false false All Reports Book All Reports form10-q.htm dqws-20230630.xsd dqws-20230630_cal.xml dqws-20230630_def.xml dqws-20230630_lab.xml dqws-20230630_pre.xml ex31-1.htm ex32-1.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 81 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 645, "http://xbrl.sec.gov/dei/2023": 35 }, "contextCount": 173, "dts": { "calculationLink": { "local": [ "dqws-20230630_cal.xml" ] }, "definitionLink": { "local": [ "dqws-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "dqws-20230630_lab.xml" ] }, "presentationLink": { "local": [ "dqws-20230630_pre.xml" ] }, "schema": { "local": [ "dqws-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 403, "entityCount": 1, "hidden": { "http://dswissbeauty.com/20230630": 6, "http://fasb.org/us-gaap/2023": 85, "http://xbrl.sec.gov/dei/2023": 7, "total": 98 }, "keyCustom": 21, "keyStandard": 218, "memberCustom": 32, "memberStandard": 21, "nsprefix": "DQWS", "nsuri": "http://dswissbeauty.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://dswissbeauty.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "10", "role": "http://dswissbeauty.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - PLANT AND EQUIPMENT", "menuCat": "Notes", "order": "11", "role": "http://dswissbeauty.com/role/PlantAndEquipment", "shortName": "PLANT AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "12", "role": "http://dswissbeauty.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "menuCat": "Notes", "order": "13", "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "14", "role": "http://dswissbeauty.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "menuCat": "Notes", "order": "15", "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - FINANCE LEASE LIABILITY", "menuCat": "Notes", "order": "16", "role": "http://dswissbeauty.com/role/FinanceLeaseLiability", "shortName": "FINANCE LEASE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "17", "role": "http://dswissbeauty.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - CONCENTRATIONS OF RISK", "menuCat": "Notes", "order": "18", "role": "http://dswissbeauty.com/role/ConcentrationsOfRisk", "shortName": "CONCENTRATIONS OF RISK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "menuCat": "Notes", "order": "19", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://dswissbeauty.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "20", "role": "http://dswissbeauty.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SEGMENTED INFORMATION", "menuCat": "Notes", "order": "21", "role": "http://dswissbeauty.com/role/SegmentedInformation", "shortName": "SEGMENTED INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "22", "role": "http://dswissbeauty.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:GoingConcernPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "23", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:GoingConcernPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables)", "menuCat": "Tables", "order": "24", "role": "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationTables", "shortName": "DESCRIPTION OF BUSINESS AND ORGANIZATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "25", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - PLANT AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "26", "role": "http://dswissbeauty.com/role/PlantAndEquipmentTables", "shortName": "PLANT AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "27", "role": "http://dswissbeauty.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "menuCat": "Tables", "order": "28", "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "29", "role": "http://dswissbeauty.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - FINANCE LEASE LIABILITY (Tables)", "menuCat": "Tables", "order": "31", "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilityTables", "shortName": "FINANCE LEASE LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "32", "role": "http://dswissbeauty.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - CONCENTRATIONS OF RISK (Tables)", "menuCat": "Tables", "order": "33", "role": "http://dswissbeauty.com/role/ConcentrationsOfRiskTables", "shortName": "CONCENTRATIONS OF RISK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "menuCat": "Tables", "order": "35", "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsTables", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SEGMENTED INFORMATION (Tables)", "menuCat": "Tables", "order": "36", "role": "http://dswissbeauty.com/role/SegmentedInformationTables", "shortName": "SEGMENTED INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_custom_DSwissHoldingLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "menuCat": "Details", "order": "37", "role": "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_custom_DSwissHoldingLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_DSwissHoldingLimitedMember_country_HK", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "shortName": "DESCRIPTION OF BUSINESS AND ORGANIZATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_DSwissHoldingLimitedMember_country_HK", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ComputerAndSoftwareMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "menuCat": "Details", "order": "39", "role": "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails", "shortName": "SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ComputerAndSoftwareMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_PeriodEndRMMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "menuCat": "Details", "order": "40", "role": "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_PeriodEndRMMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-172023-01-18_custom_DSwissHKLimitedMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative", "shortName": "VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-172023-01-18_custom_DSwissHKLimitedMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details)", "menuCat": "Details", "order": "44", "role": "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "shortName": "SCHEDULE OF PLANT AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - PLANT AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://dswissbeauty.com/role/PlantAndEquipmentDetailsNarrative", "shortName": "PLANT AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedTrademarksGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "46", "role": "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedTrademarksGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "menuCat": "Details", "order": "48", "role": "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails", "shortName": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "menuCat": "Details", "order": "49", "role": "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details)", "menuCat": "Details", "order": "50", "role": "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "menuCat": "Details", "order": "51", "role": "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails", "shortName": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "menuCat": "Details", "order": "52", "role": "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "shortName": "SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_custom_FirstFinanceLeaseAgreementMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - FINANCE LEASE LIABILITY (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative", "shortName": "FINANCE LEASE LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_custom_FirstFinanceLeaseAgreementMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "menuCat": "Details", "order": "54", "role": "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_country_US", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "menuCat": "Details", "order": "55", "role": "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "shortName": "SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_UnitedStatesOfAmericaMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_UnitedStatesOfAmericaMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details)", "menuCat": "Details", "order": "57", "role": "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails", "shortName": "SCHEDULE OF CONCENTRATION OF RISK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details)", "menuCat": "Details", "order": "58", "role": "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails", "shortName": "SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "DQWS:EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "menuCat": "Details", "order": "59", "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://dswissbeauty.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details)", "menuCat": "Details", "order": "60", "role": "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails", "shortName": "SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "menuCat": "Details", "order": "61", "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails", "shortName": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "menuCat": "Details", "order": "63", "role": "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_RelatedPartyAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "64", "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_RelatedPartyAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details)", "menuCat": "Details", "order": "65", "role": "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "shortName": "SCHEDULE OF REPORTING SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION", "menuCat": "Notes", "order": "7", "role": "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganization", "shortName": "DESCRIPTION OF BUSINESS AND ORGANIZATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS", "menuCat": "Notes", "order": "9", "role": "http://dswissbeauty.com/role/VieStructureAndArrangements", "shortName": "VIE STRUCTURE AND ARRANGEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 57, "tag": { "DQWS_AccruedAuditFeesCurrent": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued audit fees current.", "label": "Accrued audit fees" } } }, "localname": "AccruedAuditFeesCurrent", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_ComputerAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer and Software [Member]", "label": "Computer and Software [Member]" } } }, "localname": "ComputerAndSoftwareMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]" } } }, "localname": "CustomerBMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer C [Member]", "label": "Customer C [Member]" } } }, "localname": "CustomerCMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer D [Member]", "label": "Customer D [Member]" } } }, "localname": "CustomerDMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer E [Member]", "label": "Customer E [Member]" } } }, "localname": "CustomerEMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_CustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customers [Member]", "label": "Customers [Member]" } } }, "localname": "CustomersMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissBiotechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Biotech Sdn, Bhd [Member]", "label": "DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissBiotechMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DSwissBiotechSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Biotech Sdn Bhd [Member]", "label": "DSwiss Biotech Sdn Bhd [Member] [Default Label]", "verboseLabel": "DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissBiotechSdnBhdMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissHKLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss HK Limited [Member]", "label": "DSwiss HK Limited [Member]" } } }, "localname": "DSwissHKLimitedMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DSwissHoldingLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Holding Limited [Member]", "label": "DSwiss Holding Limited [Member]" } } }, "localname": "DSwissHoldingLimitedMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Sdn Bhd [Member]", "label": "DSwiss Sdn Bhd [Member]" } } }, "localname": "DSwissSdnBhdMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "DQWS_DSwissSdnBhdandDSwissBiotechSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]", "label": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]" } } }, "localname": "DSwissSdnBhdandDSwissBiotechSdnBhdMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_DisclosureFinanceLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Liability", "terseLabel": "Schedule Of Maturities Of Finance Lease", "verboseLabel": "Schedule Of Obligation Under Finance Lease" } } }, "localname": "DisclosureFinanceLeaseLiabilityAbstract", "nsuri": "http://dswissbeauty.com/20230630", "xbrltype": "stringItemType" }, "DQWS_EffectOfTranslationExchange": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange.", "label": "EffectOfTranslationExchange", "negatedLabel": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchange", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_EffectOfTranslationExchangeOfOperatingLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange of operating lease liability.", "label": "EffectOfTranslationExchangeOfOperatingLeaseLiability", "verboseLabel": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchangeOfOperatingLeaseLiability", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of translation exchange of operating lease right of use asset.", "label": "Effect of translation exchange" } } }, "localname": "EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_FinanceExpenses": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance expenses.", "label": "FinanceExpenses", "negatedLabel": "FINANCE COST" } } }, "localname": "FinanceExpenses", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "DQWS_FirstFinanceLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Finance Lease Agreement [Member]", "label": "First Finance Lease Agreement [Member]" } } }, "localname": "FirstFinanceLeaseAgreementMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going Concern [Policy Text Block]", "label": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "DQWS_HongKongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hong Kong [Member]", "label": "Hong Kong [Member]" } } }, "localname": "HongKongMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_IncreaseDecreaseInLeaseLiability": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in lease liability.", "label": "Lease liabilities" } } }, "localname": "IncreaseDecreaseInLeaseLiability", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_IncreaseDecreaseInRightOfUse": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in right of use.", "label": "Right of use" } } }, "localname": "IncreaseDecreaseInRightOfUse", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_IntangibleAssetsEffectOfTranslationExchange": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intangible assets, Effect of translation exchange.", "label": "IntangibleAssetsEffectOfTranslationExchange", "negatedLabel": "Effect of translation exchange" } } }, "localname": "IntangibleAssetsEffectOfTranslationExchange", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DQWS_MalaysiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Malaysia [Member]", "label": "Malaysia [Member]" } } }, "localname": "MalaysiaMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_ManagementServicesAgreementIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Management Services Agreement I [Member]", "label": "Management Services Agreement I [Member]" } } }, "localname": "ManagementServicesAgreementIMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_MotorVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor Vehicles [Member]", "label": "Motor Vehicles [Member]" } } }, "localname": "MotorVehiclesMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "DQWS_NVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NV [Member]", "label": "NV [Member]" } } }, "localname": "NVMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "domainItemType" }, "DQWS_NetIncomeLossAttributableToMinorityInterest": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) attributable to minority interest.", "label": "NetIncomeLossAttributableToMinorityInterest", "negatedLabel": "Non-Controlling Interest" } } }, "localname": "NetIncomeLossAttributableToMinorityInterest", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "DQWS_NoncontrollingInterestChangesInOwnershipInterestsInAssociate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncontrolling interest changes in ownership interests in associate.", "label": "Changes in ownership interests in an associate" } } }, "localname": "NoncontrollingInterestChangesInOwnershipInterestsInAssociate", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "DQWS_ParticularsOfIssuedCapital": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Particulars of Issued Capital.", "label": "Particulars of issued capital" } } }, "localname": "ParticularsOfIssuedCapital", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "DQWS_PercentageOfAnnualNetProfitToBeReceivedAsFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of annual net profit to be received as fee.", "label": "Percentage of annual net profit to be received as fee" } } }, "localname": "PercentageOfAnnualNetProfitToBeReceivedAsFee", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "DQWS_PeriodAverageHKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period Average HK [Member]", "label": "Period Average HK [Member]" } } }, "localname": "PeriodAverageHKMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PeriodAverageRMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period Average RM [Member]", "label": "Period Average RM [Member]" } } }, "localname": "PeriodAverageRMMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PeriodEndHKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period-end HK [Member]", "label": "Period-end HK [Member]" } } }, "localname": "PeriodEndHKMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PeriodEndRMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period End RM [Member]", "label": "Period End RM [Member]" } } }, "localname": "PeriodEndRMMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "DQWS_PlaceOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of incorporation.", "label": "Place of incorporation" } } }, "localname": "PlaceOfIncorporation", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "DQWS_RecentlyIssuedAccountingStandardPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recently Issued Accounting Standard[Policy Text Block]", "label": "Recently Issued Accounting Standard" } } }, "localname": "RecentlyIssuedAccountingStandardPolicyTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "DQWS_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Parties [PolicyTextBlock]", "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "DQWS_RelatedPartyAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party A [Member]", "label": "Related Party A [Member]" } } }, "localname": "RelatedPartyAMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_RelatedPartyBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party B [Member]", "label": "Related Party B [Member]" } } }, "localname": "RelatedPartyBMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_RelatedPartyCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party C [Member]", "label": "Related Party C [Member]" } } }, "localname": "RelatedPartyCMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "DQWS_ScheduleOfObligationUnderFinanceLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Obligation Under Finance Lease [Table Text Block]", "label": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE" } } }, "localname": "ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "DQWS_ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Operating Lease Liability Disclosure [Text Block]", "label": "SCHEDULE OF OPERATING LEASE LIABILITY" } } }, "localname": "ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_ScheduleOfOperatingLeaseOtherInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Operating Lease Other Information [Table Text Block]", "label": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION" } } }, "localname": "ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_SecondFinanceLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Finance Lease Agreement [Member]", "label": "Second Finance Lease Agreement [Member]" } } }, "localname": "SecondFinanceLeaseAgreementMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Property and Equipment Useful Life [Table Text Block]", "label": "SUMMARY OF PROPERTY AND EQUIPMENT USEFUL LIFE" } } }, "localname": "SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "DQWS_TaxationPaid": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Taxation paid.", "label": "TaxationPaid", "negatedLabel": "Tax paid" } } }, "localname": "TaxationPaid", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DQWS_UnitedStatesOfAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United States of America [Member]", "label": "United States of America [Member]" } } }, "localname": "UnitedStatesOfAmericaMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "DQWS_VendorAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor A [Member]", "label": "Vendor A [Member]" } } }, "localname": "VendorAMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor B [Member]", "label": "Vendor B [Member]" } } }, "localname": "VendorBMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor C [Member]", "label": "Vendor C [Member]" } } }, "localname": "VendorCMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "DQWS_VendorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendors [Member]", "label": "Vendors [Member]" } } }, "localname": "VendorsMember", "nsuri": "http://dswissbeauty.com/20230630", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_MY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MALAYSIA" } } }, "localname": "MY", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_SC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEYCHELLES" } } }, "localname": "SC", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r624", "r626", "r627" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r613" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r632" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Date of incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r614" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r617" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r243", "r244", "r245" ], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r238", "r597", "r658", "r676", "r677" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r265", "r266", "r267", "r268", "r303", "r439", "r468", "r496", "r497", "r556", "r558", "r560", "r561", "r563", "r580", "r581", "r594", "r595", "r598", "r601", "r657", "r669", "r670", "r671", "r672", "r673", "r674" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r265", "r266", "r267", "r268", "r303", "r439", "r468", "r496", "r497", "r556", "r558", "r560", "r561", "r563", "r580", "r581", "r594", "r595", "r598", "r601", "r657", "r669", "r670", "r671", "r672", "r673", "r674" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r238", "r597", "r658", "r676", "r677" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r265", "r266", "r267", "r268", "r302", "r303", "r328", "r329", "r330", "r438", "r439", "r468", "r496", "r497", "r556", "r558", "r560", "r561", "r563", "r580", "r581", "r594", "r595", "r598", "r601", "r604", "r654", "r657", "r670", "r671", "r672", "r673", "r674" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r265", "r266", "r267", "r268", "r302", "r303", "r328", "r329", "r330", "r438", "r439", "r468", "r496", "r497", "r556", "r558", "r560", "r561", "r563", "r580", "r581", "r594", "r595", "r598", "r601", "r604", "r654", "r657", "r670", "r671", "r672", "r673", "r674" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r236", "r237", "r493", "r494", "r495", "r557", "r559", "r562", "r564", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r583", "r596", "r604", "r658", "r676" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r236", "r237", "r493", "r494", "r495", "r557", "r559", "r562", "r564", "r568", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r583", "r596", "r604", "r658", "r676" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r19", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other payables" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Account Payable, Trade" } } }, "localname": "AccountsPayableTradeCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r514", "r569", "r605", "r675" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts receivable, trade" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r239", "r240" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r53", "r152", "r461" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r27", "r93", "r156", "r456", "r476", "r480" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated other comprehensive income/(loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r2", "r13", "r27", "r369", "r372", "r429", "r471", "r472", "r641", "r642", "r643", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r85", "r600", "r679" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r332", "r333", "r334", "r491", "r648", "r649", "r650", "r661", "r682" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r185", "r186", "r187", "r188", "r197", "r241", "r242", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r264", "r332", "r333", "r334", "r346", "r347", "r348", "r349", "r356", "r357", "r358", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r391", "r392", "r393", "r394", "r404", "r405", "r407", "r408", "r409", "r410", "r425", "r426", "r427", "r428", "r429", "r446", "r447", "r448", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss)/profit to net cash (used in)/generated from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r7", "r48", "r51" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization for intangible assets", "verboseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r119", "r154", "r180", "r211", "r225", "r230", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r360", "r362", "r390", "r453", "r519", "r600", "r612", "r655", "r656", "r667" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r147", "r160", "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r360", "r362", "r390", "r600", "r655", "r656", "r667" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r360", "r362", "r390", "r655", "r656", "r667" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-Current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r78", "r105", "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "DESCRIPTION OF BUSINESS AND ORGANIZATION" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganization" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r29", "r150", "r584" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r29", "r102", "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF PERIOD", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r102" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease)/increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r602", "r603", "r604", "r606", "r607", "r608", "r609", "r648", "r649", "r661", "r678", "r682" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r84", "r505" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r84", "r505", "r525", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r84", "r455", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares issued and outstanding as of June 30, 2023 and December 31, 2022 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r28", "r162", "r164", "r170", "r449", "r465" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "TOTAL COMPREHENSIVE (LOSS)/INCOME" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r35", "r37", "r71", "r72", "r238", "r570" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r35", "r37", "r71", "r72", "r238", "r481", "r570" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r35", "r37", "r71", "r72", "r238", "r570", "r634" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS OF RISK" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r35", "r37", "r71", "r72", "r238" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r34", "r35", "r37", "r38", "r71", "r118", "r570" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r35", "r37", "r71", "r72", "r238", "r570" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r60", "r587" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r98", "r444" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Purchases" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsTotalMember": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsTotalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r99", "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r390", "r655" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "COST OF REVENUE", "negatedTerseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r636" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of revenue" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r635", "r647" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "negatedLabel": "- Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r635", "r647", "r660" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "- Local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r36", "r238" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r115", "r647", "r659" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "- Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r647", "r659", "r660" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "- Local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r637" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r7", "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/PlantAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r7", "r52" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r7", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r171", "r189", "r190", "r191", "r192", "r193", "r198", "r200", "r202", "r203", "r204", "r205", "r385", "r386", "r450", "r466", "r590" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net (loss)/ income per share, basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r171", "r189", "r190", "r191", "r192", "r193", "r200", "r202", "r203", "r204", "r205", "r385", "r386", "r450", "r466", "r590" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net (loss)/ income per share, diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r32", "r33" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net income/(loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r663" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash and cash equivalent" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r181", "r339", "r352" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory income tax, rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r14", "r143", "r166", "r167", "r168", "r182", "r183", "r184", "r186", "r194", "r196", "r206", "r250", "r256", "r291", "r332", "r333", "r334", "r348", "r349", "r367", "r369", "r370", "r371", "r372", "r374", "r384", "r396", "r397", "r398", "r399", "r400", "r401", "r429", "r471", "r472", "r473", "r491", "r549" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity ownership interest rate percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r9", "r15" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r413", "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Total", "totalLabel": "Total" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance lease liability", "verboseLabel": "Current portion" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "SCHEDULE OF MATURITIES OF FINANCE LEASE" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Non-current portion", "verboseLabel": "Finance lease liability" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance lease" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r665" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.", "label": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: interest expense" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r414", "r418" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Repayment of finance lease" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r153", "r263" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r108" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Trademarks" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency exchange rate, translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currencies translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r97", "r180", "r211", "r224", "r229", "r232", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r390", "r592", "r655" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r645", "r653" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment loss" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r95", "r122", "r211", "r224", "r229", "r232", "r451", "r463", "r592" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 }, "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Net (loss)/profit before income tax", "terseLabel": "Net (loss)/profit before taxation", "totalLabel": "(LOSS)/PROFIT BEFORE INCOME TAX", "verboseLabel": "(Loss)/Profit before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfCashFlows", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r181", "r335", "r340", "r341", "r344", "r350", "r353", "r354", "r355", "r486" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r54", "r114" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Largest amount of tax benefit, description" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r130", "r139", "r195", "r196", "r215", "r338", "r351", "r467" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "TAXATION", "negatedTotalLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r165", "r336", "r337", "r341", "r342", "r343", "r345", "r483" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "negatedLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r76", "r638" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Tax recoverable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Reversal of deferred tax liabilities" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "auth_ref": [ "r644" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "Tax payable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r6" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Other receivables, prepaid expenses and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r50", "r441", "r442", "r443", "r445", "r588" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r47", "r49" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r173", "r175", "r176" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "negatedLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r639" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods, at cost" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r158", "r585", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r131", "r149", "r157", "r257", "r258", "r259", "r440", "r589" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeaseDescription": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's finance lease.", "label": "Finance lease, description" } } }, "localname": "LesseeFinanceLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "FINANCE LEASE LIABILITY" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF MATURITIES OF OPERATING LEASE OBLIGATION" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r422" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "December 31, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfOperatingLeaseObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Add: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r361", "r362", "r363", "r390", "r504", "r591", "r612", "r655", "r667", "r668" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r89", "r121", "r459", "r600", "r646", "r652", "r662" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r148", "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r361", "r362", "r363", "r390", "r600", "r655", "r667", "r668" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r17", "r79", "r80", "r81", "r82", "r180", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r361", "r362", "r363", "r390", "r655", "r667", "r668" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON- CURRENT LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r25", "r120", "r180", "r246", "r269", "r271", "r272", "r273", "r276", "r277", "r390", "r458", "r507" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "NON-CONTROLLING INTEREST" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Subsidiary, Ownership Percentage, Parent", "verboseLabel": "Equity ownership interest rate percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r174" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r174" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activity" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITY:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r102", "r103", "r104" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Cash used in operations", "totalLabel": "Net cash (used in)/generated from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows", "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r102", "r103", "r104" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Cash (used in)/generated from operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r96", "r104", "r123", "r146", "r161", "r163", "r168", "r180", "r185", "r189", "r190", "r191", "r192", "r195", "r196", "r201", "r211", "r224", "r229", "r232", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r386", "r390", "r464", "r527", "r547", "r548", "r592", "r610", "r655" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net profit/(loss)", "negatedLabel": "Net income loss", "totalLabel": "NET (LOSS)/PROFIT" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome", "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r58", "r291", "r648", "r649", "r650", "r682" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of reportable operating segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r211", "r224", "r229", "r232", "r592" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "OPERATING EXPENSES" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r664" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "negatedLabel": "LEASE EXPENSES" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Lease liability", "periodEndLabel": "Operating lease liability, ending", "periodStartLabel": "Operating lease liability, beginning" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability", "negatedLabel": "Less: lease liability current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability non-current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r415", "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Less: gross repayment" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r412" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right -of-use, net", "periodEndLabel": "Operating lease right of use asset, ending", "periodStartLabel": "Operating lease right of use asset", "verboseLabel": "Lease asset- right of use" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r645" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Operating lease right of use asset, amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r421", "r599" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating lease", "verboseLabel": "Discount rate of lease payment" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r420", "r599" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term for operating lease (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r124", "r126", "r127", "r128", "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.", "label": "SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS" } } }, "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Cumulative net operating losses" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Net operating loss carryforwards expiration" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "Other payables and accrued liabilities", "totalLabel": "Total payables and accrued liabilities" } } }, "localname": "OtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued other expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r4", "r12", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r3" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "- Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive (loss)/income" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r172" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "OTHER INCOME" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r155", "r513" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Lease expenses" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r101" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r83", "r279" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r83", "r505" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r83", "r279" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r83", "r505", "r525", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r83", "r454", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r640" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Other receivables, prepaid expenses and deposit", "totalLabel": "Total prepaid expenses and deposits" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r159", "r260", "r261", "r586" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLeasePayments": { "auth_ref": [ "r423", "r424" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from lease payment, classified as operating activity.", "label": "Operating cash flow from operating lease" } } }, "localname": "ProceedsFromLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r610", "r680", "r681" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r109", "r134", "r137", "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/PlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r110", "r151", "r462" ], "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r8", "r452", "r462", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Plant and equipment, net", "totalLabel": "Plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r8", "r134", "r137", "r460" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/PlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates." } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r75", "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "verboseLabel": "Total" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r433", "r434", "r666" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r530", "r531", "r534" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r430", "r431", "r432", "r434", "r435", "r487", "r488", "r489", "r532", "r533", "r534", "r553", "r555" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r86", "r112", "r457", "r475", "r480", "r485", "r506", "r600" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r143", "r182", "r183", "r184", "r186", "r194", "r196", "r250", "r256", "r332", "r333", "r334", "r348", "r349", "r367", "r370", "r371", "r374", "r384", "r471", "r473", "r491", "r682" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r212", "r213", "r223", "r227", "r228", "r234", "r236", "r238", "r300", "r301", "r444" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "REVENUE", "verboseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r140", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r582" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r169", "r180", "r212", "r213", "r223", "r227", "r228", "r234", "r236", "r238", "r246", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r390", "r451", "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r419", "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-use assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r238", "r633" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF PROVISION FOR INCOME TAXES" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-term intercompany foreign balances, including related intercompany entity, underlying foreign currencies and amounts of intercompany foreign currency transactions that are of a long-term investment nature (that is settlement is not planned or anticipated in the foreseeable future), as of the balance sheet date.", "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION" } } }, "localname": "ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r18", "r90", "r91", "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/SummaryOfPropertyAndEquipmentUsefulLifeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r74", "r75", "r530", "r531", "r534" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF RELATED PARTY TRANSACTION" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r45", "r94" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r42", "r43", "r44", "r46" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SCHEDULE OF REPORTING SEGMENTS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r62", "r63", "r65", "r67", "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "SCHEDULE OF VARIABLE INTEREST ENTITY" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r34", "r35", "r37", "r38", "r71", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "SCHEDULE OF CONCENTRATION OF RISK" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRiskTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r207", "r208", "r209", "r210", "r211", "r216", "r226", "r230", "r231", "r232", "r233", "r234", "r235", "r238" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENTED INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r222", "r236", "r593" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r100" ], "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "SELLING, GENERAL AND ADMINISTRATIVE EXPENSES" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling and distribution expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Consideration price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r105", "r178" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r14", "r23", "r143", "r166", "r167", "r168", "r182", "r183", "r184", "r186", "r194", "r196", "r206", "r250", "r256", "r291", "r332", "r333", "r334", "r348", "r349", "r367", "r369", "r370", "r371", "r372", "r374", "r384", "r396", "r397", "r398", "r399", "r400", "r401", "r429", "r471", "r472", "r473", "r491", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r182", "r183", "r184", "r206", "r444", "r482", "r492", "r498", "r499", "r500", "r501", "r502", "r503", "r505", "r508", "r509", "r510", "r511", "r512", "r515", "r516", "r517", "r518", "r520", "r521", "r522", "r523", "r524", "r526", "r528", "r529", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r549", "r605" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r182", "r183", "r184", "r206", "r444", "r482", "r492", "r498", "r499", "r500", "r501", "r502", "r503", "r505", "r508", "r509", "r510", "r511", "r512", "r515", "r516", "r517", "r518", "r520", "r521", "r522", "r523", "r524", "r526", "r528", "r529", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r549", "r605" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative", "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r83", "r84", "r112" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Number of shares, acquired" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r83", "r84", "r112", "r484", "r549", "r565" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock issued during period, shares, new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r84", "r87", "r88", "r107", "r507", "r525", "r550", "r551", "r600", "r612", "r646", "r652", "r662", "r682" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "totalLabel": "TOTAL DSWISS, INC. STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r58", "r59", "r70", "r143", "r144", "r167", "r182", "r183", "r184", "r186", "r194", "r250", "r256", "r291", "r332", "r333", "r334", "r348", "r349", "r367", "r369", "r370", "r371", "r372", "r374", "r384", "r396", "r397", "r401", "r429", "r472", "r473", "r490", "r507", "r525", "r550", "r551", "r566", "r611", "r646", "r652", "r662", "r682" ], "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r111", "r179", "r278", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r375", "r552", "r554", "r567" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r436", "r437" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOWS INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business.", "label": "Trade Accounts Receivable [Member]" } } }, "localname": "TradeAccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r185", "r186", "r187", "r188", "r197", "r241", "r242", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r264", "r332", "r333", "r334", "r346", "r347", "r348", "r349", "r356", "r357", "r358", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r391", "r392", "r393", "r394", "r404", "r405", "r407", "r408", "r409", "r410", "r425", "r426", "r427", "r428", "r429", "r446", "r447", "r448", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards." } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilityDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r39", "r40", "r41", "r132", "r133", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "VIE STRUCTURE AND ARRANGEMENTS" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Proportional of ownership interest and voting power held" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityTypeOfEntity": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Structure or legal form of Variable Interest Entity (VIE). In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities.", "label": "Company name" } } }, "localname": "VariableInterestEntityTypeOfEntity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityVIEActivitiesOfVIE": { "auth_ref": [ "r61", "r64", "r66", "r68" ], "lang": { "en-us": { "role": { "documentation": "Description of the transactions or business conducted by the Variable Interest Entity (VIE), including how the VIE is financed.", "label": "Principal activities" } } }, "localname": "VariableInterestEntityVIEActivitiesOfVIE", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r199", "r204" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average number of common shares outstanding, diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r198", "r204" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482669/740-10-15-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "https://asc.fasb.org//840/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//350-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "50", "Subparagraph": "(a)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org//830/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "47", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c,d)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r613": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r614": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r615": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r616": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r617": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r618": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r619": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r621": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r622": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r623": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r624": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r625": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r626": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r627": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r628": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r629": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r631": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r632": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org//705/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 82 0001493152-23-027997-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-027997-xbrl.zip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

=GSGYE4*Z T18=(DC'94:Q<4%VI2>; M)C)%4$'V1==4G#0H0\L$]34#_Z(YCDOD)0$$S!V1,@OGB7&)V9:M+N8^[E#VM]?F9^085!-2$R=[ 4MN CZ >&6)H?"9F-NIF M]AE/WW%,V=Q*PFPC\4B,L10[)MC;YM)ED_K1YUJ%YY.0SW/;P'*+^,>/R#+)0"CATPT>I'N M1@7G9Z+60^@-OR"@H06 !-NR:NT@-+"1Q-D30WU;!(;U,TJNG,OF+G!_Q[;/ MN68.".# X%Q[?B:KMBFGF5:<<<-M-\;&*R1?P*>\13Y-A9\CL5Q"$K?UD+O' M\H33I;&\8)>ONT$C6/S+\M9YZ]H\NJVC+>HRN=7-\HWT4S$RFU?]9KM,[-.( M+)$7G9=[=9M,08>[GZ9UU?IYT2JVBS^_2']64,:ZS^T!]*;,'^J&>V-H1GZ& M80X[\H!GU:"C(U4##B'9L>QP1]?>S.Y"5DYWH[JWW5@WY>U[O%GZ4WHM:T*O M-C0WGYGFFZ6>*.+OJ1DE9CT$*,;HPL5923TGU#>9(4?]B;2 MY3$ 29VBGSKAYI=%;IN9=DY8$)8:,FAJ']S?PN^;EY=01\[,PX/]]%*G3)*O M@S)/V)+838[8KMA'P %M8.)S(*T:O;OJ[E@=>X^[VR9I]\% *SD2[?5= Z_O MQO F>.<.!;W',$'?*@:(5H<3G@.W,XL565='NKTBN1LYCT7Z$+>(>X\\/ZJ= MXI6Q8;*1$DPPF@]ISUP,N?T'J10B%DI0!JJ$U4K3+\%_\GF.*Q8CW!DTV7L3 M __]@H\_!GU!MP%^%90!/(ANA@-JO%B>M-H,L?AA'S \(=E-N>1$?5:L]VNH MU=J%F^Z?Y)]1K%>TG"GBZ&RHMNRY%U.A(6L?M^T9#J* 0-),"8IR3U N@//! M^/>B5"Y> 'S4JO4(]VADADK'D M5AZ&,CH\Y4".0MF55$XS$*/]#3W@[P"J(K[1IH%E6^<9LO"XF3ETTY;@C"/= MRSKN22ICTN,[1FYC2@9=@KG&RC54[HE+(?O2I_!CZ(,N9. -$.SU/7=^5BF" M?*5*>!86#W1TSBXW]T E69! O M=J#TV!H'FP[/9[YZI_6)09$_D\C&F%3J<] "'#1)V%H=E *L[80/\GV;AU])@0YUG"1#.\ZNP]:7A^[L@FC M+*2E.O> #$^HXCDM44R0X#?*;*. CR3$@4:!*_/V)[YR7RJP^.NQ\%I'%C[@ M6&3(H9]3X*>"1+ZLF:BZTW-DMX%4E^4513&RX(R(?]' M(,%I&^8X*,;I[$G;:JN PNRR@)(-$OP'MLS>6&41)]3@0:'$YQL\CT]H9,L% M]!][_\R7>'Q,X;B:@LLM]@&/^)H:QS?NZ]8EE2I7LRJ$_,&+.1-/6A 38SV6 M],0N)3T7)/@_\?&CI3J2S5^<);3HBWOW;RSS]Q6^@009L->51AT\L+4[K@YJ M)?[NX 4YU'CC,"QTONE,':1,9A:F2$0:C\18I@]2,+,75]S3;>FZ5"?6<3WKB+[' M;_OW@ME@<\?.:S2YBRN^=%-FZV,_>.#%F4PT]OGN>?,D\PU4^E8_W25^D3,V M_1OXA??97Y[>WDJO76+3>WXGB.F2\1NH#_OH_:PNM&3Q&\#GP-BD+FN8@/34 MUD/W+FO_<<#[-D+1,EC+#[3@]%BX>E-[/;ZV"+5\X2!!%@[66S@HQLG20107S?:R;+#K<;ANA0O/>':'O*R -H] 2)!L4V:IIL?[;<7YC;?5_^6NBB\'O00.D/K MDLMQRH<2)5]E\PV6J_U%\G/+U=Z)HT?^[<6)R4GBTUEK_ WB@];P\Q1IZD+O MICZ7FLE<*PA:N:6)P2/K8?#60MBCWA,1R5ETJS<=1F'<3AF^'HSL1A!.LA57:!P9M?'H<_KK[0ZX%1@L:;V9DY9MN!@#GF.44CKM^] M_1A6,M$T]MPFIG@-%Z58%4) M_X-7L5X%!:>>K)D7='V(R&\5&1'GF5*S)^0_RNU6\Z/ _FC!QSNIP*3"T7LG MY$A3_\R7 F<%@[$% R^NX-AHW.W5M@>*$Y69 M.,W$$_2F5&9H).KI7'!4]M9I=M)ZBR)2.-.HH; -88KRD3(T'6,^H\KE^U>V M4,_=9.Y:.S3FMLZZ8 )]!&?8-G2YC"RC6Q@*F,W$J"R]4C+VY7 ")M:6>D1G M8LD+Q=+)*@#5;A-:;:U M_XIEDJO=UR9ZQTWHG=VK5Q?>X81%F=&T3'' F[K!#=C,SIT5@@PKEX;>MW]' MY4FL,!0F0WF=W7H(VN*?1%OJ1R:Y+8E6.Z62^HJT6].'R,7.Z,3PB7M3[^FD MD>J&XWV\E,&%1X:&+RZO+D3ZE8/UGN134L;$#4.'DK%$)ANN%ATV?;=5P%@R MNSJ)W40%\XLJ8E@'ZT@)35L)L3)J+U3SX^7C^6>CS+SEQ4T*(YLZJ(3MH#13 M4( #(+#!W7.&$'8XQS"I&)7('*B'"C]R2Z/0+;&MZ?&]=K.F?XEPU31:T/BH M]UB25-94T;-@_^==>>C]R/PQ[X6=%^S+E7*<%.V#8'ANJDBA]1$#AU5%0-Q6 M)5S1[.,.@:GX\/8!-C^NL^_R8X9M5V_"7*-;F3Y9D%KU!^C"&@,JW'L98C$= MPW!8J60LF=FVAG4PQ-HVKF-B=":8BB&OM^," _I4LTJGX4K:$HJ%T+)%*GG#Q8WV*;ZG?R60LE0PRY_.7572!5ZN[7%^>K(@@&./1JXJ,*1=*V3X;RZ1"KCGNET#;+B8S M5(S.IDEIY!@S97K.3N%"B&.=+*M43SUUZ-_F4!WD K1**QIT;?#KE3I[OTXI MQ-,I,993DK0!BA]]]4ZM^90U%#4,^Y6@$K%,+N2EQX,D[+;1?Y:.Y9AM S)B M]R)I]R:7J^YEH24KLBE#@U6ER9DU]JR:B3[^H.,RO_WZ7NIU7V*O2_?C W7X M>B5_=UNY+W U?C1LQSIZ)XILB18TJ[=T3 B)=ZL_G^W_>I+2OW+\)JW^ :3F MTUW_$](118)'"QIO]A<\VH2KPA WQ\QU-Q;_#IL?/YY_&1F93]P4I?TU"/=M M"#I)*Q#+UM&_5J%;2'GD&KX)]Q\O=V;SX\]U MO?3@Z&B^]3)O+)G>EN:KNSP][?I$ M)QA6Z5$HFNMTJL74G_N71I@+"6[8B="..P!%I^#I2:]#U;D(4"EJ6D+"S\B$ M(-?>9LIM!$/Q1BN50D;*,4Z/XNUK[4^Y)_[>9)=4 UAZT:=T6U>"GG=ADG1 M,88.><_OX5)WVY0\FXAE,D'NIBE!:&V(8B^[>7!F#&@J M\=;\T)Z?'V]^/3+ZRU[7C$: HML0I#'PW_$A!ABMW,S6Z4FTJH)>T:WYZI*% M817J/!Y3WY1+37$\2=QX:CV]WA>>WM^R%\"430SK2F25[, )#8& MP)GN+7?^ODG]TN^/:L8? *LFB?D (0#O72H7ISU,U7JR$2* ZSG Q0!27RB* M\DH.YKYPQO];_XQY$ .S0I!>* 3V.]F!V=5T^0-*,]+7*!5_O-!/;%'J+&:^ M?;H"$$8/64<*%P'@SI9_&M[WJN;/Z]]K K &DV=!"%SZ-I$\7T!M(W$N4 Q% MQ2C[O[5%;H[P\Z)WO8+S)<,8V%R7U$G)T_7T?5Y*:TQ;7LEXV7K&O-055[R[ M,C -4U"Q69\'H-R__JMG%9-]S:T$0!L_:'W9GZ. (_JM(FN6?[P-2E1Z8PKD M-Z* T _>2^RV>+P)077I,#:[%/#\L] MEOF1\/'JY9/P5[]\CZ'_IM!%-^ZGO1F_(NC_\?KPT&(^:/8/O8#A/B+^XGJO M=F1-@E7M;=BN79>$-5[MEZL1"?37A2B(*#\=;I2_P,+,!K@30M;NER#]7.PR MPS_+.;THM,TM>^5,7#OQWE;QF;_17YY[B?;R]RZ-Z9>^?!I?1[*Y!TGYU2D] M5I*YS?#-KXFO\]Z/WLV[5J$2/V[@.OBN)\!KAN\AJ],FH7O((*T9MN^90,&4 M%=*Q')6,I;)>VPV"#=RG-&" ?P=I0K00_KXA/M7J&RZAV;[[8RS\6PH M*YE4+)W;^6$4.Z+-MNN00=#&QS%W*(' #Q:4JB!+)34O]&534&:RES]_LW]^ M_7J@^<(FK:F!K7.,@07X')"XK +1AG>__3H+B!C*ILU8(I>*)9E#[:M?AU3; M;C(+B%2K%PI941ST!@I.TZQMJ<@^]'78A:J!;+A]#,>]9N !EY5V77B?4:Y? MO/GG]4?EU2SN?N?F!.1 LS9,BY.P ]D"_NLG!8'_><^2LQZ10_%7:92X1%?S M/H5/P+55TD _GL1GQL#'I/F5M@<#6 MM2?P7*G*?E#FS^:':!3D(6_\A.F0SNM:U&%) M&9!51(2%7FFCFWVX#[)9?QX!Z^R:2KE>J]S?E\HW2'/J7(WCZX?@$_TN M"F?"6M#>-_Y+=6A6V$))P.E8-J1SZ8)OY)[Q6V-E@D^IHF\QQ MW\)M;>FI(BV&P?#N\-WDJ3(I,!^=R\;HU%YW,I(L(] L8\$N:\]1SLZ>QG'. M8=EK_HEM=5YYIA+6N<";;6X,8JKS0>S.\V15N*;ZQ*?F;T3\P$QPP)/UOUK> M!'T^/_O>GU0Y>_,;J,L]:( R? ,UK2>H,?N+&."A+K>_@9Z@=V0U;FK]2X N M'WWA$MSZ;A(4$6)'-9,W6"K>%GJR,KQ<]4;K6D/^@.[N/!*&E]5;H/4V!Z9>=W%5C$_2RZ74-U ?]A$$K(Y,F_@-E)'!LZE9UC ) MF!PL#:W-Y,X+THYT,)@A3P[ZT1HJVKXS!H""6G'GQ^A@O"1X79N&E3 M$)H4E;QP45 I@DJ5J['U$KI@ MEU39K&F@\L =E2P4*[7SL_HM!^JW-8X##Y5R M_=9)0DI/[I\<$HL"^-$H<^/F1'P)C@^/BAJ?[&F>XO#\#+[W=6C@N$5600.% MLNB3M=?" 7L$74#?,*Y&4-]:_#_M3[1WS[' 'P7(4(7>0N PF3O'WV5\],6@AU 9 M6I=A16W5\:5%"LFOO#.TQ$:F)O_ M7C!C%B5S7-/:?8'7#IKC?1A"0G_]HY7NJ+O9^'A)#+ZB\.,BA]\RBYHG'AY/ MW"EIBI@@S(@TC$V:A\$C<]L3'V]2="BT80Z"-GE;6.AIL>G=]3HOM4ZG+<,3 MEIN<+2WTM-P4_G:$]DOV]II-15EN[$+3RE)_) Q9.GA"UKLZA*"'+NX: ")_ M)+E[4Z(J>B$0@9??0R2![^6D2,@82L68S.HEXD 'H@>( =D, M,ONK-R'Y)A5I%R301 N:U:%77C/,2MO1SJ9<;DIRLVZ9AA576OCP29U:Q,,#NEPU>SQ*=_\X.6;4B>K MMAB3V=7NQ9M:A>=!M58IEOQM&-Z"J,MMT@1QPHVV%QQ5*@48?="91"R="_F@MWV*4T"5':1UV>2VF[Z(TR?01 L:;Z<_>8:2 M-<:MK*F:W2J*]UKCMM"QU^^_#7\(U;MW1=K9J)U*_9:KC?KH]VF %E GW B MCJ5\K'=%TV*O0[#@@@$J=P+D"C J2,2HW0]MVH^$!1,?I&*)W%[/+9\MQ['^]!F5@#LD*&Z@.;>GOJ M:]UA9E2N427\<;$7]Q@'NJXGV+_HX&WX(5 M*ZJ;_F@:,0++-S()F*Y;0:1'B+Q@BQ)9.D8E=HD_#A@ M^@57J4BE8TQRDRE59&6"0!-):+S#$&JR2#$=Z^,1\^,"A?J[#E]RK_?WC[F= M%2CLX0;EFZC$%!X$"CJ 6#"8.Y'=Y("9?5MRO_3:(F981*_D(7J^->1K\S!A M <4RN?!F[N^?8EL$!HOHE=U"PDAT0*")%C0+^U%%JP\\'B]:0^+%$MEMISG .Y)W9,9*OQ\Y"]G*!-N22%+;[+*O"\S[9L^ M@54-Z%B:WF2!.?(4"K(T$,MN=$A"Y&D46/J?B*6W.8*(N'<"3;2@\7;OUU[) M_ST4C$5+#G?P^C8A*.5\NK/KH]=FVJ[O.9:?7VMP'W-TO=J>W FY/X**I3.K MJPZDH7X#)@47[E"Q5'JUIR),VDR3@HJX&!26^CA%D[!I,UT*)NA#3$HFR!Z5 MXPAX"#0;U'I&P>"XFNJ.!9#5 1+Z\:33:VL&NWU=77B'!O=NZ@(R!"A-TX.?\%1)5YBNJ&IYD7NH8JM+8@CRI\5@S6[9;87J-,/S_+.QTL@X(MZQR3HT]L%_ AY%H> MJ1%-NSE_)TXS3'KQB=.^Z>4-]^$1+5C!#FR356+UH:E@=_ND[+3W1:Z70WF:\R&YZN=MOX+_?@PK*FQO/CDB=P80R] MF.LS%4BD%J<"^XKWEG2"KB$%.]IMA,*Z[";E_!V1TJ\89$Y-# +>$I1$+FS; MB4+>-I">'24U=<;HF QUX9UM&=8,_Z9\W?QXY%]OVTI.$A([[]><-( 6R(@' MD^>B?E(0O)^_RA;L4

"32' HVWSK ^=::HZ1 ]V#UMNJX+JF&K+JM*UE^* MM;;)2G]0&((/_466I]+&)QW)2#%'-8(GJEBNWWP8AMS>280Q4YR;UCO&TKLX M<) #HH,=,,<( 6&$T>&7/5>U$X8B #O:_$WC21YD 2>:[ X^FDS&$DSP;:B' MS.W(,#O(=2LZEDT%>)[$B:PR[E:S TX04C'*1X*PTP;S)3%^A",^ LVA0+.P MIC=QSM6<,H\#;/M\!"N^?J>3B;]=.7%3V63"P.;QM5,HKE?J[#W(5QZJ->Z6 M*_-XU*&S$#<]0OF0"\XK3XQ9R*H=A<), H7"9&DG5*X%']'B10,?QTB<%M<" M5[7 -BL&NQ+G+S ]/8X%.*L2A94[6)(CL26!)E+0!-IQN/B5$RU7SL[ *E<# M_"U;X\#__I-E:/H;N&;Y4MZ:AETHW3?J7&$WBWIN1)VC,A,1-2?H*M)THPIU MOBOH\%HP9+$I8L] X;6DIO4IG:":'Z\]==!IW/[\U887P)1-_#9DM=S5&6 O MSX ^1!3&CXHA2J*'(8.F"(9AO[S?5_S-^/*:J4ISH_F=S@]\VO M@BEQY=>6BOZ[45Z>GVK*[_QU7;HI4K\?::6EUCY*-[E>B=GGV6; MS7FJ%)90I2 K Q-*"^CR.YOOP)>W^K7DDRZ2_;BH4F9%C.@I,H'&]*5R<4%\ M6+7>:*SRKPOXMVL@J2\417DM]L]]X2RD^UQ/#W]KWXQNT+XL!C/2#,;6C*'( M7K>D\L-// ?X^"Q&TJ?%F*/+2[%3HU]NKM6?Q&($DT_NU&*$"*1E,2BOHL6A MF8QKGT$&/>U,V03'L2*O5DM^5>.@3$;6=Y Q0Q?A_5?MNE 5])QX'"8CP!AC MPV*&I8[A!Q>!0V?;B!#"BEVV&(Y5(N$SMJ"G?6BI\;LE])7,75$X1D.QC"K3 ML<4,7:ZK-UHJ\U2_Z2C$4 110]N%F0@>-MM(A!%)D)(?@>8@H-E)R6_A&O C M5[JYK7,%P/[B:NP-!\J-AVNN!BI%O##\4"G;54$>5!IUOLZ6"_CLFI4EPH-> M$IEQ<<4)%_<(\3508A&'A XL#WHMJ%?:MC6K#$S#%%2,\)+R)-.X?WYZJ+VD M%'KD^-S' L%^+E"M!P.MC3O,>\AF6S[0 -KX%0<6*.174]'Q/'/$]*9C6^1* M>?UG[P\'MZ3C00<6:TED\(7%D5/W%VRLR?D=P(O"T5@.>?=4UFOFQEHQR"DN M'R])!]:WE7,%R/QODS.X/C,HG)2M+&QI*^?H^-LPV[7!PZW9^T-LY3:V.*V?HF$D5Z>=*XZ51 M:Q%;N65<&4A->:>19: 0$WL9I+U,;1E;SA2@NQTQET\)Y<>';?/'@[*7S-:Q MY0P=F62M5M68&XU+$WNY96P90'%]I[%E@/#NVU:.JK!?K8$;Z//YV?>^^\@V M0M^>_ #J<@\);AF^@9K6$]28_44,\%"7V]] 3] [LAHWM?XEH/!KG2]<8*A9 M4$2()WK,C#3![XNWA9ZL#"]7O=&ZUI _H#N:PD7+(4[_D''A(3P_$T0\9T-0 MAWC2D*J9Z FFAD52PD-9)?S)VGPI8)/3M@Y5E 4%O1]]@;=$&E\"(,8\GKX( M%#IC$3;_%X^#H@P5Z1)4D39_0P_X.X"JB&Y,@7C<]>V2_.I_&^L,)FD+$TLU M$/:*XNB8U;J/_T8@B>[?T^\0-441^@:"Q?WT#;S)DMG%6%'_>*"Y9"$$4=I+ MD1FG3P*% M@;6Y?; "_KTU0K1U=1P&#*%4X!]+/!\[/RN5\U^."K-Q<"D(38I*7;BHY2OE M C[%LG!^AC[RE?M2@<6+C'P=_?/ E>N\MP<= -\PMQGJ&\-_K_6)_K; MY\_'0XY/ U482!COS\>!T#'%FDA6>?G]_.P!_= U (?"2PG\&*API)?@4V." M?\T@5)"QX$U-?.EJ"HHHC?\)?U6^^MW3P]*E\HQ# ,>#8)ZMENKL_0R"D1+N]/K"+8J#WD#!;F?1 "Y7T.GL\.'/ M*Y>\R\NG+>E3HX*.5][M+?%?[0WR49;Z]?U=#9J"K$+)[?IW13R=9;H_K@5% MKXJG+>)L/M]X:-RS5C/SL0IX@2N6\OBB*-KVV:'L?PCH2\)HI=)\K'PVF M?=H"GJ^4Z[7*_7VI?'.\ EXJU[D:QT=:PM/-CY]JJ?Q7X'[W.R<>0EN3"(]7 M'#TKV9L+H[U6O7*_T.;U!^\V'H^;UYG%.]*"].P2X9)E2)\ NUN5\"J"+[IZ M/#ELM%?67GSBRA8*)7RL,%:88#$-!ZWCMEPG$2]6ZK=<;3/SM2N=VLJR'9N) M*%?*\>CCN >6^=YK&^G:_7I#Z ^EC+\M/CQVLHXV3V2[HE2H_WMGOT"CF;*2\F,$M-8.;K],^5FS[8XU* MV]KL1S/QQ&AYMCD'<(C; #W9[8N/X4E($(0/1%%#Y=;\B3I4+)VC"(]"X-'2 MMLN-3]2))7*I6-+'*4@'Q+(5\]QWR3._W80!'+B936[)Q%TXS@/CGW=?W/:G MQ,423#)&4:L/Q3T,AD6&7\N:O38VD70LZ^-(OP.RC_MFUZ:)*RB*%[PK2Q)$UR"I8.3WEJY03"YM 1W! M PE\P)Z)(.P;'8 >BO(MF_PUGOL59F W;>L2R.ND5L<'D9>Z7 2ESA_L"8J* M(.R'H3%!',X;B 9XNWBN"46$J-9;M#W V6)<4BMO*@J#NG+?_05]QQJ&)LI( M]9L?:9U_^U%HI_\60RJ SF,WL?M9[ OJ#(6?C_SE-G9AS5@BI")#(AU+TZM+0DO*"D=.]V"*!8M*//ZJ M!B="_:8>"CHU_RE;O,7Z[=#3$M M7]@XC<\_P\>?;;,O8Z/^@K6']RY\TJ)HPD'7F%T>? G[=);TD]R!$6T0T MFA!M?:(QA&A^5YZF_$(THCPF&\OY6+WUS8\=U^S+WN>.!])GEWE2[^]_E9]_4/+*/KO-CK2P$7?0#Z 7;];U[*\7 M[Q3/)]G7XGI07-^TIX_P>G^\WG-O(&']'ED?]DHTDXY1%)&!2/4I[BBY1!8@ MFXNEDLG@N!^5Z'([Y?>983)K%*1.0%_VK2Z;6L 4$TMELN%80*\#ID(<&;]L MRQON_9#;PR#WO+F8[F8>_L[W\RT_%X#9U[D NZ6#-X_7.A,J],'\9!(>F81W MC)B.)T< 9QA;U!$F ]E4,I M"@/9=D6]P$SXHBEM41>?P C@3G([&82=,6D. MOTPGAA*!\>R>DT'?FH8S.N]RWWYU MM1/U3:'U'D6>3)Z\\,G>O1P%JQV &;4#,.'-0"I0+/?C=^(7^_ZR[QE(=)1G M(,TR(Y#>C,8KWZTHAO1!"Q&8@423&4A+GARU801!<8O,0-H=C\@,)+\LV]_: M]!S/=C8#*<'$&=/;&[RYZZK=SO+DO+)6Z6PRDF"7N@?F2(OZ^(_U2=0,CANY^8/3(S2QE9OC;AW4>>=@/9VA8=$8P,J,1%$SX6\463J.GF-6;AO;ALOU*'IF6&Z#@ MA3*6W<>>1&(C_+)J^Z%LL1R]>HO40HWWGLF67#R3+9O[,'_\?$T5DIN,2M]@ M\NK2\6Q]76O+YM=/>$S;$4S0(7/:_/J)%!DYM@'1R,BQ#8BV9'#QZ1%MRV%5 MBT.5;>M8<\5TRL<,\Y/CW];3QL*.-1='.3[RFI,:MAE4365S/> M:4VVC8X@A-90S&1SL72*,#ZJC \Y)V88POIH^?U-/7H6,9,.D)FK-T9F=Y=& MIY[9RF-7J78%N/T*TH99=42$>YPVY_>6-J?OC>)'#=9UH4W29I(V1]VDDK3Y M!'E-TN;3#9I)VDP$@:3-I\QXDC:?F-^/;MK\??]G&>WHF!N$W?_%XZ H0T6Z M!%6A@T2%AW\'$.6%ER -XG%7<"7YU7_KP@RV:>NXH;5.U/%W3H[7J4:+)T,C M;GCQ?T$;JLV!F6-YBO%)>KF4^@;JPSZ"@-6%EBQ^ V6D238URQHF87+RIJ_N M7?B7L=2Y,O?]*Z*T%]%U*+S$6Q#I#'IVW^+4I)39-!Z)JOV3)6ACUO>GGSX) M% ;6YO9F N]%.1]*$/!Y5BZBNSNJ*ER=12@5^,<2S\?.STKE_)>CPLQ^&"Z. M"4*3HM(7+FKY2KG E7FN<'Z&/O*5^U+!.C^ KZ-_'KARG0>5(LBS_"THWE<> M^:.B2K%2.S^KWW* +SV!ATJY?LL##M&C 'XTRMSXO'.V7+#:A(X*^4_NUN'S M,_B.\C_#@!*05=!0<1L4L.J?!BA@5Z ;X-/__I-E&.I;@_^O]8G^]CD&X+L( M$;K(3 )U=.",7>#4R6H8DE#GZP 1A@)&[[$:LW+"T87%!7MS9@\ M%'%W!P#Z6CK9Z-"+*;X% M]^T.(L//]ME\NH^#5<8$234]5G@^M FQ!$.6CZ1EQS0T W4+V922YU\,&K+]SE()Y-H/$6C,2$8(QW MB>!](2CJ0=(P0 +A2 :*@JZM.H-]75UXAP;WC@0$*8&LHB"JA (C8U'O!_)L M_3[5IYH]H9RO7C<^\F^-YL=3/DUSY>']S^Z? '=5.!%3.NDQ*'RL\W:!S0XP M\?YA>^/P5WL;,;!+*BC+P+@"4WB?I780,][_N^"A]"SD_LKR(3+0<]]0PMXW M9&J;G$5O(!;#9<5Y)AM+Y:)XBL*Z7(L6T[:9D35BV4;;OK8;WS]EJL:CPHRZ M5H,(35%6X-1.M[JVMI>CZ)#\W"2Z&'"Y/;RXFL !F!K072R .F>,T,_X2Q%G MF_9YH9\&=@WD\]<.5#%*Z*\V8C#07 2!,,*0>,<-O>/D_-D"[",6R8(SMX[M MX>6N#^M/)#F,EW?K#K7'ZMUM6AH((U[GK2T$^@5FDCQR:H';FE0-8P MH&DL5+S.[^'+X&^?S;=W/45Q4@ZF*(W&:H; M!47<@((AZ&**WO8D&6]%9*>30QT*!BQ ^]^)4,IIR)R(HYA-XBC_,]/S741F M:. EH(EPQR*YY>H466C)"@E]MN$]O93WK"@BUIE&51CB11C$\H27'6Z;B7+O M6>28Y[V:80=8]*,%[7Y-QDIB[L[N,E2,3AWJF4B;T3$$Z\LD8XG$MI'DZOQC M,;XH_X7RJZN'94<1);G9,R9TL9A_^"V]?= UA=YY,C+20'T$:MC"L[I4MI*: MNU/$#!5+)0[Q)*:-R1B&'F9BRV9Y3$0WI0P8W=P0B:*^@!*]^,X M9)&'["7:?_)WUYWBGTT*X(&Y2 L/US_:091@XS 93$5.V'R3?P_E:YJ.I;*; MN(7HZ?1V9 Y$U1?MVHGEZ$S0*G^]5.5+ZBM434UWE'J1NY43-+SY _EB-XQY M89.Z.P%0U"*R"=#VL8 4RU#'$]VNHF68:I:,);<^.]77^O,,SE4=]@59*L V MU'4H<>]]W)&'3(]MD=P:X.*8]_'^9JC=1S[&C'0MS$#T$;)=KD2 M[&N&O.^JX&9LV(>'C3')Q-'H]\9$#M>_)M*;G%&Z6O%S32@.#*1Y7GI_C_]Q MXXJA%3M/1U8(M 5%SX^B7(UL/%/F2FC==+!Q#,LVL42YN!HSV4W*>2 M,>34M&V20O\J$*X)2"37GZ*TQ2%%U$8-[5[=E=@RU-W2K#DV$*ZQZ"OYYH=4 M:A<&V?[#VU-J5XFD]8V,]Z A^Q"GJ45&P]J"MJH=$.&YYZKB=DS:0W:9H6+9 M="379'9.Z##:QQ(Q*KG)P;J^%DW=N!=90 LM/#AL09W(4F_Q/I^K_>UG6W5I MY_FD[?1E:9]YT"2==MB">5!+GOX(%8*J)'-;'#GOK2+II7&U6X):OGQI*Y7JK&)X@1W J"W:M4@@L40%)Q62@Y2>"N/5_7F@&-&GX%V@ISIO,4: MJ(=2[+P:2\=RS.K5SG5/O@IRQRC>0S,*IH5\GJOE/SIE8Q186T;#R#ZIN6LH M,BDY0&_K8R_ITN-#13]Q]-2VFJ/7 O]\WT=\3L<8'\N[Y!RX@+@91A) Q=)! M&K2-)BBL&9A$N)$[6M"L;BM?()"XT<%8.(B@^6'R;"N1>\IDBKOU'O.3"$KE M7QP_.8G@F6PWV% N)@\=KPI#9V[> D9)25]C)#5^@%=E([ "_G, M1Y+D,&7?D9A_E0BWRH]/QUC=R%78&8B;;V![,)F'?%PG"@VM_2(] ME6#4<@\G]4#_.9NSP?6Y)[O&CU_SXF]?2&@7S[$:3P<)?6>C;.. HOFWCB)XB&$?0N+/" M[2SEZ ZW3,8R(=3""=_"K?AE-CIM+;05# \/-;6"88X-TE0607]\Y-[:=XGT M2VY?681MC2C/#*+MHN6Q6!&M]A\/!NQC*<&7+8E.*T) 1 USJ=*?HN\\Z%_6 M@1[=,"M:T'A;V\DS;+EV&XIFI/KJ_92 MR%UKB:BT>MLDPM$C=(@$\&HS$)W11DC7+9..:\/6!SBBQ=%'*OL7G]UMFZ)C MF=SZAY:=$(OII&,[$DL[KS+RKE-.)9P_*LV0G/NI6<5Z$N:])\:YLC M_9,:96M94QYG0A/N5&S\$*OO3[\_7C?9#+%IM_1X3KOD0/[YJ^S@@I.>1>YR MWYG/;EFVCVWX%(7RITCN_8T\9\)HJHJEZ7!F=12#,D3K!O,R;YNA2!6"QYNO MO(Q.#+1@1U;Q6=56HXO[UVY EN[H^D$4J[U6T5\G=5. MN!^6;PUJ3BL*Q>C4^J;5%_=73YGC!_V^8IW@*BB83/CTUI)J(X6/TXC F7>> M-I!O5*OWUCG7[/W$*=>@5"Y6:@]LO50I1[&F$2UHO,4C-7<(GC-10Y;*T)SI M4OG@:L-KX^DG=7<;Y"#M#<2"L<]\GCUE&1\&C(19\7'N,!X>BM&UH3$QTLY> M]*D.S#4Y.&E[XY8A[$U?7KDDWV.W0)%3,I_GP;LZ_7[VR8C M=H,VU4NCV&!4U:;&^9F'BAYHS+-2LJ<$8'D=6XZ;6MX*WT1][G0 MH@A&$)$71$\@;"!;WTS?@'A]+4?]XH+ED/1MQPTOG%\0H-@>F7G=Q58Q/TLNEU#=0 M'_81!*PNM&3Q&R@CNVA3LZQA$J8F;_KJWH5_&9L;U]1\_XHH[45T'0HO.1J-H_.2FCR_K^]-,G@<+ VMS>3."]*.=#"8(4\.^M$:*M MJUWI<+@ZBU J\(\EGH^=GY7*^2]'A9G],!SQ"T*3HC(7+FKE2IWCS\_J%9"O ME M<*[L8<]A[P=;9NE3_XHZ)&L5)#*-]R@"\]@8=*N7[+XYHV0OU'H\R! M!!4#.+ ]*IP_Y0>ZCDSA\/P,OO=1[.CTK3=0@(<^\=@E&Z" +;]N@$__^T^6 M8:AO#?Z_UB?ZV^<8[IJ$"%U\J"H*'EM0QZNL1E= #_M\7+1JE-E&H53G"D>$ MEW)50!?I/V'-3\&W,^W;K>M*K( E D7N6M7=G,0Z!D[_%D"L0-;VOV>/7-!4\"$/ M9+$CI%-?0!'9?+,+07^ KL%'YXRV8$[E<_B(G9%*(F@!M+Q1 @W]\L9$QS M#'[+S!PCN5Q_?G9^(EM39/LV^TL. :,%P0YHH7] M-LTYNTBQF.$ U-B1L MK[*(,+4]_@25K/>Z,(,*]_"U4G@801B)I#X$)3MJ"U(9Z.=GB(-MY&V1] A8 MB 459ZK6+$9[NK-50!PHEGI;P9\H(_F5VU@F%$M$7Z%J"8B#WD.USQD*]XX]$B \0.4N(>U-&#'UR1L>"MZXL=BV/A_P?UZML&1'E/L<""3T5\24$?= !K&!IR>UAT*WW[+TMD@]8 M?(G('2!RR/?/U,$'JH!LBFF7O_T6PK$UG8Z63/!CH,)1,<(2$[R6 [K"*T1! M 3*TUH&&NIW'8Q!T"4\;.#^S!-L>IHLM,/H)Y>W0.EX8'R>+@71")1S'N+G^ M#\V'8:*/VSK+95]4BU"Q#;74_OM MIXGH31!+T<_/,'X3Q!LS!Z&JH;@84<@*Y0RX%N.,KC90<)2&XBO!>C.ZY\] MM9?M+%;@T&QT+PH$QS=;KM)>-\%1,"+C)([(7:(K5.01T;,M_X2>Z-+YSN(1 M?O00"CJ *KZI $5H5682M"4VS!;QB"/K2 $Y#UE?6I MI !+2D]X@19NWC1!] ]V5 0-?&KQAQS26,'W.BA \56G/&!*R.:V,W_AD.6 M!9KD (8U X6QZ+WG9RX"LB5N.(C'H0M^B3GQ3H0$XC<^1U2TY,)Y:7N :(FY M84,XQPR XG!+((TNA";"S+ 10[1#+W&G7F,?YEH03XD+6D0B9)E)$6 +Y!Z1 MZ;>TI8O45].=H!S;LH$EIEA66DY!#4D%2AL[7'N<^IO"$7B*/]*M1Q0149P:9<:O9EJ2GUFX,J\BY- M$9L$*IV@FDU#-^-Q'D$E#118:7L_<_Y;"/$:)/LN&\VF>PB.30:'" X-'BRU M^6Q!*96+HR:4.#/1A8)9 M9NU^]&A#L73Z'VM#F#DLK)5D6S3G1)&*O"@B_4;JO;8(/CPW/^3&QS"E56^5/_1!B. 4JJ[H/3SO M5?003%^P??T"*BI@!QT$K^-_Z51L.O!_0U$!OAO'UNB5TOF9'6U@-SYK%W&P MBV32U)S"Q@!%^G8!%5\]$19I;?+W6?("#]TI"3BF-!DL:5X>'U[J_P/^3Q[G9JS"MTD]&NM,ZMH%45 P/:& M"F0 D4 P"2#\^F]TZ2"T)A Q%WNOJ4(RFK=OGI?A!XB1480*^__C(5HE/+N! MC(UT[)+S-'3*XV'?(>N8HA"\APD8CNFD>&-L_)J3F<*+9]H\-)*1OIW UZ%@ M-NI5E0T1J[)%3\]4V/"#**Z%X[K0TB-F)]Y3!YUP&QG@R%[5\!]L_:X: M\D2)W7N%XKKP1'0KV+2AH8^AR.J(1.20;X@->7J F*P48O'JD?[ .CPUZY#8 M643343K.D%2(U0HT$B8K3#V:J-MIVXHQ =1] ZZ\,KQD;-R^T!4]*G4X'2_9:'/BW4 VR2 M..TA)R,.RG\,S+],@5;?H*[)[7Y15<= R.'8+H&1J./"%<@_^$^J07OD]Y3Z M6#;1;-)_)7JJ1>33K$>X7^%-HL(Y!(-E$"(5JI$V*&4&3@ M3ZB;B'&[DUO=(< FC'\E+4Z AS1)E@;-M%@X%%YMJAEGH0 : T('M4A$&1?% MF/_(YU6YF2N3<2/STO*A&#LAT@,#YMB)(M/\I#8ZM/C MI$;ZM';/L%=,N@.?BVSW'I%GJD@RH:O>L6@\,ZN-9RPM#>O4-.5\8^ H9.GWL>*:K>4%>!GAZY///9;R MYV>5 O.4KA73F5*>*98;^5J^WF#RY4:Q\;H@13SFU9TZ6;:_INUZ7BZV@VU< M/>'$0]"ABS^ZBX9$T4%>6(6_ MCO0_E0YM^6POSW#^0KTT>$BNLP*^'1/8QQ MK3I: #%XR8*@E!8U7CK,.A8K#K\XHA92(2+__[O@%KNSUBY"1ID_7+5E7HJ# M$4?^ANYO(I,J 'D*30_RZQZ0]@!+VQ[;=,KG4)E_QKM2IRCN8XVB4SU)$'/13\;]W?";/4<<8!' &(EY,RO/R>W[<-]P4J^ S/)'-YMPN.:M% V_SQO4B[,58M^Y7 MT/69UO>7KB[UU_)%<4V@GRB6U)5.T2J8W;Z9WF/L/1I^>NI/C(M94!"+JL'C MN\H]/-?_=MHYZE;6L\TKKB.TY/WGFP"?#3D6V_-R"/]ZX7 %P>WSO142XV>^ MQ]X)T:,?L-7%1F\>P.?V!'Z&ZDK 4+\ N->_MSNNBS_6_@)O6"3IP"()"XN8 M)@1<'#8@LL1R*A<3'<&D5*ME# M,07C-X_U_[ ,X-L];VXMYI).>BKFS5$LT*$NYMV^UCA;C%^_?\3"9OC5R1P\ MJH):/@6$:;-89^/-33I>Y()[9-QH,K[Q1IV"K<+([5NMA9\?6NWQ].;-(G6M M!K:S:;UD5"-S^F+Q2*(+9[(5"N'6I[$.JF=_<>]NI80C13F3RE\N&-2+R&_[ MPN0YPM_M[TM\Z0WN?_O ((!NND5_N*L]M^M@[QW&S;E;D#@WMZE2[7%P__S4 M\\S#N7/+N;&F7S>H#6?V6&>1N>NT+)[S?7D8OP_'>/#LX9&N\4&,JL*M79#P M;BZ(>T>EM1+CFGHKM8H=+X[JJ-[$=F3)>NPH+)[XX]W\;92OI.NIWN%\A'4D MO*][<'.WG7OP16F=.JP#L'A=0TG@VV]23^AW/3?^]Y'=3G8_!F'&R>&%')F[ M-[72PM_LL[ENX2]>6VS^SDZ&[>R@UG+/N/>90;].V'IIRP<&?&# [V/ 1[Z; M 6_K+YC/PA6E,&>?[A*\5]:[]85?,-UI<:\KYE':*ZO=?KB=Y#@)PJ-R.I'P MZ!S7V.MZI?/6YGK\JK27>-G<[1,E=G0QT5'Q[ 4(\>U%"WWU2N-5.G MO4FY.&EY;:7O+J/]:*(7#FZBVR],>GG-#5J3:3O7/E7[?+5T#8SSP#CWFW$> M=>61>$OL/+OF"?+S3A MN6(8>582M.&;_A=&?ATFOWO1/I MW9D^9\ZC>B#'P_7,*4A@IR#N"NU'O74*-MQ1M-M[UI+A9[[1.IB7L)$1UCD+ MI&/.#RY#]J NPX9[_/RH%=188\H5!*]]B+W5R097@NJ5 _L2[,%]B0TW&%$ M@!,@*7(.\X'"S;G\>5]EG_K*+2^B:?;W]^G:*YH-5"]>EXN%8C9=;C#I;+;R M6&X4R]=,M5(J9HOY>C AR NP$!R#N98A569E:%\J0TRVBN+4/=AZR0-R@U0-%#F2'0 M&$E6<9SW/XOQUYQ%J9:!AB+U U""GVZ*Y:8@.@;HYIW:_8SM-0;7.2.X!K^+ MTQ$#@-^U*3)F>Y4'8^7B2',N&4IQ\57@7R%&'7+0!CT=*C/'X M(P2N!Z"I(6J.!VCM9:PA^*$A$/*\@H!:U;3YC!QY!#S58G,T"H_"YN'B(Q4[ MT>=:2:R+MPGC3-/+2]ATKIM7L Y+86L;8TO. MS\2.768BV&@<&%V_'S_!) ?FQ!Z <[O2+R0, 8P ]D68\0AROCA \^_P,#D\ MBDCNB/KD.L-NH$]<4.KC$4I"G9]A[$B,=X>")015'=H']\;X'DBKD@@FU$0! MGW1,C_7C:)H1/#6X1/AD^@[XD:DH27@^'Q1#Q, 0!)'FO;!T17-YT% :S>E, MY!:\ PHES^.7(Z ]K-F%,;ABRFABISI6\' ;Z( CGNJ*:!8@YC/$2)TQ0K,W M5Q1"X.9# 0TBP&O#GZ'G_"BA+E-5D*8%XW?A,BC1,WX,!HF!)0!Y64D%%2X M1)5(KID.@D^W%'0BM(8JQ0\BTM3T9 D MA.Y++WKIH12FU'CLSQ))W@>HZ-3IA=C2;+T3;VUZV^X!S7D^\MB=II^?7EO) MG^[09YKSS_"C')8R<678O?B#CQ"[7-:A8KYU[(.!!:XZ^[N,Y4/Z8,TXP.W' M(XI#,D':G@"!%)C&HH6WY$ 8ZPA%/XG?X]"A]R(Y:Y !E +K!;%U1-.ZKS7G M+TDN/>"4MX=*Y*>+WTASGKQ-/HR2X=)]3+"*W[;U" /YZY<-NRY_=Q&YNJ^M MQR_'=*ZMU>)&CM BHC<2SR0*NV";X^BF(@ZP8]Z" AM%J^ /5TP:N@"X0N]2 M'X5EO!"[6N80*<&*"1AD.\ >RQV8C83_+Z%&3SHXI:'.!VT*!W=4$:6T=K MV#_8G L?0N;S2:I'TJVCEOZMG$_C \&<:,[O*HG7"M]5,U4HF.$98K$,]&,, M1+)_-GP 0BI"(Y58N\AZU?0AUNL%=L@R&!H/959-^J$3Z-3Q8$0G?.,@2Z<# MVAK-CZ&8%;*:!X:@)TDR:+0/!5M*C 8J;-./53) S'G"'IU<9!WDK+\/#1+7 MR+AC,HL9!6,$$25IC-DK2]S5RD^CKT+[64%[A&3I:65S" M )3UUGG*EC';Y4'-N?0F#B9/T7A:ZP3Z8G4[%'WK&YV<* M_'YW*'X[*_Z(K'3J L2:%8%_E21Y2DSQ[E@D 104_#!C)74-RFY>@3(Z*PNX M ]'K7^EZ]G?3#P<#S'_BCK!$1&MLS5J1?H#!7H]BS['M!5 5 _45A-PJ6I@ M='XVD 4@$>VC #SM3S4GNFHRU!E ::,B15SBCE@[K^K%^&YV%\&[EJ M)/4BZBE9G7QD-*B)IW.:2$*7WBQ#+U8VSYC>T M#9<++SDP'7[$K@U=2,Q'A1?H0&4%3PYCNC*R/T758 TTQ1E1*J8P8L6*:A]] M Y=4H &VN.%+5&HT3[&\ MM34L&D.BZ<1I(ZS=FA%I0Q]+UXY#*Z0A%*^+7,=#.]FP&,MHH29-N]]B&:>-7 I%Q.U<^%!P5H 4XY"\*CD*%0U4)*X&37## MI9(J*]U#@6Z- HP=!K+A1^S:9@O1N8/(JIA@S:$:&E+W/#'%(\KO 5[2>LA^ M@A1E#B.\UK-.]LI,0[*83\1<6LG?AY@;5&;1@MPM$,]Z 0Z*7X(W7.D)%7] M#:0*0I:$M1) W5$D&5_T$]&?@LN8\7A/:@W"B MJ@Z..1/4WZYPMCDOCHH-D%9>1ODXFJ*HDB)NRGF!&^Q[T>_FYA:OW_0'L8DT M5J#C@(.IJK9D$R(#0H'N#$_+0VWR=00O!LE39)8H(B]!!Y/,>(8FB_P)U-]7 M3%%C:"NWJK\)ESL3&Z\-Q FI>E U7.VEC@!Q[>AOIKCJ#[416#Y$*_\,:Q#_ MP6)BD9]1#9J(2M9:I,0,VFM36>DCB%C^N[\J(H2O@&UIL,?D+)!E9D*/R$/T .&\F @DWK( M$/$A4=4-2:QU $!UF\2%'0%-D27X&:B@J+NK](V%H(3$2']J#_X??@5Z@)]" MB"=;%<^K/2AMT7_R'V-QPDLHH;)] LT?2&-$\WY M34_NB@\LVU/XBS_HZ @GX-Y*8)YB((7]LF'/TD1Z.0+*<3(]L=N#4E<2(0D@ M^QX*Z+&M@F3 :V,%]6WB0GD% :#:>,^7@F@=#+)OFIP!3IH-*[>T&34!+M M7X%X]5Z\HOGI0]1BO'WGYZJO-.==,.C/:G?31BOUTX5HJCE_#5?5Z^3#73=- MQM2C,Q,#T]4_&W:W9MVX8-QGI%(T ]SF&( *,JA0ELU1'+<&J[-H+)1 MPKC( M(?]"(">_"L5"Y3K7!%3GB U]?L!WX1=Q&LHH9%Q"I-!! M7'2CW5(7@YZ"0NA0?VBTN0N)2/@$>'4"KLE!A8;R0*9H"& X$15YB'27O<1/ MPXT#1AU2R+E.R59OI&?5X&D^&X=%'!7C()TR47JU3M9H2LM:>QSJ9BL:?&/% M@%_ :T'+54 /?@UA"Q&@J4!;>J\M$<(^4+1954*XG$,!>10C=$G;^R/;/J(Y MSROC\>M+H2#7XS]=FV:;<['6;A1 (R)/X>GBPR,^"=#/S\=Z]6AQ5I?A/NOC M 6I?K71T(K;2[Z,*.F.I)'9 ^FX%;R02II H'L]KCD?AMN\<#?LQ9^."7E[ MD%MUHO,%DP'K%>);V=#TH'YHBR36A=N4H7X3%:+PLD= M#=5DD'I:7FJ3)Y^?R;3(5%-XA#AVB3B6VA.,/ &X(EU4+ ;!&-\D]!I1G2%V M!%$-"NEAL !7J'I[QM\N\.YB0<"6]WXX1K4+N$RD.0\_Q)Z?A0>YJ!E4#4TD M>#?P)9")@0%Y?'Y6*3#56J6:KS5>F70YQ^0?'HM5E$EE'NOYPF.)*14+^05! MZ+&D,>M K'4?BW4A.]^CK2QD9?G(Q>*\P.U?L/UDP>G"?,@5A3.MY<*9G;<; M3?WE?BIIWF9'I!]_^3S>;SA8(#Y6_[-GCL8;BD18=Y0HM>VB-?8W% M/"8ZFR:RC[A>Z:N8QEE3+#8%[=6"]-O<_/4,GAEJGWJF7RS\7)U>JSY(^3TY M>7VX?;H1NZ)MUAEZ-F.SC4(KS(Z+=JGP\)Z(I]]BX?@!.=UQ,>XR.1OV'9?[2;'?RYJL MP+7WQ+84F.\N,OA6J08/S'=\H4_D/@T]'N??/G+CMX>W1^YPAKO#2HZOOXUA MP6M'!:>:\SNQ&RED7Q_[ /RT4<$'J7;1^&%7A%>1QNAN!1$U*)0@I0DD_;:0 MN&-M92\;OMN<-^[N;LK]F]LR_^/K7W+->:X[O+O)->27=@_51^BG=WY&D/5\ MG*\+6I,/BO:X2!E;9;CX 1IU3V::H3H6_2'Z<#,%4%!]0 %G0).BHDY:1(M%E"Q(F05-W;9.U+I-YV]ZKHO_FA@J"M(1^WI]_*50 (<%J,/X>@UY!&DTD@LK,\\H"!] M!.MH@>-U+C6 ]K6F]DG>0O+8%KL8BV; HTWK\T/('"@ %'ZDH,])Y0I!H<7D: M_-(4_=^B#+&. 2@:"Z]TG$T59% +^FP^V7E6W$,J%XZ,I')C:HH4^S%>;!@2 MM^4Z]IH0AP71<#PP!-&*D7WV&7%#>>6(OF42,8@#@>\M*14#<$_\U"O;'095 M^DF4G8+57D+]Q*"$RD8V-/Y8&6+-MYKS? JDRHE:;33^\>T^^>:\I-TUVK1?&)3=K@VJEI7IQ($>9O'0.JH$GGMFZ!.$^21;H_;\'?Q>SC\'O+@$'KR MHD*'!X.14''1N8$R!TUM!9O@ MCD:=XE(=J)7,YR,(7M)X!3=B+UK7CU5?+&D!X!$HK8A0;!'.DR(3P"7TAM%( MD?EV#\]JYBGT?$A'GQU@;%WT.7/!XI H870H/5[%B\4S2,8CLC<#U9-<%6[> M;4.-BE)HJ%U75O0^ 3P1%:'KHS63YTW T@-INZ%,)U;J=AL%Z2?$:1G,@L=& M&L#-""&70/L3=2VK)O#^+Z@2()7"-;!A7PVU.@4]3?H0&OSG>B6=LP75G+_2 MG*>%:>4^7F$GN?Y/U]"%YIR[C0XC E=Z?>-0Q 0=&F18_M/'BCIH)_NJ2XRQ M?56JB>CL>7SG"RU?#@,!:8<2^;JJ:S+B3R>01J<0/(24F 9Z*L7B,>!YT#?@ M9XT1@.=GCU3PPM>3@N\0&MM.@*'AP@PG=V%BBMX*1>&F=2>*#M%%7T2*D@*H MH1YA@ON@#[,E\U#(WUI FT(]0925@T8U'&CK)!=CM/"J]1'M)2+\0T-+HF7A M>!ZJE]^X1X*G/("VQ%@QFO# D,<8U.;5,0H&0D)H%FT:+$!X\J2+CO_$.Z:? MIMUANN*R3!63G\GZ6,3V1S4$2< MGT$9@>-D;E1-P*F M3DU)G2,@ESI;TF,TRAQ/L4:T.9)5D<(^\WUH6.)!XC;&H+]'47Q,S!C,_8IY M-#P?+"?MSQK (V10$$O$_D,++) ^;;MU&"=HF08QD%$04.P#Q/WB._&)(LN!DW.7-A9?0 MOL6>+ N5SN.PPT^@%(-2KXX%$SHJY[AD;CXLY#^%F]&S62=46K=&I)D016(G M8VWB8YVUN\*^W64_%W^Z>!*,0NXZ%OYK5?F 9#P*1Z);@$PM@=P[URD .FHX MS$P%.9D0H^M[*RW,R+@S[*V/(3'UA_(4"OXN,-J7=5HCKX*VD-[T 9(&R'B$_VXAHP3@(#>*@D^,:79&GI,T"N)QIN]X,AXV2HA< M@[]^'RNB*HAMDG&UQ X6WX &7>LOL,>:L&#KB))EAH\I>\TI&=85. @]U.H/ MSW%)^)WHU7X1[YD-!X#/K@ ^)P/ YP#PV8TM!8#/)[7I / Y 'Q>>U9^ 7P^ MA1Q#GE?0'$FU"I0ZHI7UJ0;K9/8-WVS.,^4W_O8F%N\*W9^><8@UY_7P;2'V M,E?:TXL_9:"A6-ZDXCCBF]770&!8%?6KL M\@JIUS@%J$H ")<\]"B0G6QJ'0P4/:3*AY''&DXFHRH&C0FPT)JE;'#BVHJ >#-%188?F^!B6B%>D7?E\@7T>0K33C+W9( M'F;E^W'1HH".2YSX*L!_JOTM!1(9T8VSACE!64T/!?RCA*7_ACHZ*]SKWL]L MSI]NX:E_BI71-/'3-6J\.9]THI-);:[UAZV+/_14T6!:?*YXI+1YEH%6]&\*C)<7FFE&<90"<6L:O7S'W,M2K*-V\(COLXEZ0I;EF,P:^+9G$WL;A MR(6MT>VT> F;(FH/ ))DIG5^)&R-4_3Z%Q?2Z$8=N)'&#F!: V9>-I%)32*> M6:D3*&4?W7B&-MS601&CCA+/+D%?QPD\IWRR:<\9\1=,JO!IJ!O.L,EL^1>C M,!6E?Z')S"MZ^+G)4.K MS4),#6ZAB[)#QJ/UC=?N;?LVW[9X0C=WY@F9%3IH[+2!%>TH5E0]B4JJH=#0 MF-G2/<'U(]'5MF)"6ZMM@%YS+&/>]E>:*6#@+S6>GI]1_-$0#D.:Y=HHV3@: M*R,9E:*OJ8A"=&WCI2FNSG*B1I&434/^=-+=YV?P#Z'U+G0R$KZ,F*5[T)FV M&-]H-05#4!A:R>)4ARRJTZ8O]>IUJB[/STQ]><74=+1R#-=@G<)DV0'*VE*G M>M&VW8)>VF-_-_:2>[($C7ZC@0_YS-K,[S+B)""I MC5%_[1X0QA+ _89 H9ISP6W-$.)65\%26SW>_1[8G&?CV!W_['\!M6'80-EP M -\E)=Z_-\B820R\*ME3@ MTM+7H\%!+SGQF51S7NW.A7?A99QKB,XPS?04]QZ!E[W)YQY+>0SR7*C4\L7K M,I-]K-7RY6PQ7V<:M72Y7DHWBI7RP9&=MRCXV/Y*MBL-64)V=H:[@>US8]L:-K?G\5[^^]?*=K!*E MV_K%A:,A+I(,<;'8;P=2I>(B'OW+J2ZLBK7()60II+#^)KK)IGP6;\2 -%]! M#O:/L8YO72 ZHSXZF5D=6<_31=7@FBR*ET7(+T[X;&DTCV@9B8UL.#\4:OK$&ET2'> MEK9H0XE "!&"K%%L""M(1+%C5_&$ SZ$(TEL==>'H*+X_E3$ M[4U%-\/^\UM[.@M_QK\G%7%>4E&4=8^*OB0QGU? ?*X4C;KKOD$\KB7C'6@W M?" )F";;,NGWZ>4]'RYRBO+:^A+]'E_R+6SM:W0;VTBWFR[7+AU'5FV*G)KR]0QCYFF$6& MW?,@F[_AWI^%[T,9Z\PP=R@CXI8<,T#H-\#0AYOS^=.S.)/D7",B'325Y9,L MY0[=M6S07>M*=VTJZ*X-NFN#[MJ@NS;HK@VZ:[]C=^T1:ZJ\:RS*/3S7_ZX! M7"17Y154][B^\J($A6#!V3@ MOM@QJFY&);&HNED4,!*DC@Q)ZX_M#0L]"@%',;-#C" JH(UPXNA#R4\A]!0D M6A19(FV@I(864>:,P.T!I2VJP(YG/>Q(Q+#'4W(6OR:B:L&^O>D!U4B1VGM< M3@R]98QI>D47K .,0@]:/C_;L,G9(KH4[5>E^V!P$3CI8'5:M+_*>D]0W1@! M&5Y4GGAXZ)6.4=1>'*KPH[CXVG%6FQ5Y<*OO-^=\N=:;/81G+XEC(C[X6P6E MF_/7DBH+M\-4[SD.O7MXM.=G$W2XC*TN7S3/EQ+,WW[42WX*,YV\_, ]<@8D MLT$T3BUICH3T-YFQA(-G%CY'Q")\$9I-4K2/(64CU9/VHJ+W-HT$3="-J3U:T2P3͐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®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

DNF'PA,S1YK\G!^%#\P[JF\"6G*^"CE +E7^)I0!#?EQE@T\0C$=?NLO M[S7\*5#P/>7^OW_!44\Z=9-)ST=U(A!?A0[=51B^^"'[0,I_(A + *$S/'IX M4;A:OJ 0="P+]Y/.<0Y<6'&%=F_70R7:UXK*:R\Z7ZC^+%6KL<.#4CE_O%<[ M*U=JQ>KA0:TBY"OE0K%<+1:$\U(Y5\Z7*ZB6K!F@ZK,:#'RF&?+SIR%;>CQ<^F'FNT\#-5VWI*[6.OWY^P/M[BN^ M+S%Y#'=#(_H'DSA]&I1K_YR]QG^EW)GI>M2K52L^A>_.;".K"%K4GZ-1D.5N:U04HP.DO%<-2]D M4PFN>[8\A1/U.=2_I ;0%.&[I(.ZW!=$Y'+B*38SA_SAY"B> M./8'-$P5]AFV#BJ'!_"G@$956T7;GR&@.BL)+NMH&XK:4!D:)&W30+,=6B5= M;H*!!;JEDO%2ZG1,0Y);7.5446^T>1]8&+(MO:IM. !?B^8J.5>@09.PK,,# M_$ECK_@^C"8T'-+Q0Y/Z4QP+%5WX[L F.(\7L[RI['FN>@8S6PX=(6T_>R2* MN !XL:LJ+-@GJJMH9%59@UM%N=77PAZRJ/SC6E"Q)4LMJ$)H:I!H)9:GZ^MP MWQK0-'P$#;Z*9"JQ\+GC@[V6"F?";\8*IF]+?8&A/9=LMK! D\F2Y=H\^!GA ME@\//%M#T+6VUV)ZZ.#)P&IX-PQ7/1D.\"!B0^:/2=.'IO:L'/B28VG]R.RZ M@YO+<6@>HA5>"V8/#N#JC:8.+RD 0 A0Q?Q M]6O51>K1D!"*;0SB/!3<)5F,S@T3-N)&(\ PMZ:APT>9T,Z:'!\"CU5=3+/N M.VC70E2+)_PDL=[U]8];^]9L:WZ\!BU/T+SU><<;;.IDZJ;N,#BCTKBW6 Y$ MEK%HEXUNK5N7+AZ=2_DTWAS9FH1K.^*1)$AR@'[/"BB9\/"5ED R/WM$W;.$W$3B;6-![[PB5 ]$^,&$L(:I&]]QAP1/B7+OK(:!PY MWN5S1QW\2F^!WH?_$PWB#3 M0@=L&[X%F5VAQNJ<)PGH./0MX);3YO4!T#I/MF0TX$L:-C7DEF*)..@832*. MK(!6X#:#]XS>H^B:G8JN/ZD[*E-R7?BV21H&CG4' [EAOH3!8Y'7FT)ANU9[ M:;5_O1BO 77R%NEOEU^\>UB+H<'L_6\<,V:$*J>/)Z5Q$PK\VY>&23R[=>H: MZ+!GDOXLG#&S)2DH@XJ9;]S[#,?&W2;(TJ%N$HJ*L$!T)@*JJ3I#V%$M$)J! M=H( W J(%&"BX2%7>#Z@@:"J:$!VN5J$5 M4@^!9A.(NIY>JSBDB&N6(L&(8 M"<[2T(R>%<'@#FZ.-/=1P."2%RJS$[AVP\#HF:][>AZ3+WOU=L=A1C>_ ?+T M?*JT\+8E\K+U\OW6"(]7= !LN?Y1@AH"TPFEBXD?5EL,H1SW<(5 M.?\4T!ZVVYZ=/ V29]IY9M#[GODN^: !TD5'DV 6@'OF#K;LQ-7\9;%P?UT\ M/*B<"Y7;XEVN5JJ4A9"%6( ?? MQ=5AU\*]AH8B!^:]JOMB"3PNWY9X41>#? MZN1L&3JY'@F].*"F3*TM/*M1]?S!&1/FG.3PR7$=)XQK^E>?2>:FVK^EYK=<52\\+&MVUMSA?0&%EVVHY&>0-2 MVX Y!A3\ONJ^.:?S E@NM(CB:X?I%GM2RR[,*>IDZG*KZH.'HL)^7 RU8IRX ML[>Z('Q^!X1-6/A;I32&59)WYS6*L9/4,AWMOJSZHN=F%?-<]!A]>97O7WK= MP>_"[^V_Z'!%AQ71&4P.%^/+7_,F>W#X0?Y3A,5BHX%^811JT,>LT7GZ@>/; M5KFY^,2\U&V^\$JC%BS;2SAYFW5.+\@WJ'2^-[N:IA=_!760WSZ@]]6FG +_ MA1\_JU^7W=\ZJ9T%B__?IZ.QN2^Z/Q[S12OW^H,MH+'$!.X&7&LUCL45FE7*D\GTXI6O=Z@*37(Y^!FC MH853B_%QUKO4=INZ!@3 MX3<-'5-M+1PZ3.:E"_QA(>L+9*9GH\STU62FGT29Z5%F>I29'F6F1YGI46;Z MGYZ9ONY04#)'5^464QR-51I34IAF1X2>!<;[949[&IR;UXW"CVQ*^;4O2>J3 M]/KQ(- _+ZQY)/:S\#0P9*WQFN^E62&UL=C/\L5( 8#''8[X?%]07C;Q=E#> M<%+96,CENL*TQ'G28J=$X!52+Z54YN&R59JN^?N8%PO"#M<1G#4K$72KHN_6 M[IKC4V*.P%>HWN6D+BD#1:IV5*6=R%Z%@KHF;>1\D333Y/.W(@B2@^1+\E)GIE7?ZBB::7O;F[BM#XAN'(V; MF9B(LR#UG=61:JK@]V:G\XC_HV$)ZQ5WMMTU,IVQ-Y/):Q< MEAI5A;T"U1UTGP7Q^5M$7VY>U#QMLM 0?MM&3> M:JFV\IB85CEJTB&\-U L;+$ZLIA\I+X>M51%8? ,;"VAOM9-313%DT]_'_GF MGH\(UCI]&ORP7JQBO_U/^BJ[)W;/354O>%/-N9%LQX1_:]3:;8K1.CNOAC=Y M-+B\XL/ N,X9]=-]B;1S=ZHR;KP>M58;=0W[[E!IRC_37)T %=Z^4.6?W8>+ M?]3UFZMO3[S^1R:9KCR_6GM0ZC0=4C N M*P_JS>/CH/&;O:4V3(X$GU\D]R>/STVJ//-AP6%EF*?68UJ7W<#%MJR 1;>E MZ\KU]>U N]:>!LW30KXH&<;KZ^FGU2D!8=_"%'E]-+YUNF=AL2(,+F_>ZTG3\_K2X#Z MBK4!ZF_^\?+^&G,RYKVNK8#>S4C\A:=!K?URS=1.1\OM2Z3#AP:I5+ S62GH M9/BFQ"_.#E-Y>SQ@_9?%1ZUUIEPP;4^NCW:,K4']/?]9(OWYT^ BW>Y52[[+LM'M<>BVF-KJSVV''#-?5J3-O[9T25'P6#; MB<5CWCW\FX-_B(\OSROVJFZCXC9O1JSJE.2@>.5WW8KE7@'>8:>%RJROJ]&^ M5ZM:;]=JUN)[\^KLQ:>%] 5N4+]H,J\%/F+JVU247]C9>XNMNIEBH7PX'*?U MAJ_W[/E'(UM7NHU\8X*O]^U-CH7[G2RCM$]=]@9#N.*Q3':%-=G6?^_I!>]] MK!9!36_USTY_9>Q>?2?N?3T5LN PMB3X -DC3JVAN+35.?G?ZBE47?1!>U7$L'\WR MCLUNM ;@^Z-?5@<+D=^.0"F@AUZ/ MGW"[C4GW]QFK5%DKJFGYQOV/%(68'A4RTBG'WPC]6(-MB.B!4NS'<(A((U6Y MJ]2:/Q,G00>N18_@TUM-6=\P)V-LR%?%,7&4MWLCS-[:I[_CQ^DQT^_DX)*/ MTE+F[]&VV%6Z%*I_5NY85U=B(JNM]2HG48;57J6XDHO"Q+<]W+EI MTHU\E&=J*H_-KZ9%F8--LH:"U![M9CU[<_;K.F"LBQ_7!HN;+=F1;#'9:ZD> M8TMZU/Z]=; VO27GDK#FDLB?OZZNJ@^.>9:1]AK6%A/>/@#6%G;-EFYIAY0;^X0YR=G(?^HV&GY MUW?M,3D2_NS---/$-#S-ZO7K]Q>)R\PXE3%%]N;QIA!O_TIUS]9X*._0(Z/* M:(M4AQJEF:N/\[YCU.[@5C+M/J7Z\2NP9A8EB84'NY03!W#?0W'/B0*3X/+O'G[^Z7P\'"=^/3W7?$Z5RL6A-O<7>U1J-WE MRM5<'F,2@H9HFRNMLTUPOGJX#@*0IL'FFZ%,875HT:$ PL\S9_U>KWW^P#X0 MPB7%WC X'87M8+,"?\T8;INP++4=MDQ\S:-MPSG]6M!3V-[O2V[\>OQ=DZV3]T5)3*=)^1$G-62U^Y8$_DZ)1 M/@1PUU,KT#"%490?H>K"_NS6HV7[N\,)A1WW:'>?[T-!9D.;7)PL1#0DHB$1 M#9E"0Q+[N[N5TI#-5_2Z-8T&LRR0L"5-.&=1 .E'Q21XT,$A5R1@GA94RI=T M)-R%M2$AMZD0PM/A$$(??A!\YFI.,D59YLTFO#RA\$,YK[-$XKSY6/V52IQ7 M6KX1C0EY?&)K'\ MV6S^;,FCFD2?BT..FB[3G75Q\#./+HNEMEB7'Q^[W: 5)L'C.V)AW94OSZ'/ M5D5WQ40F)L;?6W-U)7=[_O;=KI#G^G>KU\[:J9.KZYM45U1Y"B0O509R MW70LO[*^=.F8F)XM0"Y5;F9[ "NU,1+I Y8,?SB_=.OLE[8E@#47$5T98&5B MZRMSL: EKU/) M7$O/_/;)!VU[O>1C[K5O+A%1S( TEEX3*=D*\$F^&WQ&&=C@UDJ?OQ;/7PN) MYNZ SQB#6H$H?Y*.945QS7QHWA#WDZ=!\N&?1*OS.WO1VI>"MA_2VG1;0M]J M+79X8 Y[9V*":@D2S&5H6E\P>I@J;#EU2U54;/)E-.#'T1COL(!ZH^H&UD(N MN7UJ*CWL!M)2.VX^B-1D9U07'!9CPAP M_R14%Y,D'WU9)GVT9$_QAP&=>U2 M?$Y*OU+W/T*MO;SWT5GO+F(6.5AZ'V\E5[W?F#XC%R9SG$Q."T;_-V_K"1>K M\"Z?H:C&;8I-WPCH;UUJRT&0$7U EYA:>.0 M(PPM;^HFSH?>/CSPPFD!M^ 8,+TMM )X2'9_/Q, -2OP+6;DQ!,\(X>6",O2 M#4$S]";\(HT"M__^\91 T'V_ZXBS#0-Z_KV OD5G&%'"-0!(81Q 9E ^&&24 M[(P,B2.,@.$VP5'$:C<)8*$\$82+)@-Q44(IV_N!5^6!!4AF&W:@-^T6+-5" M@=PFR/,:X< FGYDM="7-85[)11W%1PWXGF-B)XZ&4'6M4T MT=YAU76 MQ#33.T9=B?3F['S#L(-HCK>?!D8E?F6G+Z^Z]>?]4;?%](0\P]S3()%/?>_> MW0PR^LFGOZO%BYMB&?-Z)M4]WBIY)B*5[]UUKIH_/$ADXS$!.7 B_LU%#L'' M#OI>_ ;XB+8JU6K!^/!15R13L:@$AND]*H3JE M2W7#L4'D,BP]LH4XAN:05 M: '\8^-\F+O'J #V\!79!MP%E47GI,T_#?\?DM M9G95&98L S-H&J:*A^%1YV!-*(VVI=^P&6XE8*:%5=>%AJI+NJS"Y+!EFVKJ M6L=""4:79<-4J.,F91WBPF>=8,WH /US!1DX^)@P:;MR2V6A[DZ'!VB P,A! M6. S"#J8 UEG##$89E$;*M??:"AZM?C*9 ?3WH5*HP%[Y[+V+2I[^$8,[4MP M9UV5]:S0_<#OC@9'81LTD>!-:_&3/#P =FG(_K/ ZO!8<6BL;F=9^#T,1A> MQ])P[[T>AI07!T0$9H(P@+L)7I)T MW2$9 ;=@]X]Z<'Y4 88S"X 0#F.P.@5@D1^&!W"Q47B*\=%1DD"K-D(BB@]\ M[]Y!@:2"\JP%+\.*$.[>_#P(+A*-$Q9N"T-R BO M%=ULFLSM#L;EZ5G JH!T T, IXTV M\GD0SE&N,O&Z9>L;L'!"5X#_B0?VC?Z"GV2W>#6>H.XT),1RW!7^#*IX)SUZI&OC?__V_HR/A7&6:\E6X!4SZ!H.]. SP#08Y M%8Z./*^4HG;G]^R,',H)R14+I?7.EZP[27R9[C*&2YOD<9GBE>8Y/B.YP>=' MX0/SC@IH=K\#*\B94EV5OPEED$+Y<98-/$(Q$W[K+^\U_"EP]'A.GO_^!4<] MZ=1-)CT?U1G@*0S>H;L*0R,_9!^D^4\$D $@=(9'#R\*5\L7%(*.9;%DTCG. M@3D[;UM;>XY8H?JS5*W&#@]*9;12[-'.RI5:L7IX4*L(^4JY4"Q70;$X+Y5S MY7PI=RU4:[E:$=6-ZEYM&O0FV/)E4:B6?@DWE7+MLBH48?<%X?M]N1AJ4[)' M>_[,>U'+?1 "7CLFG)32S2L]"(3X-<^K*??KYO:L7$OM?JJ84]ARU)00<@J>9'GDYE89"J MK_?QW'Q+0$J H*8<"U6G#;N!,9608AW6Q Z0%^EFL235&.N *$PY>N!%JJ- M5LOH4=?C.MNRIL>1D7]MNSX#/G/!C*8I=5K]__RIESY2 :KP-/B5-Y32V66A MV%4V40'JMG)'_?)-\-7%X]#7I:H7A[][/( M^NEWWL"E@89[7/ 5?!J]A>330#[+O5PT?[V<7Z3WZA;.WW<+-X]/@\=6[>J? MM*6FN^^M=W4C >6VU#$Z!,BFOO[(U4]+^7CG]UZ=?W;2^0]26='*WW\?W)3D M=QXISY\9.4^8H5OMF5+BIYCYG?CP\^3!]1]5Z%',OO.()]4V6Z*Y[7KZN*Y' ME%F%K+%SU?A"7'KGUH[\C;.VG5NZSQ1V;N5+YBXNA?MSI9"&=O;&\W_TZ^&S M][ET?$)2.=I"\YC.(LGV3]5NY5U/>Y$<=G##.0JR8$I->GT:5)/WN50\FL=3PU?;T6PX:=/IQ39"IM/L*_8D?IZU%(5A<$S<+8) M];5N:J*8@5LYFB)!?'CML]7N-/G'[#2U\SN=IP+#(H1@WBH@7+UZNGGDJL(Y M#!V/PXFFE^V\OOK#&[?O0R[N8:NXV1KKF,VV\H;EHTM+>ALGM3R MDZ(^#4ZR/V_/DC>G:C>Y!%L:JT&'<_"\CF$&M*Z"%G-3HNQT2O11Q3CF7OOI M[JX]&]^^M7]^FW@,HU?E-)ZO9Q(<=VV0R M&JZZ5V =$Q9 WF_XK#$J>Z$KN3:&'_!0=X^ZZD7V4FZV?_QRI/4(_>/[""^/ MAWJ'UK4U9.$-P7#K25IZ^]8^ R7G =D%*=WEU0C*+BT)I<79_4BWC\JMX4C' MF$=FV2--GL2H.\,?=ZIOL)3L.PXSG9S4Q?-='"4=XB@E70:UY-JP+$]C474' M"Z3P[!!#M\XHTIP_!\H*LXJOH-48)B@QDMDOV:QM#==6\ZL^UAX&5 MNY/9"@3\Z;LM,UOXK,$>OOS5,8V&:@L\/%ZPI=>-\)X9H+7&0UZLLJ<7O#$, MGZ>+U+^";0.+&@/4-&B4RQ2R_6BLWX*K<4EP-3]R*PO([]-N)0;*9W0I[[B4 M45'C= 'M8.JEI%.SZ^!^P*7LRIV,RBJGR679JYB,)1/+L->MD*P_Z$:FRSFG MJ7[@'A6EYCE[B@4"NU?3[8NEUFN MJ;;NL^N]GFD2^])VJ(08.UW*TG\.%U+\EKV:9"^SM[4;Q^MO/KA M.0ZKO('BW+PW M@_!F2NX:*./IS'V]:]1*Y=_UO3K_W*3S'URWBK]/KI.7R9^9=>2N ?%BCU?7 M4OKB\J7>^/#SW/??Z< M+0RZ["43Y:Z-AX2" +3S>4[S[O1/R=)+Q'<_2V\C.5(3&@U/-C,#"5C: 1 3 MLQF@'[-#6J.;>;/#YM!U+._#7/UU+)F])EZ^%K3?W<+U]\0>9Z\EXIGM2SF8 M>^V[FWF7B&]AYMV[LZ_F)]CB C')PQ3B]#0=2V8SVQAAN?KS&SFTI5/^WGUH MJ\U=2^=^/*1+]]6ZV(IRUT)$07Q#,-QV@B9N8=[=NE*"IM.YDK(42Z?!IB)G:3>D5SYP9EKV5\= M4?GY\[R8/HTRUS:88S !R]^(A4V("X0V35(;T@FV M^T)&;F'Y_,$TR(OO#=N/4M:BU42K63^JO)&REL1B_OJ#\?M<^=[[O?F4M<34 M_(%EXYO]C .Y53[_>6ZE2X:VEHR#N<3TQ-+>MT0&_3W;D.-Q_NX[FI2R5HW; M9NZ'G;Y(U]=[/=-$]:7-3YE8//W>S) MNYAPQEHZ5SW-)VZ3)V9XOK2 M1BPQ%JT^B%]=W30R;",W,R:T+VT32X&@ELDN8VM8 M^=6.N4SEIK/.T1XYXZ:3 5#H9RR23NYNQMLGLM' VVFBV MVL)[74T*VH16W1/LJ NO*GZ<2*OZQ.Y[WH'[TF \_S1XO3JM_+CLL7R3K2+& M_XT.?T/!_^_8Z#P[$T^?!A7M^;&31H',=GCT"X?6:'6KWF$L#^^\WZCWKE M\:+<6 (75M49)VZ1>WN[6(7^[#6V,0VN_&A-KO3WGD:J$I* M9)7RQ>L_']E(=\7W(YXG]6+?ZX+Y9K M0O%AJ('FYMI"S]73E+Y4=87AU F^Q?UM8;O*S97TPP-)E@U3D729 0NS6T*N MFA=J1@>0,9M.QP2W&?I_U;\#'!$XD@ N_^UV2(\ADY%;@)=(]E2K!HKF8J%1!1G<] *VZ1VS$B7%=62-<-RD###$XS&!NHKV8(ARPX\U+ 9 MS]ZJ2QHM%,9GMJ" -"\ !?<"ZIE.4R)A3LW"RW)@JDDS9&0 M TB:YDULF(<'MBGI%I?GPBLQ\4E:S%#7,\'IP$/ TCH6**\Q7,F'2=J=;&.%:)D44 M3U$N>$;3B'A\?A0^,.^HO@FU?@=6D#.ENBI_$\K 0/EQE@T\0C$;?NLO[S7\ M*1!S/!'GOW_!44\Z=9-)ST<<-[\*';JK,+SQ0_8I*?^)0"Z@NIWAT<.+PM7R MZ]Y)C>E-(6E/V OL,9 Q).DICE'2[E[1LW9XD#@6;B0=;A)I'_(2,?/-(H[@ M6)8?'JE+6M]2B7\$)!,HJ:+Z(90FLQS-ID<,W[>WQT>[UV()"!NU%D@#JLY- M,WC)J!E(J@Y<4T75#*#AQ9%,Y,4FZQBFC1K;.3P-0QS] (X+C]D\RQNT.Z?C M\^2I8QH@:>1TW0'0NAL:\? AKPB<04'Z#/)=//'"TPF%X20%'D..8%B!V$1 M-TR" Q!!X L6R!M=AM(/L^ '(T9/]E00.^@'?(K+)ZZ\-8X5AP>%8;3(A=#B MW$>+_!!:W 5H$;B\79F-'C!@3G/ZH5@."'7>L5X="W0M#>!L1@]%N&F(*FF6 M 4*:X6@*"&>T.]ATD]%D)&7B:<^4A6A0/!34L_'8QD0H6,RD]U0=DX=@5*99 MK >3,A]J?!A!+3ZB#CNX.8\Z3 1#%WHMD(9,_!"&"L+'MM1'D%08?*EXV ;0 MWP,-Y4@SC&<<,'C)PQ4$6I7;A-I,TO$AP"D;UW%KJEVD+E4&*@*@'FSF&OYI M1D2KD23T_3QT(5L2H,YIT.$A487Q)TAR@*/-L!,959/N!RHA1S M81L6$*-%&:#_:&I;M6FZV.'!5 (BK(I^''N' M=@L5%E"W!5: )IEH#^,HM4 MNH9C@W:'M3>(S* DB8.K>M?0D/BIUC/(\>'+/3P(+=B"@W\&0J_U!IM#DZO+XP':J.A9\,UV$:>A-& M!MD:5HSR+!P)J-"&2<1.AATU'(VFEC@A;(!2BK\JS))-M1YP+B)KU2-1R,$$ M"DXBE(WC;$S@U/6[ Z,D2%\53P07D"U&&N[A 3RMVEJ #G=P(<(YG\J[:]+6 MW7D[ODG413*Z07Y#,AY,#%-:$$6(X"/F-.&"9)\0 MT!P7 HC3>2Q.)?KS&P"9#H@8':[#T27 6+P'Q"ZF6_Q3P/P"]/-=E( YB (N MYT,61NP/<8!3BW'6Y@)HQ-=V9797U(@UF-S=7J/94RP)N M7-+E8Z"& J^G!.3!!!SEDL%GE]J&+(4NL?TB]"028MVG@4( AW%MH)K4\SD5 M40O\PQT>1KT!^2:1)4(/D@9?Q^'!I:&AR ""29OHD-$#$0DM1/@R?TCX?'GU MQ7L E^R7(_)6YQEY)[U<573AK.7J,*X&#F_>N'6!!!^RX14^BAKF8G4&9/58 M*.G$H&*3EN3R1DZQW=_/5""/,)8_^]"9J;H_/]>W8.'P=2K^;V!Y(%D OU#= M8-XQJ^N>P.$?@&2'!ZK%$0-8,,)<&,=0:@$1L:T"\N@.%IE@#IE8A3H''=W0 MC";"@7!?S7$H0<] T]"1KP++S0'TZ"'W,&G$\$0>A!H *Q]) ->K,+L$4S-8 M>4M2-1B,C^AC@:_ZMM1F"T5+$EH:KL JVHQ28-'+*?3T4@,B G6,XH5*-R" MO."0D"_TF*;I:$GHF(;BR*ZFW.&*R.&!)M6Q!)K"Q\%5@_RM/[,^/M]5D9)\ MKA1O_JH4;KX<"Q58CZ.K+XXGE>L&#*."8-Z!T73$I*'#B@FZ!./!:F&_*'Z[ M*C=)X^YR_I_4[GP#"1>YF.R90O!@ZXSIM KX!UYHXC1U9@,6QD"XM=">@XOH MJB#2:; " T4R,I#XXB+>-4>GMFET]^Q ,VJK=#F@CJA'4A.? MQ GJ3'+@Z!E(GO($I\N>8,A>HW\>'7*ZK?7A=GN,U#_0EAHJ96D@1M!(9!3Z#!VD$]#%1: MCD=?Z!WOR<.# L.LIM'G -<$'Q\(6T)XWS ,)0R7WC+#W%+V]NL* ].V0%3F M\, G.B[R>F9R_@ZF@#*R!8 &PVG T%=PF6@_$$@GXY$O%"?G:'X\C"4CYJL- M)*=:_\A%:E):.'V +SE^ 0+#'5E ^-!K)IA2#X8'5 >%Q_*OA B;1Q)=Y3V& M*INKVN' EM1@J.4!QP9U$NZ92#G^B>/6^Z@'@;[7 96]#X)2'4>7Y.< [:V6 MVNF0$2 @'$ Q4-G#G]DKM[&@.UB#BP)-S1)TQM"4"'J>%P$$Y)@T/?2XF22! M@;*'% Y(4]_3#!7#E6=0[?8)/\P ^V:N"03D$/S;5BV&1)W;@H'#H)68:_[P MNT2V9C)I:'CB%*&$\.V2\ "J0H# E&'><.98*G(,0.&CNOM9^'R6./LB%,JY MPX,F TVSCT?CL1&!N(@P3,+9J\P\3S8MQG*M2[0QF1NA(FJZ@YOSA"EDTC+/ MDS,U'8?$1_+UP.$],YL^'Q3+J6X&9CH&14QYHBSRR2 W9QOE= T#X0F01V\:* 6 MD(\"=*]E@%S:<'!Z1Y=3RTLFS?.XBR#?.)MIH# X0M "+[ YI]7V>4-'2_\YA^R8NKX((;BC,MM<-Y!Y)UD]F2 MBC8CX NR&Y__F36/,=Z!U0WC.284CVYH+@K ^<(=_TW-J,-2,+:/C#=#2\-Y M6TQSC2Z<_AN'!XX5F+PQ"%:G= -$+1@%C6$LYJ%-CWFH0FC)=6XZ ]]8$X2U M<@VV0R$'](A)H_2 Q."3A.(\^I&6$9PX*, :W-GPXFT,HI!D-R0OT,=QUW48 ML*'R^)^AESCS=(!STH28A '+:TD=[HII8X5IN%-:<9>?!@[O!@*Y%BZ$#_Q6 M"H(WX!!T "%^7?YB! 4HFHR67KY:F=&@+:;"D""-8\HC &?E7-T26=DOC@6 M*CKGU1A)$4,=D07O>"8W=TB%$\S U!:Z0"!J9@\N&=T)<)2>8\+SB89 @ L" M,APJ""J28!IPA;9[27 33181N!WICH_$2: ZA'Z U(RQ?9#%%]51XB[*[G,[0!<@:A&AHBHF':&9P7TG0X0!#O M@6$AMIKH+6!N:#:<@O>M%Y>(/ L&[N%1HXE?;>!G/ PE?&TD+@'!Z^VM!OQ' M):^$4ZT40$,.25^Y%PZ50-"/[\]W].N:! *6HMDX&" M!H^T.,&IJJ_>G\6Q5H))>F2HN>#QED'!2-)T_#BMZA%DS+DY'RQL @N2Q@$> MVAP>QEM+)HG+ R]!X5OQVJYXYAZIC0P5)>Q_)=/I6"*3HA'_=9(08^)IF@1, MC?GI1T-S O>=-FEBXJ36A%DSR=-8^C3-9_6;WG YHDG,DM>+MB:OP=TW1I&/ M(T(/XY/_=2K&,F+2G2"3C)V<9F)!7$.;BE C8_T75KE,QD?FF;Y%TCLTRJCB MKV=C8BJ+F2'\_3=O!78X!!)3ZZ:,RB1H#C$I&M/@VB2WPJ,YC_Z@_?@R#48: M<'LGUWW@4MH.Z2FH(5C<-AKHMMR6RHD,[,(U0I+F.FX?^0CL6CN5F)'B+7X# M#DNBW%>2Y M:'VM4D%#.A9W(F^GSFQ0C9]Y>LY0ZS/.Y$:^]":Q>%X8=8UV3+F%Q-I[=#CN M%H@)TNY03!MYG P,'C-L;SR,0>WCRD,UI52]CAQ':)@,J]L),(O9Q,V[,WIQ M:]Q Q38]]KLX5(%[ KRIG W2:AU93LQ$8O'7=DND8V= M)DXH)X][<+6^)[Y2%O?P5(%L-TEV3% .S+_$4Y (,SRJ%%YW.Y?@ &\+=^[; M5#5]FP V L[YU>]K]<51%=7N] &=WUT*^R>?U;]$,1E+ISSRE 3],#U,G\CD3-9WG37)675X M$*2OT9@-S>AQFS#S8[\HEHRB!X$A\B_$T@;7Z^/"@%JHCQOVK\*[M9P.$)G:Q8FAY=1 AY% ^WG!T *9T8Q#"JXJB M"\HZ/88)^?S\MXEL1KCU3DNV^G?% X+#@QP"/PG4/%<\(J/[)&K;9S^^:_S(H^V[SH/@&QT&)C[))'Q[(\= M4T6?(&S#4'BLP22J&ZX8$H0QF*RA$1U4F&M#0Q,<+RQI@3;61]4RQG6;PP/W M;ZZJP5,FEF+45!YTH :I"$,KVB+PB/#AW:2O1'PW(GU[?=6+2Y!C-%#UX&2( M!I*:&W>=,K%34':'%5R7'/$,*6XB(J._;S3BM9QT-\70RR.-:,R> !ZG,6X) MGXC&[/-5KX#&-#PX&:0 ,!H8@\%NJ2_NP^&2']G@ #5:S$$CA4TO7P MH%+7W++'\%+>S_?S\LFI[0L#X3=RW7WTAE=-$H+:5)PJ<"U$D)HFX^4!T!Z" MZ73P)%0$LJC<:1V^'I M\*!*+9YRIBGIO(SYMM&,Z&87H _AEQ2Z;:]D).:2 M\]KNZ.HQL-9"7]#49W)7&QZY\;SAAI]CRJM(N,E807<)(%5>@?L81MO!=):7 MX#ZAMTPL")PW> $K+ D7F]QN)@;K^QQKCOL/'@$=^X1'JFD)=1@)FJL(&N"1 M.6P3&LBYALP04Z>:%UNI9$30.S]ERBG\@E'<*@4MSB)ZM)N;XS;FAU(1M,/: MW7V^=G]7%'+E@I"[N\N5+XHWO$GUUAFUP.F'QZ0@I/(\$Y5DQN!>%71 M"M7+*[\L&HG%Y&+'XL"AKJ(X&Z]@G?.M49\G=EKTGSP\"!XM!3U9>(=KWBO+ M$G!VJG;BU*GB$+ 4:N7EMM+"50"7= L5,F V1EN5ARHJ36YB$MK>6EIH<)MS)L"8,0;,19BKD%O27^1PUEZ 7OE1\'W2GWJ/#,?3Z.C2:B[%86N M\YI66%^4SI?L@Z;,#]^W$# _CQH7S$R &QK+=5%X_<%H*Y:[!-X1;J_,N.=COD04GZB#&1XN%O^3%*%E MR*&F=VZ B=]Q2&K"($T\0-B%E\3O/71X0 4Q,<63'#TH*3:Q&Z,]?,%>/T O M>"5P&T22U@YNCO2$&0#'P0A"V$7/F4;'P&'<L8B@Q)6W$4).OT"7)O5X2PG4>QR9 MFGRQ=D4+-1S]NJ?PN]?(^5D"X2'D.$-T<73NIN?5+#EH M$B1*76Q;Y2;FN]R=@(?*V#&O-#IW^6(HHF%Z"1U4C,Z%?@$@B#?^E'27R5$% M92R>8ELA=(D%;(B#HJ>'NY;Q$$I:V%V7<80J& M>&P@U?NAC[&@L=XD>',L;-OLQT>Z_);LF&%.[M%6H^YV(O:4-_@W%-D9X[$4 M,:\AE1]49QJIS#&\X1[PU&=U^VG'H@ M$:"TB(T@L%0NEPU0E(V%1IT&D\(<((F?]O3F]ALLF;;@6)"R^BQ+G8I=8N)Z_YLZ/SFA1MPA=S]!'NAR!0:U8U$:0@B?H9 ME5W<1)U1>>,A,Z+)*%HNW/88O UM% M4F\?PZ0F)+;C2]:1O64'-U?"WGB^(8)(Y!"E=\M5!^34+>K]'209UA?R+0/? M"]O B1F$;"&>V3FD_._I64X&E" F*!P#-!HCM/ !#(4(30TE^D2A,*& H?DG MF!!:],D+K G"B19>:&2D$?+'*]#&E@Y^8+A M%Z.'M-ASQ'@V2^),B&.!74.R7"+M&MS\R&=-ZH4,&UXXUM; Q6:1DG*\QM57U$UQFZ M8S?$>=]%VCW97*VE6H<'#Z4BC&8Z,H\C&/8J2V2 TOI'W*>)BK6JJ)+9#\7< M7 (70,+MAA2%NA&0S6OF^R5=CF&T@^T:Q R-&H0-![98;N>F<,0/NF5=O;\E M44%GR>UN)GB.ZY[;R6@<;O?K*I=)_4A&J1\K2/U(1:D?$P ^2OU8>(]\,%7Y MWR=)>HK'3S]Y>RW9K'UXD!1^8.PA!MQ1Y!M0PQ_4[)7_75 M63,LRHS+U9$D MWE ?%!#$K>=MZY@4<>@Y-Y<#_BQYAD6K+6D:0P,TA6GQ-L"83^):&-$"H@![ M=!U "#8P#++*H!V]4#VZXJX +Q=%Y7T50A&A?E2J&H3YH]?7?8!"ON M'/^/ M8J?[LKDQ6B/&1VA-B@I,@"#&I2Y0XF6F(&F)",F.;FZ1!HQ%:JW,L1[E;)^S M3(.*()8Q HY=W!P5'0EY@K'?JP\#?M:%EX7(8Q_YESS2=CAFUFLXK@1P(X?A MIN/#C? YQ+% 02N^&=!1Y@R^E@+!(YR_T>M93'(*%:H78"!,#-Y%LJ:\ "F>R0N%6A M2BNFX#7%Y;^?^RD;[N_'PIF$I>$H<)I,*L'B8C,''AGT\,#[$X=A4:),%=6 3KZ/ %Q=$ZA61P(N#_3AW(%@&4& ^/ M(H2QJ>:B2H)P*">I8UB6ZO6ZIYH?09)R6[4P,H-YU5R]8HRNJ$QI,VX:$(]9 MA-?:H77X+UO4B=MKM=:A\B4VAOQ1-TF;ITDC 1%L.$2M3RU"K.-PPA!F?ZE8 MPTAM4&=KBG'QO)IC!XOX2,8S"GBA\!%45HK[7X7/ZAL7#W(->++S>IH1!I4%S.$"AEG!?%2YR MN5O>=;B8%YH.7 T*/5&NU"YN;A&A-L^CY2ABK>31H7R8#@7,^\X#M4BPW>W- M4;U>%%>(S(V6J)J;';F)H41HW&Q.K,J+7XW0W:#.ED?:_8A"IL2(;TRMOC7V M1FRQ5?Y1)&R&:R,5N396X-I(1ZZ-R+6Q!G.CZ)L;;W-WM<.#4HE,W&+BFU"I M71;OA%+YO')WDZN5*N4]/IB]9KWCMYX8,3*+Q\(U:!8:-R0RI*M1=;,=W1Q: M$)]UHX>:EAZ(,C'>EX52.#JNQ*31G7>"._?+6C@P@>Y*2#WT/G4-K8MYTFAL MZ&CP$"R[0?WI]'Z@.X>'HCHBWD2J[5;"\!HW2%P,#+] &5:H<%/>H6>XQ! 2 MPX3E\(+*)J6]@E"F:MC2V_+S;7@X"K<9A(H?2";U)_>22LBDV.=I+-90,35* M-*!*(?Q!D *=2!7=U.:^"760_YHF-HU'>^X1U:+LZX@2[>#FQ@E.:H3@)(Z%>]UD M3=7B>6Y52>-I-&Y < BL$(+N>2ZH*Z5%(MJ.;JYLZ%O5R2ZZN*41.CT:&G@L M%%A#HGJ[]^AIKC(=^R\'B!PA[6YN#I%V3[>VU_&XH?#?"U=W<7-G NOWQRH47F"6;:H=W'0E6 MO[T5!E8/:DGQ6%P)>.U8@0I):)FL\;]/[#4I'HG'+;N]R@UPRWKRL_3E2$S! M__\2TY\5][.01P!IA")).Z:J8WX MB/THO9=/^%__$.0_D#83/SQL)E8/6Q6 M&:_@*";3\85@4?BC@5&,B\>E5K;6D8^BT\.OL[AJT72RH*3.A8,@. M1MG_YT]EP0A9U?QE!%DK@JRJW&)M*8(KA*M\[CJ"JQ7!55[29+?H 5_PM:H_ MUR4K(F$$:H7B>01J*P*U @;IJ!&D38:TZ]Q9!&DK@K1KJKL])L(@JKAP^&4R'&Y%&=*1N.FC^'$\30ZM_?7[K7_+_SD\0 A1 M!$SH0.#85_?MC 37=)3@NH($UY,HP76O0A/6R_L7*3;M3(F&H,8=7K.FM)6D.H]WGS0X(W_D2,UTERL&41C2@Y=LLP80/* MOG+(O0F(>9_&LRE- C:.7__O4V+A,UUI$$CU9ZE:C0FEG4_9INAE'W\U/GJG26;<3AW<6^+6KS"U[B5N$^BLE(I)-JHE3A,$%4%, M\?)1^VQ8BL!DKR]@2Y<5P<5&EW76__KFFK8SK!C5>O7OOZR_7%\',_0FYN8U ML?ZR]-^_U&$5/0*K32^KIMH:>QNR%EC6[FF_Z(^C$L(QON\I)<-C0_HQ'=#N M[97VQE<_5DP=7L;"F8Z)'ZL,&Y)C(S'J:.^6; H=082IT;(\!?76#Y,>QQHA M^'$,XK;$O?C1SJ:3;VY[9NNK<"V!QA+YGM[O>\HLZWM:I7=HTL[F - U R3( M6X;2IP\MNZW!A_\/4$L! A0#% @ %#0.5_>1MZZ>#P /K !$ M ( ! &1Q=W,M,C R,S V,S N>'-D4$L! A0#% @ %#0. M5SS<@%R^% XOX !4 ( !S0\ &1Q=W,M,C R,S V,S!? M8V%L+GAM;%!+ 0(4 Q0 ( !0T#E>I!-D<$B (?& 0 5 M " ;XD !D<7=S+3(P,C,P-C,P7V1E9BYX;6Q02P$"% ,4 " 4- Y7 MA+FYS,-3 "?KP0 %0 @ $#10 9'%W&UL4$L! A0#% @ %#0.5W^9%X."/ -< # !4 M ( !^9@ &1Q=W,M,C R,S V,S!?<')E+GAM;%!+ 0(4 Q0 ( !0T#E>* MC_Y#40@ /5$ * " :[5 !E>#,Q+3$N:'1M4$L! A0# M% @ %#0.5^?/XK&B!0 .B( H ( !)]X &5X,S(M M,2YH=&U02P$"% ,4 " 4- Y7])2?M!@1 0#-,@T # H@ 'QXP 9F]R;3$P+7$N:'1M4$L%!@ ( @ ]0$ #/U 0 $! end